PROGRESS
IN
Nucleic Acid Research and Molecular Biology Volume 47
This Page Intentionally Left Blank
PROGRESS IN
...
28 downloads
1173 Views
14MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
PROGRESS
IN
Nucleic Acid Research and Molecular Biology Volume 47
This Page Intentionally Left Blank
PROGRESS IN
Nucleic Acid Research and Molecular Biology edited by
WALDO E. COHN Biology Division
KlVlE MOLDAVE Department of Biology
Oak Ridge National Laboratory Oak Ridge, Tennessee
University of California Santa Crrrz, California
Volume 47
ACADEMIC PRESS, INC. Harcourt Brace ]manmich, Publishers Son Diego New York Boston London Sydney Tokyo Toronto
This book is printed on acid-free paper. @ Copyright 0 1991 BY ACADEMIC PRESS, INC. All Rights Reserved. No part of this publication may be reproduced or transmitted in any form or by any means. electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher.
Academic Press, Inc. San Diego, California 92101 United Kingdom Edition published by ACADEMIC PRESS LIMITED 24-28 Oval Road, London NWl 7DX
Library of Congress Catalog Card Number:
ISBN 0-12-540041-1 (alk. paper)
PRINTED IN THE UNITED STATES OF AMERICA 91
92 93 94
9 8 7 6 5 4 3 2 I
63- 15847
Contents
ABBREVIATIONS AND SYMBOLS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ix
SOME ARTICLES PLANNED FOR FUTUREVOLUMES . . . . . . . . . . . . . . . . . . . . . . .
xi
Molecular Structure and Transcriptional Regulation of the Salivary Gland Proline-Rich Protein Multigene Families. . . . . 1 D o n M. Carlson, Jie Zhou and Paul S. Wright
I. 11. 111.
IV. V. VI.
Background .......................... PRP mRNAs 11-free Translation Analysis . . PRP cDNAs and Amino-acid Sequences . . . . . . . . . Sequence and Structural Analyses of PRP Genes . . . . . . . . . . . . . . . . . Regulation of Expression of PRP Genes . . . . . . . . . . . . . . . . . . . . . . . . . Functional Aspects of PRPs ................
...............................
3 6 9 10 16
18 20 21
Recognition of tRNAs by Aminoacyl-tRNA Synthetases . . . . .23 LaDonne H. Schulman I. Recognition versus Identity . . . , . . . . . . . . . . . . . . 11. Assays of the Amino-acid-acceptor Specificity of 111. Role of the Anticodon . . . . . . . . . . . . . . . . . . . . . . IV. Role of the Acceptor Stem and the “Discriminat at Position 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ............... V. Other Recognition Profiles VI . Role of Modified Bases . . . . . . . . . . . . . . . . . . . . . . . VII . The Complex of E. coli Glutamine tRNA and Glut VIII. tRNA Binding Domains of Other Synthetases . . . ...................... IX . Concluding Remarks References ...........................
Ribosome Biogenesis in Yeast.
24 25 29
44 58 64 66 72 81 82
. . . . 89
H. A. Rau6 and R. J. Planta I. Transcription of Ribosomal-RNA Genes . . . . . . . . . . . . . . . . . . . . . . . . . . 11. Expression of Ribosomal-protein Genes . . . . . . . . . . . . . . . . . . . . . . . . . V
91 103
CONTENTS
vi
111.
Processing and Assembly of Ribosomal Constituents . . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Structural Elements in RNA
111 124
. . . . . 131
Michael Chastain and Ignacio Tinoco. Jr. I . Secondary Structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
132
111. Tertiary Interactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IV. Predicting Tertiary Interactions . . . . V. Three-dimensional Structure . . . . . . VI . Determining RNA Structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . VII . Protein-RNA Interactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ............... VIII . RNA-RNA Interactions . . . . . . . . . . . . . . . . . . . . . IX . RNA-DNA Interactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
150
I1 . Predicting Secondary Structure . .
161 167 169 170 171
Nuclear RNA-binding Proteins . . . . . 179 Jack D . Keene and Charles C . Query
. . . . . . . . . . . . . . . . . . 180
.
RRM Family of Proteins
.......
. . . . . . . 202
Amplification of DNA Sequences in Mammalian Cells . . . . . 203 Joyce L . Hamlin. Tzeng-Horng Leu. James P. Vaughn. Chi Ma and Pieter A . Dijkwel I . Historical Development of the Amplification Field . . . . . . . . . . . . . . . . I1. Occurrence of Amplified DNA Sequences . . . . . . . . . . . . . . . . . . . . . . . 111. Properties of Amplified DNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IV. Possible Mechanisms and Ways to Discriminate among Them . . . . . . V. Usefulness of Cell Lines Bearing Amplified Genes . . . . . . . . . . . . . . . . VI . Conclusions and Future Directions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
205 206 207 218 228 232 232
CONTENTS
vii
Molecular-Biology Approaches to Genetic Defects of the Mammalian Nervous System . . . . . 241 J. Gregor Sutcliffe and Gabriel H. Travis I.
Neural Mutants . . . . . . . . . . . . . . .
11. The rds Gene . . . . . . . . . . 111. Secretogranin 111 . . . . . . . . . . . . .
IV. V. VI.
Making Mutants . . . . . . . . Getting All of the Genes Reprise . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lens Proteins and Their Genes.
257
. . . .259
Hans Bloemendal and Wilfried W. de Jong I. The Lens and Its Proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11. The Lens and Its DNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111. Concluding Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
References
..................................................
INDEX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
259 269 277 277
283
This Page Intentionally Left Blank
Abbreviations and Symbols All contributors to this Series are asked to use the terminology (abbreviations and symbols) recommended by the IUPAC-IUB Commission on Biochemical Nomenclature (CBN) and approved by IUPAC and IUB, and the Editors endeavor to assure conformity. These Recommendations have been published in many journals (I. 2) and compendia (3)and are available in reprint form from the Office of Biochemical Nomenclature (OBN); they are therefore considered to be generally known. Those used in nucleic acid work, originally set out in section 5 of the first Recommendations (I)and subsequently revised and expanded (2.3),are given in condensed form in the frontmatter of Volumes 9-33 of this series. A recent expansion of the one-letter system ( 5 ) follows. SINGLE-LETTER CODE Symbol
RECOMMENDATIONS.
Meaning
(5)
Origin of symbol Guanosine Adenosine (ribo)Thymidine (Uridine) Cytidine
R
G or A
Y
T(U) or C A or C G or T(U) G or C A or T(U)
M
K S W‘ H B
puRine pyrimidine aMino Keto Strong interaction (3 H-bonds) Weak interaction (2 H-bonds)
or C or T(U)
not not not not
G; H follows G in the alphabet A; B follows A T (not U); V follows U C; D follows C
D
A G G G
N
G or A or T(U) or C
aNy nucleoside (i.e., unspecified)
Q
Q
Queuosine (nucleoside of queuine)
V
or T(U) or C or C or A or A or T(U)
‘Modified from Proc. Natl. Acad. Ski. US.A. 83, 4 (1986). *W has been used for wyosine, the nucleoside of “base Y” (wye). ‘D has been used for dihydrouridine (hU or H, Urd). Enzymes
In naming enzymes, the 1984 recommendations of the IUB Commission on Biochemical Nomenclature ( 4 ) are followed as far as possible. At first mention, each enzyme is described either by its systematic name or by the equation for the reaction catalyzed or by the recommended trivial name, followed by its EC number in parentheses. Thereafter, a trivial name may be used. Enzyme names are not to be abbreviated except when the substrate has an approved abbreviation (e.g.. ATPase, but not LDH, is acceptable).
ix
ABBREVIATIONS AND SYMBOLS
X
REFERENCES 1. JBC241,527 (1966); &hem 5,1445 (1966); MlO1, I (1966); ABB 115. I (I%), 129,l (1%9); and e1smhere.t General. 2. EJB I S , 203 (1970); JBC 245, 5171 (1970);JMB 55, 299 (1971); and e1sewhere.t 3. “Handbook of Biochemistry” (G. Fasman, ed.), 3rd ed. Chemical Rubber Co., Cleveland. Ohio, 1970, 1975, Nucleic Acids, Vols. I and 11, pp. 3-59. Nucleic acids. 4. “Enzyme Nomenclature” [Recommendations (1984) of the Nomenclature Committee of the IUB]. Academic Press, New York, 1984. 5. /LIB 150, I (1985). Nucleic Acids (One-letter system).t Abbreviations of Journal Titles
Journals
Abbreviations used
Annu. Rev. Biochem. Annu. Rev. Genet. Arch. Biochem. Biophys. Biochem. Biophys. Res. Commun. Biochemistry Biochem. J. Biochim. Biophys. Acta Cold Spring Harbor Cold Spring Harbor Lab Cold Spring Harbor Symp. Quant. Biol. Eur. J. Biochem. Fed. Proc. Hoppe-Scyler’s Z. Physiol. Chem. J. Amer. Chem. Soc J. Bactcriol. J. Biol. Chem. J. Chem. Soc. J. Mol. Biol. J. Nat. Cancer Inst. Mol. Cell. Biol. Mol. Cell. Biochem. Mol. Gen. Genet. Nature, New Biology Nucleic Acid Research Proc Natl. Acad. Sci. U.S.A. Proc SOc Exp. Biol. Mcd. Progr. Nucl. Acid. Res. Mol. Bid.
ARB ARGen ABB BBRC Bchem BJ BBA CSH CSHLab CSHSQB EJB FP ZpChem JACS J. Bact. JBC JCS JMB JNCl MCBiol MCBchem MGG
Nature NB NARes PNAS PSEBM This Series
tbprints available from the Office of Biochemical Nomenclature (W. E. Cohn, Director).
Some Articles Planned for Future Volumes
Phosphotransfer Reactions of Plant Virus Satellite RNAs
GEORGEBRUENING Positive and Negative Regulation of Gene Expression by Steroid Agonists and Antagonists ANDREW B. CATO, H. PONTA AND P. HERRLICH
c.
Regulation of Gene Expression in Trypanosomes
CHRISTINE CLAYTON Oligonucleotides as Antisense Inhibitors of Gene Expression JACK
s. COHEN AND M.
GHOSH
The DNA Binding Domain of the Zn(ll)-containing Transcription Factors JOSEPH
E. COLMAN AND T.
PAN
Specific Hormonal and Neoplastic Transcriptional Control of the Alpha 2u Globulin Gene Family
PHILIPFEIGELSON Cellular Transcriptional Factors Involved in the Regulation of HIV Gene Expression
RICHARDGAYNORAND C. MUCHARDT Correlation between tRNA Structure and Efficient Aminoocylation
RICHARD GIEGE, C. FLORENTZ AND J. PUGLISI snRNA Genes: Tronscription by RNA Polymerase II and RNA Polymerase 111
NOURIAHERNANDEZ AND S. LOBO Regulation of mRNA Stability in Yeast ALLAN JACOBSON Recombination Enzymes from E. coli and S. cerevisiae
RICHARD KOLODNER Cell Delivery and Mechanisms of Action of Antisense Oligonucleotides
BERNARDLEBLEU,J. P. LEONETTIAND G . DEGLSO Signal-tronsducing G Proteins: Basic and Clinical Implications
MICHAEL A. LEVINE xi
SOME ARTICLES PLANNED FOR FUTURE VOLUMES
xii Synthesis of Ribosomes
LASE LINDAHL AND J. M . ZENCEL Enzymes of DNA Repair
STUARTLINN RNA Replication of Plant Viruses Comprising an RNA Genome
ANNE-LISEHAENNI, R. GARCOURI-BOUZIDAND C. DAVID Nitrogen Regulation in Bacteria and Yeast
BORIS MACASANIK Alkylation Damage Repair Genes: Molecular Cloning and Regulation of Expression SANKAR MITRA An Analysis of lntron Splicing in Monocot Plants RALPH SINIBALDIAND I. METTLER trp Repressor, A Ligand-activated Regulatory Protein
RONALDL. SOMMERVILLE lmmunochemical Analyses of Nucleic Acids
DAVIDSTOLLAR The Structure and Expressions of the Insulin-like Growth-factor Gene LYDIAVILLA-KOMAROFF AND K. M. ROSEN
Molecular Structure and Transcriptional Regulation of the Salivary Gland Proline-Rich Protein M uItigene FamiIies DON M. CARL SON,^ ZHOU~ AND PAUL S. WRIGHT~ JIE
Department of Biochemistry and Biophysics University of California-Davis Davis, California 95616
I. Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11. PRP mRNAs and Cell-free Translation Analysis ........ 111. PRP cDNAs and Amino-acid Sequences ............................ IV. Sequence and Structural Analyses of PRP Genes V. Regulation of Expression of PRP Genes ............................ VI. Functional Aspects of PRPs .........
16 18
...........
21
3 6 9
The proline-rich proteins (PRPs) in mammalian salivary glands are encoded by tissue-specific multigene families whose members have diverged with respect to structure and regulation of expression. A common evolutionary origin of the P R P genes is evident from the extensive conservation of 5’untranslated regions, coding sequences, and intronlexon organizations. The 42-nucleotide repeat unit CCA CCA CCA CCA GGA GGC CCA CAG CCG AGA CCC CCT CAA GGC has been proposed (1) as the ancestral unit, multiples of three bases probably being recruited into, or deleted from, this ancestral sequence during gene duplication. Gene conversion possibly was the mechanism of homogenization of the divergence of the internal repeats. Two nonallelic mouse P R P genes ( M P 2 and M 1 4 ) have essentially identical sequences, with two major differences (2). M P 2 has 13tandemly arranged 42-nucleotide repeats, whereas M 1 4 has 17 repeats. M 1 4 has an insertion by transposition of a two-kilobase member of the long, interspersed elements of repeated mouse DNA (LINE family) into intron I. The 5’-untranslated se-
* To whom correspondence may be addressed. Present address: Neurological Sciences Institute, Good Samaritan Hospital and Medical Center, Portland, Oregon 97209. Present address: Merrell Dow Pharmaceuticals. Inc., Cincinnati, Ohio 45215. 2
1 Progress i i i Nucleic Acid Hrearch and Moleciilar Biology, Vnl. 41
Copyright 8 1991 by Academic Press. Inc. All rights of reproduction in any form reserved.
2
DON M. CARLSON ET AL.
quences and regions encoding the signal peptides of all PRP mRNAs, regardless of source, are nearly identical. In another multigene family from rat submandibular glands that encodes contiguous repeat proteins (CRPs) or glutamic acid/glutamine-rich proteins (Glx-rich proteins), the 5'-untranslated sequences and the regions encoding the signal peptides of the mRNAs are 91% identical (nucleotides) and 92% identical (amino acids) to the PRP mRNAs (3, 4). Two mRNA size-classes, each containing multiple PRP mRNAs, are transcripts from PRP gene families of mice (5), hamsters (6),rats (i'),and humans (8).The CRP or Glx-rich multigene family also encodes two size-classes of mRNAs, and this multigene family has the same introdexon organization as the mouse and rat PRP genes. Cell-free translations show some unusual differences in PRPs encoded by mRNAs from parotid glands of four mouse strains (BALB/cJ, DBA/2J, CD-1, and C57BL/6J) after isoproterenol treatment (5).Reasons for the variations of translation products in these mouse strains after induction of the PRP gene families are unknown. Repeated administration of the P-agonist isoproterenol causes hypertrophy and hyperplasia of rat and mouse parotid and submandibular glands (9, 10).The morphological changes are accompanied by a dramatic increase, or induction, in the synthesis of PRPs. Typically, these proteins contain 25-45% proline, 18-22% glycine, and 18-22% glutamine and glutamic acid. Aromatic and sulfur-containing amino acids are either very low in amount or absent. Generally, PRPs can be divided into acidic and basic groups, and both groups may be glycosylated and phosphorylated. PRPs may compose more than 70% of the protein in salivary gland extracts after treatment with isoproterenol. All proteins derived from the nucleotide sequences of PRP cDNAs and PRP genes are characterized by four general regions: a signal peptide region, a transition region, a repeat region, and a carboxyl-terminal region (11). The apparent tissue-specific synthesis and the appearance of PRPs in saliva in such large quantities, either constitutive (as in humans) or induced by isoproterenol, suggest biological functions in the oral cavity and the gastrointestinal tract. Several functions, such as calcium binding, inhibition of hydroxylapatite formation, and formation of the dental-acquired pellicle, have been attributed to the human salivary PRPs (12). PRPs have an unusually high &nity for such multihydroxylated phenols as tannins; feeding tannins to rats and mice mimics the effects of isoproterenol on the parotid glands (13). The induction of PRP synthesis by dietary tannins clearly results in a protective response against the detrimental effects of the tannins (13). Unlike mice and rats, hamsters do not respond to tannins in the diet by the induction of PRPs. Pronounced detrimental effects are observed in weanling hamsters specifically. When these animals are maintained on a 2%
t
tannin diet for 6 months, they fail to grow (6).Tannins are unusually toxic to weanling hamsters; an increase of tannin in the diet to 4% causes death to most animals within 3 days. The association of tannins with pathological problems, including carcinogenesis and hepatotoxicity, and the influences on growth and toxicity in hamsters, have led to the proposal that PRPs may act as a first line of defense against these multihydroxylated phenols (13). This review focuses on the biochemistry and molecular biology of the salivary PRPs; it is not intended to be an overall or complete review of PRPs. To those who have contributed to the PRP literature and whose work is not mentioned, we apologize. Previous reviews are used for many references and studies.
1. Background4 Salivary glands of various animals synthesize, or can be induced to synthesize, a group of proteins unusually high in proline, the so-called prolinerich proteins (PRPs) (12, 14-20). These proteins collectively constitute the largest group of proteins in human salivary secretions, making up more than 70%of the secreted proteins (12).PRPs may be divided into acidic and basic groups, and members of each group may be phosphorylated or glycosylated, or both. These unusual proteins are constitutive in human saliva, but families of similar proteins are dramatically increased or induced in parotid and submandibular glands of rats, mice, and hamsters by isoproterenol treatment (6, 18, 19,21).Profound morphological effects on rat parotid glands by isoproterenol treatment were first observed in 1961 (9, 10). Repeated pharmacological doses cause dramatic glandular hypertrophy (Fig. 1). The increase in DNA synthesis with isoproterenol treatment (25, 26) probably results mainly from polyploidy; by 4-5 days, more polyploid than diploid nuclei are seen (Fig. 2) (see 27 for a review on the regulation of salivary gland size and the effects of isoproterenol). The dramatic accumulation of PRPs in the parotid glands of rats treated with isoproterenol was first described in 1974 (16, 18,28).After 7-10 days of treatment (5 mg of isoproterenol per day), PRPs composed about 70%of the total soluble proteins in parotid gland extracts. Initially, an acidic PRP (PI =
4 Reviews describing mainly the human PRP families are available (12, 22, 23). These unusual proteins were first observed in human saliva by Mandel, Thompson, and Ellison (24) and were first purified and characterized by Bennick and Connell(14) and by Oppenheim, Hay, and Franzblau (15).The genetics of this human multigene family were described in a review by Bennick (23). Other than for comparisons of the human cDNAs and multigene families, this review focuses primarily on the tissue-specific inducible multigene PRP families of mouse, rat, and hamster.
4
DON M. CARLSON ET AL.
FIG.1. Hypertrophic effects of isoproterenol treatment on rat salivary glands. Rats (150200 g of body weight) were injected intraperitoneally with 5 mg of isoproterenol daily for 7 days. The parotid glands (p), submandibular glands (sm), and sublingual glands (sl) were removed from control (bottom) and isoproterenol-treated animals (top). No changes were noted for the sublingual glands, which secrete principally mucous glycoproteins. Parotid glands, which are serous secretors, showed a dramatic increase in weight of about 6- to l0-fold. Submandibular glands are of a mixed cell population and showed an intermediate response to isoproterenol.
4.5) was identified (Ipr-lA2), and this protein was phosphorylated and glycosylated (16, 18, 19). Subsequently, six basic PRPs unusually high in proline (40-44%), glutamine plus glutamate (22-25%), and glycine (18-20%), containing varying amounts of lysine plus arginine (7-9%), were isolated and characterized (18, 19). Aromatic and sulfur-containing amino acids were either absent or present in very low amounts. Therefore, PRPs have little or no absorbance at 280 nm. Neither hydroxylysine nor hydroxyproline is present and the treatment of these PRPs with purified prolyl hydroxylase failed to convert proline into hydroxyproline. The molecular weights of the basic proteins, from sedimentation equilibrium, ranged from 15,000 to 18,OOO, and that of PRP Ipr-1A2 was 25,000. A high MW,,, (71,000) was observed following chromatography on Sephadex G-100, but the unusually high axial ratio (>25) of these proteins undoubtedly caused this value to be substantially overestimated. S values ranged from 1.1 to 1.4. Circular dichroism spectra showed no a-helical or polyproline conformations.
FIG. 2. Karyotypes of (a) a mouse bone marrow cell and (b) a monse parotid gland cell. The chromosomal display of the mouse hone marrow cell showed the normal 2n (= 40) chromosomes after 2 days of isoproterenol treatment. The mouse parotid gland cells (>50% of the cells) showed 471 chromosomes after 2 days of isoproterenol treatment. (Courtesy of Christopher Bidwell.)
6
DON M. CARLSON ET AL.
II, PRP mRNAs and Cell-free Translation Analysis Studies by cell-free translation analysis using the reticulocyte lysate system and labeling with [3H]proline or 135Slmethionine showed dramatic and definitive changes in the patterns of protein synthesis in parotid glands of isoproterenol-treated rats, and PRP mRNAs were highly elevated in the treated animals (29).There was very little synthesis of PRPs from poIy(A)+ RNAs from glands of control rats: poly(A) RNAs from the glands of treated animals synthesized mainly PRPs; translation patterns with [3H]proline and [35S]methionine gave identical labeling patterns; and PRPs from cell-free translations were all precipitated by antibodies to PRPs. [35S]Methionine was incorporated only into the initiation site, as determined by sequence analysis and by the fact that PRPs synthesized by tissue slices of parotid glands of isoproterenol-treated rats in the presence of [35S]methionine contained no 35S label. Because most PRPs are acid-soluble, a property first used in the purification procedures of rat submandibular gland PRPs (30),it is imperative that cell-free translation products be precipitated with a solution containing both trichloroacetic and phosphotungstic acids (29). The induction of PRP mRNAs in the parotid and submandibular glands of both rats and mice by isoproterenol treatment has been demonstrated by Northern and dot-blot hybridizations (21). PRP mRNAs either are very low or are not detectable in the glands of untreated rats and mice. After 4-5 days of isoproterenol treatment, mRNAs encoding these unusual proteins compose over 50% of the total glandular mRNAs (5). For example, plasmid pRP25 does not hybridize with RNAs from control rats (Fig. 3A), but does hybridize with PRP mRNAs of two size-classes, ranging from 600 to 1100 bases, from isoproterenol-treated animals. These size ranges of mRNAs are consistent with all rat RNA preparations tested. The multiplicity of PRPs encoded by the PRP mRNAs from treated rats is evident from Fig. 3B, since about 12 PRPs were identified by cell-free translation analysis and immunoprecipitation. The PRP cDNA insert of pUMP40 (11), prepared from mRNAs from BALB/cJ mice, has been tentatively identified as the transcript of the mouse PRP gene MP2 (1).However, the nucleotide sequences of MP2 and the PRP insert of pUMP40 showed only 98% homology (1).MP2 was cloned from a genomic library prepared from chromosomal DNA from the CD-1 mouse strain. In an attempt to reconcile the heterologous regions and base differences between the CD-1 mouse gene MP2 and the BALB/cJ mouse mRNA, we isolated mRNAs from four mouse strains. Northern blots of total RNA from the parotid glands of mouse strains CD-1 and BALB/cJ and from strains DBA/2J and C57BL/6J, from both control and isoproterenol-treated mice, were probed with 32P-labeled exon +
7
PROLINE-RICH PROTEIN MULTICENE FAMILIES
A
B
1078 1353
872 -
603 -
FIG.3. Northern blot of parotid gland RNA from normal and isoproterenol-treated rats and cell-free translations of “sized” PRP mRNAs. (A) Parotid gland RNAs (10 pg) from normal and isoproterenol-treated rats were electrophoresed on a 1.5% agarose gel containing 5 mM methyl mercury hydroxide and transferred to nitrocellulose. The blot was probed with 32Plabeled pRP25 (11).(B) RNA was isolated from a methyl mercury denaturing low-melting-point agarose gel and translated in oitro with [SSImethionine. The translation products were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Lanes l and 8 show S S label incorporated in the absence of RNA and with total RNA from the parotid glands of isoproterenol-treated rats, respectively. Lanes 2-7 are the translation products obtained from RNA indicated in (A). Molecular-weight standards ( X l O - 3 ) are indicated at the right, and nucleotide standards are indicated at the left. [Reprinted with permission from the Journal of Biological Chemistry (S).]
IIb (see Fig. 10) of PRP gene MP2 (5). Two major classes of PRP mRNAs were detected in the treated animals. RNA species of about 1050 and 1300 bases for BALB/cJ and DBA/2J mice and about 1100 and 1200 bases for CD-1 and C57BL/6J mice were observed. Cell-free translations of total RNA from these four mouse strains showed interesting and unusual differences in the PRPs synthesized (Fig. 4). Similar labeling patterns were observed with both [3H]proline and [35S]methionine. The amounts or levels of incorporation varied considerably between controls and treated animals, and cx-
8
DON M. CARLSON ET AL.
35S-Met
I
3
M.W. Std.
I PR
NORMAL a
-3
x c 0 m
<m -J
U
\ -I
m
I
lc
n m
m V
V
3 H -Pro ’
cv
*
a
m
-
-I
I
m U 0 n m V
m lc In
o
3
(0
(D
\ -I
I PR
NORMAL 7
7
3
\
1
cv
\ -I
U
lc
U
In 0
D
3
\
m
0
m
3
cv
\
m
(D
7
<m
‘
-
3
-IN
m \
I + a a n o m -I
m o
o n
45.0
31 .O
21.5
FIG.4. Translation products of RNAs prepared from four different mouse strains. Ten micrograms of total RNA from parotid glands of the mouse strains indicated, both before and after isoproterenol treatment, was translated with either [35S]methionine or [3H]proline; 200,000cpm of 35s and 50,000 cpm of 3H were applied to gel electrophoresis. a-Amylase and parotid-specific protein are indicated by the upper and lower arrows, respectively. Molecularweight standards (XlOW3) (M.W. Std.) are indicated at the left. [Reprinted with permission from the Journal of Biological Chemistry (5).]
amylase (upper arrow, Fig. 4)and parotid-specific protein (lower arrow, Fig. 4) were dramatically reduced. a-Amylase and parotid-specific protein expressions appear to be regulated in concert (31).Earlier cell-free translation experiments (21, 29) and RNA/DNA hybridization results (5) show that a-amylase mRNA is dramat-
PROLINE-RICH PROTEIN MULTIGENE FAMILIES
9
ically decreased by isoproterenol treatment. In a related study, a polymorphism in an androgen-regulated single-copy mouse gene (RE?)produced three major mRNAs (32).These RP2 mRNAs differed in the lengths of their untranslated 3’ regions as a result of using different polyadenylation sites, and additional variability resulted from the insertion of a member of the mouse B1 family. However, these RP2 polymorphisms had no effect on the translation product. Whether the PRP polymorphisms are the result of different PRP genes or are caused by differential RNA splicing remains to be determined.
111. PRP cDNAs and Amino-acid Sequences Plasmids containing cDNAs for PRPs were first isolated from a cDNA library prepared from RNA isolated from the parotid glands of isoproterenoltreated rats (7). Four recombinant plasmids (pRP8, pRP18, pRP25, and pRP33) were selected. Several mRNAs hybridized to each PRP cDNA, which emphasized the similarities in nucleotide sequences of the PRP mRNAs. This could have resulted from the expression of a family of closely related genes or from the production of multiple mRNAs from the same or similar genes by different splicing patterns. Whether one or both possibilities are responsible for the multiple PRP mRNAs has not been unequivocally demonstrated. Subsequently, several more PRP cDNAs were cloned from mouse and rat parotid gland mRNAs after isoproterenol treatment (11) and from the human parotid gland (33).5 The nucleotide sequence of the PRP cDNA insert of pRP33 (7) encodes the acidic PRP, Ipr-1A2 (Fig. 5). The 13 amino-terminal amino acids are highly hydrophobic and are probably part of a signal peptide (the signal peptide region) (see Fig. 8). The next 60 amino acids (the “transition” region) contain numerous acidic residues, with 10 aspartic acids in the 16-aminoacid sequence of Asp-58 to Asp-73. The “proline-rich” region (residues 80-189) is high in proline, glycine, and glutamine, and includes six repeats of 18 or 19 amino acids (the “repeat” region). The 17 carboxyl-terminal amino acids (the carboxyl-terminal region) contain single residues of tyrosine (-2O1), tryptophan (-203), and phenylalanine (-204) clustered close to the carboxylterminal serine (-206). These data, derived from the nucleotide sequence of pRP33, gave the first complete amino-acid sequence of a PRP. This sequence has been compared (7) with the partial amino-acid sequences reported for the human acidic (34) and basic (12)PRPs. Subsequent data derived from several PRP cDNA and PRP gene sequences show that the first 100 nucleotides in the 5’ regions of PRP mRNAs, which contain the 5’5 Differential splicing is considered to contribute to the multiple PRP mRNAs in the human salivary gland (33).
10
DON M. CARLSON ET AL.
'
M
L
V
V
L
L
T
A
A
L
L
V
L
S
S
A
H
G
S
m
D
E
E
V
T
Y
E
D
S
S
S
Q
L
L
D
V
E
Q
Q
a
N
Q
K
H
G
Q
H
H
Q
K
P
P
P
A
S
D
E
N
G
s
D
G
D
D
S
D
D
G
D
D
D
G
S
G
D
D
G
N
R
E
R
8oP P
P
H
G
G
N
H
Q
R
P
P
P
G
H
H
H
G
9BP P
P
S
G
G
P
Q
T
S
S
Q
P
G
N
P
Q
G
P
P
Q
P
G
N
P
Q
G
P
P
nP
' " P P P Q G G P Q G "
P
P
P
Q
G
G
P
Q
Q
P
P
Q
G
G
P
Q
G
P
P
Q
G
G
H
Q
Q
I w P A Q D A T H
E
Q
"'P
R
Q
P
G
K
P
Q
G
P
P
Q
P
G
N
P
Q
G
R
P
P
Q
P
R
Q
D
P
S
Y
L
W
F
K P 206 S S
FIG. 5. The amino-acid sequence derived from primer-extended pRP33, arranged to align similar sequences. [Reprinted with permission from the Journal of Biological Chemistry (7.1
flanking sequence and encode exon I (or the putative signal peptide), have unusually strong homologies (>95% identity) (11)(Fig. 6). Sequence data obtained from a multigene family encoding CRPs from rat submandibular glands (3), are unusually high in glutamine and glutamate (4) and are very similar in this region, 91% of the nucleotides and 92% of the amino acids being identical to the sequences of the PRPs (3).
IV. Sequence and Structural Analyses of PRP Genes One of the family of mouse PRP genes was isolated on a cloned 3600-bp EcoRilBgZII-generated DNA fragment from a partial Sau3A bacteriophage library of CD-1 mouse chromosomal DNA (1).The transcriptional unit included three exonic sequences separated by 1434 bp (intron I) and by 450 bp (intron 11). The upstream sequence (Fig. 7) had putative induction sites for CAMP(box I11 and box I) and an activator or enhancer sequence (box II), ZDNA sequences that flanked an 86-bp sequence, a TATA box, and a CAAT box (1).The derived amino-acid sequence of this PRP gene ( M P 2 ) revealed a protein that contained 13 tandemly arranged repeats of 14 amino acids with the prototype sequence P P P P G G P Q P R P P Q G (Fig. 8). Each amino
-30
-20
I
I
up2 A
M(terenrs:
C
I
A
C
-10 I T
T
C
.
~
0
10
20
30
40
50
I
I
I
I
I
I
~
G
M
A
M
C
T
C
C
T
T
C
C
~
~
60 I ~
T
~
T
~
~
02030000000330220001003011213010000000230130300130330003301030010123311010010230111123333333300010
FIG.6. Comparisons of the S’-flanking regions and sequences e n d i n g exon 1 of PRP cDNAs and PRP genes from mouse ( M P 2 , pUMP40, pUMPl2, and pUMPl), rat (pRP25, pRP33, and pRP18), human (CPTI, CPT3, and CP6), hamster (H29), and rat CRPB. The legend indicating differences of 0, 1, 2, and 2 3 denotes the relative conservation of bases at each position. In 65% of the positions, there is only 0-1 base change.
~
T
C
C
T
H29
HE2 C T A A C C T T A A G C A T C T T T A A T A G A A C A A ~ T ~ G ~ G C ~ T C T-650 AT
I l l
I I
I
I Ill
I
-494 TCCCTACTGGGTGAGCTAACTCCCTACACAAT"AAACAAATCAATCAACT
I
D
I
GGTCCTTCAIAAATGTAACAGTCAAA-CAIACTCAC-CAGGAATTACGGATT-602
II
IIIIIIII Ill
-
1 1 1 1 I II II
I
-444 AAGTGTTAT GCATGTAACA-TCATGCCA A-TAACACUTGAA
+
I
I
-
d
CAAGATATTGACTCATGTATACCTCATATGTGTTGTGACTCCACTTTTAC -552
0
TGGGACTTTATAGATGAAATAGGTCTCATGCTTTACTA GCCAAT GTTGTA -502 GTTATTGTGTTAGGTCAGGAGAATAGTGGGCACTCTTACTGAGGCTTAGC -452 ATGTTAGGGATTCCAAGGGTCTTGGTGTAATTGATAlTTGlTTATGAATA
-402
GCCTCAACACCATCACTCTTAACTAATTATAGAATATATAAGAACATATA
-352
TAAGTGACAGTGGTTAAGCTATCCTACTGATCATAAA?iATTGACCACATT
-302
CAATTTGGACAGAAATCATTACTGTCAA TATAAACAAAT
-263
I I I I I I l l II CATAATTTTGCACCTTTAGTCTCAGTGA CAGGAA
-404
-370
I l l IIIIII IIII I Ill I I II II IIIII GAATATGGACA AAATTA TACAGGTATGTAGAAGCACCTCCCACAA
-322 TCATACCTAATAGGTCAGAGTCAGAGTTATGTCAATAACAGTGTCTTACA -274 CAATGATAGGCCTTAAAGGACAATAGACTTATTG -238 ATAGAACTATATATCTAATGTCTAGACTTTGCCTGTATCACTTAAACTAT GTGTATGCACACTAGTTTTA -244
I
I I
-1aa TGTTGTCAAAATTTCACATTGTACCATAGAGAACTGAAACATTGACTGCA CCCCAATGCACATTGATACACAAA AAATGTCAGCAAATGCA ATGAGATAT -193
I
II I
I I II
I
-138 TCCTGCTGGGCTAGAGTCCCAAAG AAAAGTCAGT GATGCA AAG
TTATATATTGTTAGTCATTACTGCAATAACTGGGTTATATGATTACATAG -143 GAGTTTTTTCTAGTAGGGACACTAGCAGCTAGC
TCTTCCTTACCTCATCCTGATGGGCAAAAGTCCCAGTGTCACACAAAGGA
-60
GAAAGGTGACATTCTTCTGCTCCTCCTTATAAAGGCAGTGTCTTACT
-12
II II I I l l II I I II I l l I I IIII TA TCCTGCTG TG TC AGGT CAGATCAATAGTGAGGA
-95 C
-60
I IIIIIIII IIII IIIIII I IIIIIIIIIII II I I CATGAAAGGTGCCATTGTTCTGC CTTCCTTATAAAGATTTTGGCCTTGC TCTTCCAGCACAGACTTGG
I
IIIIIIIIIIIIIII
-11 TGGCCCAGCACAGACTTGG FIG.7. Comparisons of upstream sequences of mouse PRP gene M P 2 and hamster PRP gene H 2 9 . The upstream sequences of M P 2 and H 2 9 are aligned to maximize sequence similarities. Putative regulatory regions are indicated. Boxes 111 and I, M P 2 , -640 to -623 and -218 to 203. respectively; arrows, AP-1 binding sites; GCCAAT, -513 to 508. CCAAT box.
13
PROLINE-RICH PROTEIN MULTICENE FAMILIES
I M L V V L F T V A L L A L S S 1 6 A Q G P R E E L Q N Q I Q I P N Q R
SIGNAL PEPTIDE TRANS I T I O N REG ION
3 4 P P P S G F Q P R P P V N G S Q Q G 52P P P P G G P Q P R P P
Q
G
REPEAT REGION
66P P P P G G P Q P R P P Q G 8oP P P P G G P Q P R P P
Q G
g4P P P P G G P Q P R P P Q G 108P P P P G G P Q Q R P P Q G 122P P P P G G P Q P R P P Q G 136P P P P G G P Q L R P P Q G 15oP P P P A G P Q P R P P Q G 16‘4P P P P A G P Q P R P P Q G 178P P T T - G P Q P R P T Q G 191P P P T G G P
Q Q R P P Q G
205P P P P G G P Q P R P P Q G 219P P P P G G P Q P S P T Q G 2 3 3 P P P T G G P Q Q T P P L A G N T 61 G
CARBOXYL TERMINUS
2 5 2 P P Q G R P Q G P R STOP 26 1 FIG. 8. Amino-acid sequence of PRP GPMsm derived from the nucleotide sequence of mouse PRP gene MP2.
acid within the repeat had its “favored” codon ( 1 ) (Table I), and six amino acids had a total conservation of codons for all 13 repeats. Subsequent studies (2) showed that two nonallelic PRP genes ( M P 2 and M 1 4 ) are tandemly arrayed and separated by about 30 kbp. Analysis of DNA sequences suggested that M P 2 and M 1 4 arose via gene duplication of a common ancestor. A homology matrix, or “dot-plot,” showed virtually no spurious background, and, aside from three differences, the sequences of the two genes, including the introns, were nearly identical. The differences observed were two additional sequences in intron I of M 1 4 of 223 and 2005 bp, four additional repeats (17 repeats total) in M 1 4 , and fractional sequence differences of the simple repetitive sequences (CA, TA, and TAGA) of intron
DON M. CARLSON ET AL.
14 TABLE I COMPARISON OF CODON USAGE’ Codon
MP2
Other mouse genes
CCU Pro (47)b CCA CCG
16 16 60 8
31 25 38 6
GGU Gly (19)b GGC GGA GGG
0 62 31 7
21 26 32 21
CAA Gln (17)b CAG
53 47
35
CCU Arg (7)b CGC CGA CGG AGA AGG
6 0 6 6 64 18
7 13 13 12 31 24
ACU Thr (4)b ACC ACA ACG
23 0 77 0
25 36 32 7
UAA term UAG UGA
100 0 0
0 0 100
ccc
65
“Reprinted with permission from theloumul of Biological Chemistry ( 1 ) . b Amino-acid composition in mol%.
I. The additional 2005-bp sequence was the 3‘ portion of the mouse LINE element, and it apparently had been transposed into intron I, but in the opposite orientation of M 1 4 (Fig. 9). This mouse LINE sequence (LIMdPRP), like most mouse LINE elements, is truncated at the 5‘ end (35). LIMd-PRP contains the typical polyadenylation signal (AATAAA) and an adenine-rich sequence, and it is flanked by a pair of 10-bp imperfect repeats (TGTCTTTTTT and TGTCTTTCTT). This IO-bp sequence is present only once in MF2. These and other data are strong evidence that LIMd-PRP entered this PRP locus via transposition. Both M P 2 and M 1 4 are transcriptionally active in the parotid gland when the mouse is treated with isoproterenol (11). PRP cDNAs pUMP4 and pUMP40 are encoded by M 1 4 and MF2, respectively. The number of tan-
15
PROLINE-RICH PROTEIN MULTIGENE FAMILIES 0
10
5
15
20
30 35
25
40
45
50
60
55
65
70 75
80 kb
GENES
Hindm Sol1 BamHI EcoRI
CLONES
I
9
I,
1
0
I
,
b
,
,,
I
f
,,,
, I
c
,d,
e
,
I
,
MC I6 MC22 M I4
FIG. 9. Linkage of mouse PRP genes MP2 and M14.The organization of MP2 and M I 4 are shown by the expanded scales and the relative lengths are indicated by the kilobase bar. Solid bars show the three exonic regions, and the open arrow ( M 1 4 ) represents the LINE insert. Arrows show the direction of transcription. [Reprinted with permission from the Journal of Biological Chemistry @).I
dem repeats within each gene varies, as we indicated (I, 36), and is similar to those reported (37) using variable number of tandem repeats (VNTRs) as markers for mapping human genes. However, PRP tandem repeats are the major body of the active gene, and no sequence similarity exists between this repeat and the invariant core sequence of VNTRs (37, 38). Sequence analysis of a hamster PRP gene (H29) showed that the hamster, rat, mouse, and human PRP genes are all closely related. Mouse and rat PRP genes have two exons encoding PRPs (I and IIb) (Fig. lo), while hamster and human genes have three exons (I, IIa, and IIb). Exon IIa of hamster and human PRP genes are both comprised of 36 bp, seemingly coming from the 5’ sequences of exon IIb of the mouse and rat. Whether this difference in PRP gene organization resulted from a separation or combination of exonic regions is unknown. Upstream regulatory regions of mouse, hamster, and human PRP genes are discussed in Section V. Unlike PRPs from mice and rats, which are all blocked on the amino terminus, hamster PRPs Hp43a and Hp43b were partially sequenced from the amino terminus (39). The open reading frame of exon I (H29) encodes hydrophobic residues, the putative signal peptide. Exon IIa contains only 36 bp, and the derived amino-acid sequence is A T I Y E D S I S Q L S, which is exactly the sequence of the amino terminus of Hp43a, except in position 8, which is D instead of I. Exon IIb contains 514 bp and encodes the mature protein, except for the first 12 amino acids. Exon IIb has 10 Hue111 sites and six Sau96I restriction enzyme sites, which is one of the unusual characteristics of PRP genes (I).One open reading frame of exon IIb encodes a 20-
DON M. CARLSON ET AL.
16 EI
E Ilo
\ ,I
Hamster
'\\
H29
M
ll
0
Human PRHl
,'
N
\
I,
I,
,
,
,
,/
,
\I
'\
'
;
:: I t
I
U
I
3'
5' 1 kb
FIG. 10. Comparison of PRP gene organizations in mice, hamsters, and humans. Related exonic regions (bars)are connected by dashed lines. The gene organizations of hamster H29 (36) and human PRHl (8)show the additional 36-bp exonic sequence. [Reprinted with permission from the Journal of Biological Chemistry (2).]
aminoacid peptide that is repeated five times and has a prototype sequence of P P Q Q E G Q Q Q N R P P K P Q N Q E G. The first 43aminoacids and the last 12 amino acids derived from the nucleotide sequences of exons IIa and IIb diverge from this prototype repeat pattern and give rise to the transition region and the carboxyl-terminal region, respectively. While the 5'-noncoding regions and the sequences encoding the putative signal peptides (about 100-110 bp) are highly conserved in all PRP mRNAs (Fig. 6), there is a discrepancy in the apparent cleavage site by the signal peptidase in hamster PRPs, as suggested by the amino-acid sequence of Hp43a. From the amino-acid sequence derived from PRP gene H 2 9 , the nascent polypeptide chain has the sequence M L V V L L T A A L L A & E H f A T I Y E----, with Glu (E) and His (H) preceding the apparent site of cleavage ( t ) (see the amino-terminal sequence encoded by exon IIa, above, A T I Y E D-----). Histidine has not been observed in position -1 (counting from the cleavage site) (40). We have proposed that the signal peptidase cleaves between Ala and Glu ( J. ) and that Glu and His are removed by further processing (36). However, this proposal predicts an unusually short signal peptide of only 12 amino acids.
V. Regulation of Expression of PRP Genes The upstream sequences of mouse PRP genes M P 2 and M14 and hamster PRP gene H 2 9 contain potential regulatory elements (Figs. 7 and 11). In each of these genes, three highly conserved regions were identified (boxes I111) (1).These regions include two putative CAMPresponse elements (boxes
17
PROLINE-RICII PROTEIN MULTIGENE FAMILIES
Source
Sequence
E. coli CRP Binding Site
Bovine a-gonadotropin Human VIP
A A N T G T G A N N -122 -81
Reference (411
- T N N N - N C A
T T A T G T G A A G - T A C -
- .C A
-108
(55)
T A C T G T G A C G
- T C A
-65
(56)
- T C T T
PRP Genes, Box 111 Mouse MP2 Mouse M14 Hamster H29
-640 -640 -435
A A A T G T A A C A G T C A A - A C A C A A T G T A A C A G T C A A - A C A G C A T G T A A C A - T C A T G C C A
-623 -623 -418
(1) (2) (36)
PRP Genes, Box I Mouse MP2 Mouse M14 Hamster H29
-218 -217 -114
A A A T G T C A G C - A A A T - G C A A A T T G T C A G C - T A A T - G C A A A A T G T C A G T - - G A T - G C A
-203 -202 -99
(1) (2) (36)
Human PRP Genes PRHl PRH2
-484 -484
A A A T G T G A A A A T A C C A A A T A T A C A A A T A T C
-467 -467
(8) (8)
Relative Base Frequencies: A T G C
0 1 0 411 12 11 12 0 0
0 0 0 5 0 0 0 0 3 1
1
11 0 0
- T C A - C A T 1lJ 0 1 0 11 0
FIG. 11. Sequence comparisons of the E . coli CRP binding site with putative cAMP regulatory sites (boxes I and 111) of PRP gene M P 2 . Similar sequences in the E . coli CRP binding site are reported in bovine a-gonadotropin, human vasoactive intestinal peptide (VIP), and human PRHl (PRP) genes. The relative frequencies of A, T, G , and C at each position are indicated. Positions 4, 5, 6, and 8 (TGT-A) are totally conserved. Positions 12, 18, and 19 each show only one substitution: A for T ( 1 2 ) in M P 2 , and A for C (18)and C for A (19),both found in human PRHI.
I and 111) with sequences similar to the CRP binding site required for transcriptional activation of CAMP-regulated genes in Escherichia coli (1,41) (Fig. 11). Also, box I11 of the mouse PRP genes contains a sequence (-637 TAACAGTCA - 629) which resembles the 8-bp palindromic sequence TGACGTCA, a cAMP response element (CRE) in eukaryotes (42).The palindrome is imperfect by one base (A for G), and it is interrupted by an A. This sequence in box I11 of the hamster gene is similar, but it lacks a G (TAAC-TGA). Such overlapping sequences of CRP and CRE have been shown to be functionally related (43). Mammalian activation-translation factors (ATF)can bind specifically to some E. coli CRP sites, and, conversely, E. coli CRP-binding protein specifically binds to some mammalian ATF sites (43). Of considerable interest is the observation that multiple AP-1 binding sites (44) are present immediately 3' to box I11 in PRP genes MP2 and M14 (Fig. 11).These sequences are not present in the hamster gene. A perfect
18
DON M. CARLSON ET AL.
copy of the AP-1 heptamer, TGACTCA, is located at positions -594 to -588. A totally conserved CCAAT box (GCCAAT) is located at positions -516 to -509 in MP2 and M14. Proteins known to bind to the CCAAT box (CTF/NF-1 proteins) activate both transcription and replication (45). The proline-rich transcriptional activator of CTF/NF-1 is distinct from the replication and DNA binding domain in that it requires an additional carboxylterminal domain (46). Preliminary studies using gel-mobility-shift assays (47) have shown that nuclear extracts from the parotid glands of isoproterenoltreated mice have about a 6-fold increase in protein(s) binding to the upstream sequence (-702 to -574 bp) of MP2. “Footprint” assays indicate that the nuclear protein(s) binds to the AP-1 repeats. Adding Bt,cAMP or forskolin to hamster parotid gland primary-cell cultures resulted in a large increase (i.e., 15-to 30-fold) in PRP mRNA levels (48). The increase was most dramatic between 10 and 18 hr of treatment. Treatment of the cells with cycloheximide blocked this induction of PRP mRNAs, which is added evidence that the synthesis of a trans-acting factor is necessary for the dramatic increase in transcriptional activation of the PRP genes. &-AmylasemRNA was not significantly ailected by the cycloheximide treatment. Transfections have been performed using the plasmid pUMP2BE, which contains the complete MP2 gene, and with various constructs containing deletions of the upstream sequence of MP2. Constructs containing the sequence -702 to -574 bp of MP2 in tandem with the Rous sarcoma virus (RSV) promoter and the chloramphenicol transferase (CAT) gene showed induction of PRP mRNAs of 2- to 4-fold. Various cell types have been used for the transfection experiments, including PC-12, AtT20, and L M cells. Presently, we are attempting transfection experiments with a parotidhepatoma cell line prepared by fusion of FTO-2B cells and parotid gland primary cells (49). This may be the only “immortalized cell line of parotid gland cells available, and these cells may respond more dramatically to transfections with the PRP gene regulatory sequence.
VI. Functional Aspects of PRPs The high conservation of the sequences and structures of PRP genes and PRPs argues for specific biological functions for these unusual proteins. Some of the proposed functions, such as calcium binding, hydroxylapatite binding, formation of the dental-acquired pellicle, and agglutination of oral bacteria, have been reviewed, especially for human PRPs (12, 22, 23). In 1983, we showed that PRPs, which were dramatically induced in rat parotid glands by feeding tannins, are beneficial to the rat (SO).Condensed tannins (proanthocyanidins, oligomers G f fiaan-3-01s) and hydrolyzable tannins
PROLINE-RICH PROTEIN MULTICENE FAMILIES
19
(oligomers of gallic acid) are present in many foods. Antinutritional effects and other toxic and pathological properties, such as carcinogenicity and hepatotoxicity, have been associated with the ingestion of tannins and with the medicinal use of tannins. The general properties of tannins, their effects on biological systems, and specifically their roles in the induction of PRPs have recently been reviewed (13). Seeds of bird-resistant cultivars of sorghum, a major cereal crop of the semi-arid tropics, contain high levels of tannin (high-tannin sorghum), which diminishes the nutritional value of the grain. Studies designed to define the interactions of tannins and proteins show that tannins have an extremely high affinity for proteins rich in proline (51), and that the salivary PRPs have the highest affinity (50). Because the gastrointestinal tract, specifically the oral cavity, is the source of PRPs, it was suggested that salivary PRPs might interact with tannins and serve as a defense against the detrimental effects of dietary tannins. While the dramatic induction of PRPs in the rat following isoproterenol treatment clearly offsets the usual detrimental effects of dietary tannins (50),parotid glands from rats fed high-tannin sorghum (i.e., 2% of their diet) without isoproterenol treatment were also enlarged about 4fold, and there was a dramatic increase in PRPs within 3 days. Thus, tannins in the diet mimic the effects of the P-agonist isoproterenol on the parotid glands. There was an initial weight loss on the 2% tannin diet, reversed at 3 days, or at the time of maximal stimulation of PRP synthesis. After this time, the animals grew at close to the normal rate. Amino-acid analysis, electrophoretic patterns of proteins, and cell-free translations of mRNAs all confirmed that the PRPs induced in parotid glands by feeding tannin are identical to those induced by isoproterenol. Subsequent studies show that the P-agonist propranolol (a mixed PI, P,-agonist) and atenolol (a PI-agonist), when included in the diet, block the induction of PRPs by dietary tannin. Butoxamine, a P,-specific blocker, had no effect and therefore the P-adrenergic receptor affected by tannin feeding is the PI-receptor. The addition of either propranolol or atenolol to the diet of rats also causes substantial increases in four proteins in the submandibular glands, of MW 145,000 (GP145), 42,000 (P42), 40,000 (P40), and 39,000 (P39) (52). GP145 is glycosylated. These proteins are tissue-specific, as they were not detected in the parotid or sublingual gland, lung, liver, pancreas, kidney, heart, or small intestine either before or after propranolol treatment. We believe that this is the first report on the induction or regulation of protein synthesis by a P-adrenergic blocker. The hamster was used as another animal model to study the regulation and expression of PRPs. The hamster responded to isoproterenol by the induction of a series of proteins (39). However, the protein encoded by “PRP” gene H29 was unusually high (34%) in Gln and was only 15% Pro.
20
DON M. CARLSON ET AL.
Also, there was no evidence of a hypertrophic response in the hamster salivary glands. Subsequent studies of feeding tannins to hamsters also showed essentially no hypertrophic response, and PRPs were not induced. Weanling hamsters fed a diet of 2% tannin lose weight for about 3 days, as do rats and mice, but then an unusual growth inhibition occurs (39). Hamsters maintained on a 2% tannin diet failed to grow, and even at 60 days were essentially the same body weight as at 3 days after starting the feeding trial. When diets were switched, the experimental animals gained weight at close to the normal rate for young hamsters, while the control animals, then on a 2% tannin diet, lost about 20% of their weight. Clearly, the detrimental effects of tannins are reversed or inhibited by the induction of PRPs in rats and mice, but hamsters are unusually susceptible to tannins. In fact, increasing the tannin content of the diet to 4% was fatal to most hamsters within 3 days.
VII. Discussion Specialized cells in eukaryotes variably express different genes during differentiation and development. Exocrine glands, such as the pancreas and the salivary glands, have served as models of secretory tissues. Under ordinary conditions, the salivary glands of adult animals are relative stable and do not change appreciably in cell size or number (27). However, administration of the catecholamine isoproterenol causes dramatic morphological, cytological, and biochemical changes. Morphologically, the parotid glands can increase up to 10-fold in size. Cytologically, about 50% of the acinar cells are polyploid within 2 days of treatment. Biochemically, a dramatic induction of the multigene family encoding the PRPs is observed. The expression of PRPs for the parotid and submandibular glands is tissue-specific or, possibly more correctly, cell-specific. PRPs have been identified immunochemically in the trachea (53) and the pancreas but there is no evidence that PRP genes in these tissues respond as in the salivary glands to isoproterenol treatment. Small amounts of PRP mRNAs are observed in the mouse pancreas after isoproterenol treatment (C. A. Bidwell and D. M. Carlson, unpublished), but these results were variable. Current data suggest that transcriptional controls, tissuespecific factors, and post-translational modification share the role of principal modulators of the expression of the PRP gene families.
(a),
ACKNOWLEDGMENT These studies were supported in part by NIH grant DK 36812. P.S.W. was supported by
NIH training grant T32 HL 7013-13.
PROLINE-RICII PROTEIN MULTIGENE FAMILIES
21
REFERENCES D. K. Ann and D. M. Carlson, JBC 260, 15863 (1985). D. K. Ann, M. K. Smith and D. M. Carlson, JBC 263, 10887 (1988). G. Heinrich and J. F. Habener, JBC 262, 5262 (1987). L. Mirels, G. S. Bedi, D. P. Dickison, K. W. Grossand L. A. Tabak,JBC262,7289(1987). D. K. Ann, S. Clements, E. M. Johnstone and D. M. Carlson, JBC 262, 899 (1987). H. Mehansho, D. K. Ann, L. G. Butler, J. Rogler and D. M. Carlson, JBC 262, 12344 (1987). 7 . M. A. Ziemer, W. F. Swain, W. J. Rutter, S. Clements, D. K. Ann and D. M. Carlson,JBC 259, 10475 (1984). 8. H. S. Kim and N. Maeda, JBC 261, 6712 (1986). 9. H. Selye, M. Cantin and R. Veilleux, Growth 25, 243 (1961). 10. K. Brown-Grant, Nature 191, 1076 (1961). 11. S. Clements, H. Mehansho and D. M. Carlson, JBC 260, 13471 (1985). 12. A. Bennick, MCBchem 45, 83 (1982). 13. H. Mehansho, L. G. Butler and D. M. Carlson, Annu. Reu. Nutr. 7, 423 (1987). 14. A. Bennick and G. E. Connell, BJ 123, 455 (1971). 15. F. G. Oppenheim, D. I. Hay and P. Franzblau, Bchem 10, 4233 (1971). 16. A. Fernandez-Sorenson and D. M. Carlson, BBRC 60, 249 (1974). 17. D. L. Kauffman and P. J. Keller, Arch. Oral B i d . 24, 249 (1979). 18. J. Muenzer, C. Bildstein, M. Gleason and D. M. Carlson, JBC 254, 5623 (1979). 19. J. Muenzer, C. Bildstein, M. Gleason and D. M. Carlson, JBC 254, 5629 (1979). 20. R. S. C. Wong and A. Bennick, JBC 255, 5943 (1980). 21. H. Mehansho, S. Clements, B. T. Sheares, S. Smith and D. M. Carlson, JBC 260, 4418 (1985). 22. A. Bennick, J . Dental Res. 66, 457 (1987). 23. A. Bennick, J . Dental Res. 68, 2 (1989). 24. I. D. Mandel, R. H. Thompson and S. A. Ellison, Arch. Oral B i d . 10, 499 (1965). 25. T. Barka, Exp. Cell Res. 37, 662 (1965). 26. R. Baserga, FP 29, 1443 (1970). 27. C. A. Schneyer, in “Regulation of Organ and Tissue Growth” (R. J. Gross, ed.), 211 pp. Academic Press, New York, 1972. 28. M. R. Robinovitch, P. J. Keller, D. A. Johnson, J. M. Iverson and D. L. Kaufman,]. Dental Res. 56, 290 (1977). 29. M. A. Ziemer, A. Mason and D. M .Carlson, JBC 257, 11176 (1982). 30. H. Mehansho and D. M. Carlson, ]BC 258, 6616 (1983). 31. H. 0. Madsen and J. B. Hjorth, NARes 13, 1 (1985). 32. D. King, L. D. Snider and J. B. Lingrel, MCBiol 6, 209 (1986). 33. N. Maeda, H . 4 . Kim, E. A. Azen and 0. Smithies, JBC 260, 11123 (1985). 34. D. Kauffman, R . Wong, A. Bennick and P. Keller. Bchem 21, 6558 (1982). 35. M . F. Singer and J. Skowronski, TZBS 10, 119 (1985). 36. D. K. Ann, D. Gadbois and D. M. Carlson, JBC 262, 3958 (1987). 37. Y. Nakamura, M. Leppert, P. O’Connell, R. WOK, T. Holm, M. Culver, C. Martin, E. Fujimoto, M. Hoff, E. Kumlin and R. White, Science 235, 1616 (1987). 38. A. J. Jeffreys, V. Wilson and S . L. Thein, Nature 314, 67 (1985). 39. H. Mehansho, D. K. Ann, L. G. Butler, J. Rogler and D. M. Carlson, JBC 262, 12344 (1987). 40. G. von Heijne, J M B 173, 243 (1984). 1. 2. 3. 4. 5. 6.
22
DON M . CARLSON ET AL.
41. B. de Crombrugghe, S. Busby and H. Buc, Science 224, 831 (1984). 42. W. J. Roesler, G. R. Vanderback and R. W. Hansen, JBC 263, 9063 (1988). 43. Y.-S.Lin and M. R. Green, Nature 340, 656 (1989). 44. P. K. V. Vogt and T. J. Bos, TZBS 14, 172 (1989). 45. C. Santoro, N. Mermod, P. C. Andrews and R. Tjian, Nature 334, 218 (1988). 46. N. Mermod, E. A. O’Neill, T. J. Kelly and R. Tjian, Cell 58, 741 (1989). 47. J. Zhou and D. M. Carlson, FASEB]. 4, 2131 (1990). 48. P. S. Wright, C. Lenney and D. M. Carlson, J . Mol. Endocrinol. 4, 81 (1990). 49. P. S Wright and D. M. Carlson, FASEB]. 2, 3104 (1988). 50. H. Mehansho, A. Hagerman, S. Clements, L. G. Butler, J. Rogler and D. M. Carlson, PNAS 80, 3948 (1983). 51. A. Hagerman and L. G. Butler, JBC 256, 4494 (1981). 52. V. N. Subramaniam and D. M. Carlson, FASEB J. 4, 1980 (1990). 53. T. F. Warner and E. A. Azen, Am. Reu. Respir. Dis. 130, 115 (1984). 54. S. Ito, S. Isemura, E. Saitob, K. Sanada, T. Suzuki and A. Shibita, Acta Endocrinol. 103, 544 (1983). 55. R. G. Goodwin, C. L. Moncman, F. M. Rottman and J. H. Nilson, NARes 11, 6873 (1983). 56. T. Tsukada, J. S. Fink, G. Mandel and R. H. Goodman, JBC 262, 8743 (1987).
Recognition of tRNAs by Aminoacyl-tRNA Synthetases’
I
LADONNE H. SCHULMAN Albert Einstein College of Medicine Bronx, New York 10461
I. Recognition versus Identity
................
11. Assays of the Amino-acid-am A. In Vitro Assays
B. In Vioo Assays . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111. Role of the Anticodon
IV.
V.
VI. VII. VIII. IX.
A. Anticodon Recognition in E . coli tRNAs . . . . . . . . . . . . . . . . . . . . . . . . B. Anticodon Recognition in Yeast tRNAs C. Summary . . . . . . . . . . . . . . . . . . .. . . . . . Role of the Acceptor Stem and the “Discriminator” Base at Position 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Alanine Synthetases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. E. coli Serine Synthetase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. E. coli Glutamine Synthetase . . . . D. Other E . coli Synthetases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other Recognition Profiles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. E . coli Arginine Synthetase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Yeast Phenylalanine Synthetase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. E. coli Phenylalanine Synthetase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Summary ...................... Role of Modified Bases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . The Complex of E. coli Glutamine tRNA and Glutamine Synthetase . . . tRNA Binding Domains of Other Synthetases . . . . . . . . . . . . . . . . . . . . . . . Concluding Remarks References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24 2.5 25 25 29 30 43
44 44 44 51 53
55 57 58 58 60 62
63 64 66
72 81 82
The highly specific selection of tRNA substrates by aminoacyl-tRNA synthetases is an intriguing problem in RNA-protein recognition. Synthetases specific for each of the 20 amino acids encounter a pool of tRNAs in the cell having similar overall structures (1-3). Selection of the appropriate tRNAs for attachment of each amino acid occurs by the formation of RNA-protein contacts unique to each cognate tRNA-synthetase pair. The sites in tRNAs that govern these interactions have been investigated by a variety of techAbbreviations: synthetase, aminoacyl-tRNA synthetase; MetRS, methionyl-tRNA synthetase; GlnRS, glutaminyl-tRNA synthetase, etc.; tRNAMet(CAU), methionine tRNA have the anticodon sequence 5‘CAU3‘; tRNATw(CCA), tryptophan tRNA having the anticodon sequence 5’CCA3’, etc.; DIIFR, dihydrofolate reductase.
23 Progress in Niicleic Acid Research and Molecular Biology, Vol. 41
Copyright 0 1991 by Academic Press. Inc. All rights of reproduction in any form reserved.
24
LADONNE H. SCHULMAN
niques for over 20 years, and numerous reviews cover this literature (4-6). However, recent technical advances have allowed a burst of new activity in this area, leading to the identification of nucleotide bases required for the recognition of a number of specific tRNAs (7-11).In addition, new studies have begun to reveal the corresponding sites in the synthetases that govern specific tRNA interactions (12-18). This article focuses on these exciting recent developments, dealing first with the tRNA studies, and following with a summary of data on tRNA recognition sites in synthetases.
1. Recognition versus Identity The terms “tRNA recognition” and “tRNA identity” have both been widely used in discussions of tRNA aminoacylation specificity. I use “recognition” here to refer to the specific identification of a cognate tRNA by its corresponding synthetase. The recognition elements in a given tRNA are defined as the set of structural features unique to that tRNA required for its efficient aminoacylation by the cognate synthetase. Recognition elements are identified by structural changes that significantly reduce the efficiency of aminoacylation by the cognate synthetase in in oitro assays. In addition, recognition elements can be transferred to noncognate tRNAs, allowing them to be charged with the corresponding amino acid in uitro and/or in oiuo. Further, loss of an important recognition element from an essential tRNA in uiuo should lead to a decrease in aminoacylation efficiency sufficient to impair cell growth. In the case of several tRNAs, recognition is now known to require only a small number of specific nucleotides. The prospects are good in the next few years for identification of the major recognition elements in tRNAs specific for all 20 amino acids in Escherichia coli. “tRNA identity” (19)is the term currently in general use to indicate the amino-acid-acceptor specificity of a tRNA. Identity elements include recognition elements for the cognate synthetase plus additional structural features that prevent recognition of the tRNA by noncognate synthetases. The locations of these positive and negative identity elements coincide when two synthetases recognize the same sites in their cognate tRNAs, but diverge in cases in which the recognition patterns differ. Identity elements need not be conserved among tRNAs specific for the same amino acid, as isoacceptor tRNAs could require different negative elements to protect against mischarging by different noncognate synthetases. Analysis of an extensive set of mutant tRNAs is often required to distinguish between positive and negative identity elements, and mutants having dual or multiple identities can be created readily. At present, the size of the identity set for specific tRNAs is largely unknown. In addition, inherent difficulties in setting up appropriate in oioo assays may hamper complete solution of the tRNA identity problem for some time.
RECOGNITION OF
25
tRNAs
II. Assays of the Amino-acid-acceptor Specificity of tRNA A. In Vitro Assays In oitro assays of tRNA charging and mischarging by purified synthetases, together with sequence comparisons of the test tRNAs, were used in earlier studies to attempt to define tRNA recognition elements (6, 20-23). In addition, chemical modification experiments helped to identify sites where structural changes led to loss of recognition by cognate synthetases (5, 6, 24). Nonsense and missense suppressor tRNAs generated in genetic experiments were also isolated from cells for in oitro analysis (25-28). Studies using tRNAs synthesized in oioo were sometimes complicated by the fact that mutations, especially those in the anticodon loop, altered the normal patterns of post-transcriptional base modification, and the effects of the two changes could not easily be distinguished (28). In 1982, a method for in uitro anticodon replacement using T4 RNA ligase was reported that avoids this problem (29). T4 RNA ligase was also used subsequently to introduce mutations near the 3' end of tRNAs (30) and to join synthetic oligoribonucleotides into intact tRNA structures (31). More recently, wild-type and synthetic tRNA genes have been cloned, and a variety of tRNAs have been overproduced and purified for in oitro studies (3236). In addition, in oitro transcription of tRNAs using "7 RNA polymerase has allowed the preparation of milligram quantities of specific tRNA sequences for enzymatic assays and physical studies (37-39). Fortunately, these transcripts lacking base modifications have generally been efficient substrates for aminoacyl-tRNA synthetases (Table I), allowing quantitative comparisons of the effects of base changes at specific sites on recognition by purified cognate and noncognate enzymes. This technique has also provided tRNA sequences difficult to obtain from cells due to the effect of mutations on tRNA biosynthesis or cell viability.
B. In Vivo Assays 1. NONSENSESUPPRESSION While much can be learned about tRNA recognition from in vitro experiments, the complete set of tRNA identity elements can only be derived from in oioo studies in which synthetases specific for all 20 amino acids compete for tRNA substrates under normal physiological conditions. Unfortunately, no direct in oioo assay of tRNA amino-acid-acceptor specificity exists. In early in oioo studies using amber suppressor derivatives of E. coli tRNATyr, genetic selections were devised for tRNA base changes that allow suppres-
26
LADONNE
n. SCHULMAN
TABLE I OF AMINOACYLATION OF NATIVE tRNAs AND in Vitro SYNTHESIZED tRNA COMPARISON WITH COGNATE SYNTHETASES" TRANSCRIPTS ~
Organism
E. coli Yeast
E . coli E. coli Yeast
E. coli E. coli
tRNA
[Mg2+](mM)
Asp Native Transcript Asp Native Transcript His Native Transcript Met Native Transcript Phe Native Transcript Thr, Native Transcript Val, Native Transcript Native Transcript
10 10 15 15 10 10 5 8
15 15 8
8 5 11 15 15
Relative specificityd transcript/ native
Reference
1.0
40
0.3Bb l.O=
0.9
41
4.0 0.6
0.80
0.7
42
1.1
0.9r 1.oc 0.8= 1.oc
0.5
43
0.2
37
1.2=
0.4
44
0.75~ 1.0=
0.4
43
0.94c
0.9
45
Apparent K, ( F M )
0.33 0.32 0.044 0.028
3.5
0.096
0.380 0.06 0.20 0.5 1.0 1.6 1.6
kb.c
1.oc 1.oc 0.66b
1.0"'
1.oc
Kinetic parameters vary with aminoacylation conditions. Native tRNAs and tRNA transcripts were assayed in parallel in each case, except for Mgz+ concentration. Transcripts normally require higher [Mgz'] for optimal aminoacylation. It is not clear in all cases whether experiments were carried out at the Mgz+ optimum for the native tRNA or for the transcript. Apparent K,'s are given since assays are carried out at suboptimal amino-acid concentrations. See specific references for details.
bkcal (s-'). Relative V,-. "[ k,,,/K,,,]transcript/[ k,,,/K,]native
or [ V,,/K,]transcript/[
V,,/K,]native.
sion of amber codons at sites for which Tyr insertion fails to yield a biologically active protein (46,47). A number of mutant tRNAs were isolated, a11 of which inserted Gln (48-51). In 1986, the powerful genetic approach to the study of tRNA identity was revived, taking advantage of automated DNA synthesis to construct genes of E. coli amber suppressor tRNAs containing base changes at any desired location (19,52, 53). The genes were cloned in a tRNA expression vector and the amino acid inserted by the suppressor tRNA at the site of specific amber codons in uiuo was directly determined by protein sequencing. E. coli dihydrofolate reductase, containing an amber codon at position 10 of the gene, was used as the target protein due to its ease of purification by methotrexate affinity chromatography and the neutral
RECOGNITION OF
27
tRNAs
effect of amino-acid substitutions at position 10 on enzyme activity (Fig. 1). This approach has also recently been widely used by others (54-61). Much important information on tRNA identity has resulted from these studies; however, there are several problems inherent in such suppression assays. First, the anticodon of the tRNA must be changed to one that is complementary to the nonsense codon. As discussed in greater detail in Section 111, such changes frequently affect recognition of the tRNA by one or more synthetases. Second, the efficiency of suppression cannot be directly related to the efficiency of aminoacylation. Suppression efficiency is usually measured by the rate of translation of a nonsense codon by a given suppressor tRNA relative to the rate of translation of a wild-type codon at the same site by an endogenous tRNA. Suppression efficiency can be affected by the level of synthesis of the tRNA, the type and extent of base modifications (particularly in the anticodon loop), and the interaction of the tRNA with ribosomes and translation factors. Evaluation of the effects of some of these factors on suppression efficiency can readily be made (62); however, it is difficult to access the effect of others. Several types of data are particularly useful in maximizing the information to be obtained on tRNA identity from in uiuo suppression studies. One is knowledge of the relative intracellular levels of tRNAs competing for the same synthetase. It is clear from theoretical considerations (63), as well as from a variety of experimental observations (59, 62, M), that in uiuo mischarging of tRNAs can be brought about by an imbalance of tRNAs and synthetases in the cell. Test tRNAs are normally overproduced in the sup2
Wild-type DHFR
Ile
1 2
Ser
Leu
Ile
Ah
Ala
Leu
Ala
Val
Asp
Arg
ATC AGT CTG A T T GCG GCG T T A GCG G T A G A T CGC DHFR-amber
........................ ........................
... ...
A A ' Asn TAG AAT
2
Pseudo-DHFR
Met
Lys
Leu V a l S e r
Ala
ATG AAG C T T G T A AGC GCG DHFR-start
AA'
Ser
Leu
Ile
Ale
ATC AGT CTG A T T GCG
..............................
NNN... DHFR-shift
Ile
...........................
. . . . . . . . . AA' . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . NNNN . . . . . . . . . . . . . . . . . . . . . FIG. 1. The sequence of the amino terminus of wild-type E . coli DHFR (118) and DHFR derivatives (19, 670), used for in oioo assays of tRNA identity.
28
LADONNE
n.
SCHULMAN
pression assay to maximize the amount of suppressed protein generated for sequencing. This “fixes the game” in the intracellular competition between the test tRNA and endogenous tRNAs. On the other hand, some mutations drastically reduce the amount of mature tRNA produced in the cell, complicating the interpretation of the effect of specific mutations on amino-acid specificity when comparing tRNAs expressed at different levels. Another valuable piece of information is knowledge of whether aminoacylation is rate-limiting in the suppression assay. This can be assessed by determining the effect on suppression efficiency of overproducing the synthetase(s) corresponding to the amino acid(s) inserted by the test tRNA. Genetic screens have also been used to examine tRNA identity in uiuo, using cells that require insertion of a specific amino acid at a nonsense codon for normal growth (19, 56, 58, 64).This assay is a minimal test of tRNA identity, however, since low levels of aminoacylated tRNA (below the amount detectable by sequencing dihydrofolate reductase) have been found to support growth in some cases, and in uiuo charging with other amino acids is not assessed. Interesting tRNA mutants with altered amino-acid-acceptor specificity can also be obtained by selection for changes in chromosomal tRNA genes that suppress missense mutations in specific proteins (65,66). However, such mischarging mutants insert incorrect amino acids at normal translation codons; they are therefore expected to be significantly defective in aminoacylation or some subsequent step in translation, or else they would be highly toxic.
2. NEW in Viuo ASSAYS
The inability to assay tRNAs containing wild-type anticodons has been a major problem in in uiuo studies of tRNA identity. If tRNAs containing anticodon base changes are efficiently charged by their cognate synthetases or by more than one synthetase, they are toxic to cells, frequently inserting incorrect amino acids into proteins. If the tRNAs are completely converted to the identity corresponding to the new anticodon, the usual assay is lost, since proteins indistinguishable from those synthesized by endogenous tRNAs are made. My group has recently been attempting to develop new in uiuo assays that allow studies of tRNAs containing wild-type anticodons (67, 67a). One such assay uses the E. coli initiator Met tRNA (tRNAfMet)as the test tRNA for the effect of specific mutations on amino-acid-acceptor specificity. Plasmid-borne tRNAfMet genes containing non-Met anticodons are expressed in cells harboring a compatible plasmid carrying a target protein gene with a complementary non-Met initiation codon. As in the nonsense suppression assay, dihydrofolate reductase has usually been used as the target protein; however, the gene has been altered to encode six additional
RECOGNITION OF
tRNAs
29
amino-terminal amino acids fused to the second amino acid of the wild-type protein (Fig. 1).Anticodon derivatives of tRNAfMetinitiate DHFR synthesis in this system (see below) and produce biologically active proteins that retain the initiating amino acid ( 6 7 ~ )The . amino-terminal amino acid is identified by protein sequencing to determine the amino-acid-acceptor specificity of the tRNA. An advantage of this system is that anticodon mutants of tRNAfM” are not toxic to cells, because they are unable to participate in polypeptide chain elongation (68,69). However, it remains to be determined whether this assay will be useful for all non-Met amino acids, and to what extent the structure of the tRNA outside of the anticodon can be altered without complete loss of its initiator function. A second potentially useful in uiuo assay now being explored is the use of frameshift-suppressor tRNAs having eight-membered anticodon loops to translate four-base codons near the amino terminus of the target protein. Several such tRNAs are aminoacylated quite efficiently in uitro (70, 71), and many more function as frameshift-suppressor tRNAs in uiuo (72-76). The potential advantages of this system are that any tRNA structure that allows translation can be tested for its effect on tRNA identity in the presence of the wild-type anticodon sequence. The disadvantages include the typically low suppression efficiencies of frameshift tRNAs and the potential of toxic effects caused by frameshifts in essential cellular proteins. Other in uiuo experiments could provide useful information on tRNA identity. Mutant elongator tRNAs that contain the presumed recognition elements and the known anticodon sequence of a noncognate tRNA could be expressed in uiuo and the effect on cell growth determined. Normal growth should be observed if the tRNA has been completely converted to a new identity. A more stringent test of such an “identity swap” would be complementation of cells in which the chromosomal gene(s) for the original tRNA has been inactivated. The latter is the only kind of in uiuo experiment that addresses the issue of aminoacylation efficiency as well as specificity. Such studies have not yet been attempted, and might fail in any case due to effects of the mutant tRNA on cell growth unrelated to tRNA identity.
111. Role of the Anticodon As was pointed out early in the study of tRNA recognition (77), the anticodon is the most logical site to specify the amino acid to be coupled to a tRNA, since this would directly link aminoacylation to the genetic code. Despite considerable evidence in favor of anticodon recognition for a number of tRNAs (reviewed in 5), the importance of the anticodon was not widely accepted until quite recently. Indeed, some current textbooks still state that the anticodon is not a recognition element for tRNAs (78).Arguments against
30
LADONNE H . SCHULMAN
the involvement of the anticodon in tRNA recognition were largely based on early studies of nonsense suppressors derived from Gln, Leu, Ser, and Tyr tRNAs, which insert the correct amino acid despite the presence of singlebase changes in the anticodon. Nevertheless, one of the first amber suppressor tRNAs studied, su +7 tRNATw containing a CCA-CUA anticodon change, has an ambiguous identity, inserting both Gln and Trp in oiuo (79). Subsequent in oitro studies showed that this single mutation affects recognition of the tRNA by both TrpRS and GlnRS, decreasing interaction with the cognate synthetase and increasing interaction with the noncognate synthetase (80, 81). At about the same time, anticodon base changes generated in oitro were shown to have dramatic effects on the recognition of E. coli tRNAfMef(82,), tRNAArg (83), and yeast tRNAVal(84,), and missense suppressors derived from tRNAC1y were found to be highly defective in aminoacylation by E. coli GlyRS (27,28). These early results were just a prelude of things to come. Kisselev presented an extensive review of the literature on anticodon recognition in this series in 1985 (5). I will attempt to summarize here the' data obtained in the following 5 years, with emphasis on E . coli tRNAs, which have been the focus of many of the recent investigations.
A. Anticodon Recognition in E. coli tRNAs 1. In Vitro STUDIES
Tables I1 and I11 summarize the effects of anticodon base changes on the recognition of tRNAs by cognate and noncognate synthetases in oitro. Significant reductions in the efficiency of aminoacylation of E. coli tRNAs specific for Arg, Gly, Ile, Met, Phe, Thr, Trp, Tyr, and Val result from base changes in the anticodon. The magnitude of the effect varies with the particular synthetase, and may be related to the total number of recognition elements in a given tRNA. MetRS and ThrRS also strongly protect the anticodons of their cognate tRNAs from chemical modification and nuclease attack (85, 86). Even stronger evidence for the role of the anticodon in recognition of tRNAs by specific synthetases is obtained when mischarging occurs in an anticodon-dependent manner. Substitution of the anticodons of noncognate tRNAs with anticodons corresponding to those of E . coli tRNAs for Arg, Met, Thr, and Val leads to increases of 104 to lo6 in mischarging by the corresponding synthetases (Table 111). In addition, 103- and 105-fold increases in the efficiency of mischarging of tRNAfMefand tRNATrpby E. coli GlnRS are observed when the wild-type anticodons of these tRNAs are replaced with the amber anticodon CUA. The efficiency of aminoacylation of noncognate tRNAs containing Met and Val anticodons by MetRS and ValRS is similar to that of the corresponding cognate tRNAs, suggesting that the
TABLE I1 EFFECT OF ANTICODONBASE CHANGESON in Vitro RECOGNITIONOF tRNAs Apparent Organism
tRNA".'
Anticodon"
K, (CLW
keJ
E. coli
.41a, Ala,
2.2 ND
1.oe ND 1.W
Yeast
Ala,
VIGC (wt) G G C (wt) CUA IGC (wt) IGU AGC GGC GGCC GC ICG (wt) IUG G U C (wt)
E.coli
A%,
Yeast
Asp"
E. coli E. coli
Glu
Gly I
uuc AUC U8UC (wt) UUA U8UU
2.9
0.039 0.326 0.250
0.7~ 0.035e 0.036<
ccc (wt)
ucu ucc
1.0 ND 1.4 1.0 Active Active Active Active Active 1.0 Inactive 1.0 0.006 0.008
Comments
Reference 36 36
Also U, + A,
36 87 88 88 89 89 83 1
1 1
Also C,2+U32
90 91 92 93
1.0
u * c c (wt) GCC (wt) GCA
Relative specificitye or activity
Active Inactive 1.0 Slightly reduced rate Slightly reduced rate
cccc Gly,
COGNATESYNTHETASES~
1.0
CUC Gly,
BY
0.16 1.3
1.Of 0.005r
Relative rate 10-4 1.0 6 x 10-4 Normal activity
Also A,+tGA,, Also A,7-+ms2i6A,7
27 28 28 27
(continued)
TABLE I1 (Continued) Apparent Organism
tRNAb.c
E . coli
Ile,c
E . coli
Mek MeV
Anticodon
K, (PM)
kef
1
GCU GUC C7AU CAU CAU (wt) CAU (wt) UAU AAU GAU
ccu cuu
E . coli
Met,,, Met,”
Yeast
Met,&
E. coli
Pheb
Yeast
Phe
CAG CAC CUA c 4 A u (wt) CAU CAU UAU GAU CCG GGU UAC CAU (wt)
5.7
0 . W
0.6
1.w
1.1 >100 >100 2.9 >100 >100
1.Of
0.030
Comments
Reduced rate
Mixture of species
1.0 Greatly reduced rate 1.0 1.0
lo-‘ 0.0001f
10-5 4 x 10-5 10-5 10-7
ccu
GAA (wt) AAA CUA GBAA (wt)
Relative specificityg or activity
1.Of
1.0 0.002 1.0 <0.01 Greatly reduced activity 1.00
Reference
94 95
96 96 96 96 96 96 96 96 96 97 98 98 43 18, 43 18, 43 100 18, 44 18, 43
j
k k 101
E . coli
Thr
GAA GAC GAU GCA GUA AAA CAA UAA UGU (wt)
0.043 0.121 0.071 0.104
0.118 0.306 0.250
0.217
1.5f 0.W
0.9w 0.46-f 0.42f 0.84f 0.77f 1.Wf
ucu CUA
E . coli
Trp
Bovine Liver
Trp
E . coli
TYr Tyrb
Yeast
TYr TyrC
CCA (wt) CUA C3CA (wt) U3CA C3UA QUA (wt) CUA GUA (wt) GGA GJlA (wt) GJlA (wt) UJlA CJlA AJlA GUA GCA GAA CUA CCA
0.13 7.7
5.0 8.2 0.32 5.0 0.054
0.052 0.27 0.23 0.55 0.096 0.34 0.43
0.53 2.50
l.W 0.1s
20.50 1.4~ 1.Of 0.076-f 1.W 0.98.f 0.71f 0.48f 0.80f 0.9of 0.72f 0.57f 0.27f 0.1w
1.06 0.24 0.42 0.13 0.11 0.08 0.09 0.14 1.0 Greatly reduced activity Greatly reduced activity 1.0 0.0025 1.0 Inactive Active 1.0 0.043 1.0 0.005 1.0 1.0 0.14 0.11 0.08 0.49 0.11 0.07 0.05 0.01
Also Y,,+G,, Also Y,,+G,, Also Y,,+G,, Also Y,,+G,, Also Y,,+G, Also Y,,+G,, Also Y,,-*G,, Also Y3,-+G3,
101 101 101 101 101 101 101 101
UCU more defective than CUA in oioo
102 102 80
80 103 103 59 59 lOla lOla 104 104 104 104 104 104 104 104 104 104 (continued)
TABLE I1 (Continued) ~~~
Organism
tRNA6.C
E. coli
Val, b
Yeast
Val,
An ticodon UUA UCA UAC (wt) CAU IAC (wt) IAU
Apparent K , (W) 1.10 2.50 1.0 <90
kef 0.51f 0.1w 1.Of
Relative specificityg or activity 0.07
Comments
Reference 104
0.015
104
1.0 10-5
43 43
1.0 Inactive
84
aZn oitro assays have been carried out with native tRNAs unless otherwise indicated. See also footnote a, Table I. wt, wild type. ND, not determined. btRNA in oitro transcript. CAnticudon change introduced using T4 RNA ligase. dMinor bases in anticodons are indicated using the abbreviations of Sprinzl et al. (112) as follows: V1 = uridine-Soxyacetic acid; U8 = 5-methylaminomethyl-2-thiouridine; C7 = lysidine = Nz-(5-amino-5carboxypentyl)cytidine; C4 = N,-acetylcytidine; G 3 = 2'-O-methylguanosine; C3 = 2'-0methylcytidine; U3 = 2'-O-methyluridine. U* in Gly,(U*CC) is an unknown modified U. ekcat (sec-1). fRelative V,=. gRatio of k,/K,,, or V,,/Y, values for mutant versus wild-type tRNAs. hRelative rate at 40 nM tRNA. See (71)and (155) for additional anticodon mutants of E. coli tRNAWc'. 'A. Garcia and R. Giege, unpublished. j F. Fasiolo, personal communication. kE. F. Tinkle and 0. C. Uhlenbeck, unpublished.
RECOGNITION OF
35
tRNAs
TABLE 111 ANTICODON-DEPENDENT RECOGNITIONOF NONCOCNATE tRNAs in Vitro" ~
Organism
tRNALc
E. coli
Arglb (cognate) Met,"
E . coli
Gln, (cognate) Metflr Met,,
Gln,
+ Gln,
(cognate)
Trr,
E. coli
Met, (cognate) Val," Trp" Phe Ile,c
Yeast
E. coli
Phe (cognate) Tvr< Thr," (cognate) Met,"
Yeast
Tyrr (cognate) Phec
E. coli
Val," (cognate) Met,"
Anticodon" CCGl CAU-CCG CAU CUG CAU+CUA CAU CAU-CUA U*UG, CUG CCA-CUA CCA CAU UAC-CAU UAC CCA-CAU CCA GAA-CAU C7AU-+CAU C7AU G3AA GJIAjGAA GGU
CAU-r G G U CAU GW GAA-rCUA UAC CA U-* UAC UAU CAU
Apparent Relative K, ( p M ) V,
1.1 5.2
1.0 0.015
0.12 2.2 >100
1.0 0.05
0.19 6.7
1.0 0.21
0.6 1.2 >loo 2.9
1.0 1.9 0.1
>loo
0.093 1.20 2.50 0.20 0.9
1.0 0.015 0.002 1.0 0.03
1.0 5.0
1.0 0.5
Relative specificity' or activity 1.0 3.3 X 0.8 x 10-7 1.0 2.8 X 10-3 2 x 10-6 4.6 X 1.0 5.9 x 10-3 <10-7 1.0 1.0 1.5 X 10-6 2 x 10-2 2 x 10-6 Normal activity Active Inactive 1.0 1.2 x 10-3 0.7 x 10-4 1.0 7 x 10-3 7 x 10-7 1.0 Increased activity 1.0 0.1
4 x 10-5 5 x 10-6
Reference 100 100 100
97 97 97 69 80 80 80 43 43 43 g
g
h 95 95 105 105
105 44 44 44 106
43 43 43 43
eAs in Table I1 footnotes. Noncognate tRNAs are from the same organism as cognate tRNAs. &Asin Table I1 footnotes. cAs in Table I1 footnotes. "As in Table I1 footnotes. e[ V,,,,/K,, ]noncognate/[ V,,IK,,,]cognate. /The wild-type anticodon for tRNAPg is ICG. EL. H. Schulman and H. Pelka, unpublished. JIB. Bahramian, C. P. Lee and U. L. RajBhandary, unpublished.
36
LADONNE H. SCHULMAN
anticodon is the dominant recognition element for these synthetases. Other mutant tRNAs are aminoacylated less efficiently than the wild-type species, suggesting that important recognition elements are also to be found outside of the anticodon (see Sections IV and V).
2. In Viuo STUDIES In uiuo data also provide strong evidence of the important role of the anticodon in the recognition of cognate tRNAs and discrimination against noncognate tRNAs by E. coli synthetases. Abelson, Miller, and co-workers have constructed genes for amber suppressor derivatives of tRNAs specific for all of the amino acids not represented in the original collection of genetically derived amber suppressors, and have tested their amino-acid-acceptor specificity in the amber suppression assay described earlier (52, 53, 107, 108). Of the 16 different tRNAs tested that were active in translation, nine were mischarged (Table IV). Amber suppressor derivatives of Asp, Ilel, Ile2, Met,, and Val tRNAs did not insert their cognate amino acids in uiuo, while derivatives of Arg,, Glu, Gly,, and Thrz partially retained their original identity. Additional genetic experiments also strongly support a role for the anticodon in the recognition of threonine tRNAs by E. coli ThrRS (102,109111). All of the completely or partially mischarged amber suppressor tRNAs accepted either Lys or Gln (Table IV), indicating the importance of the anticodon for the in uiuo recognition of tRNAs by LysRS and GlnRS as well. Although it is tempting to conclude that the anticodon is not important for in uiuo recognition of the other nine amber suppressor tRNAs that specifically retain their original identity, this conclusion is incorrect. Use of anticodon derivatives of tRNAfMet in the initiation assay described earlier shows anticodon-dependent mischarging of this tRNA by synthetases specific for Ile, Phe, and Val (Table V). Phe is one of the tRNAs that retain their identity as an amber suppressor. The importance of anticodon base A3, (Fig. 2) in the recognition of tRNAs by PheRS is shown by the high level of insertion of Phe by tRNAf Met containing the wild-type Phe anticodon GAA, and the absence of Phe in protein initiated by tRNAfMet containing the closely related GAU,, and GAC,, anticodons. The amber suppressor derivative of tRNAPheretains A3, in the amber anticodon CUA,, and this partially accounts for the retention of Phe identity by this tRNA. A3, is not sufficient to specify Phe, however, since other derivatives of tRNAfMet that contain A3, insert no Phe (67a). Sites outside of the anticodon also contribute to the identity of E. coli tRNAPhe (see Section V,C). The apparent paradox of the retention of Phe identity by tRNAPhe(CUA)and recognition of all three Phe anticodon bases by PheRS is resolved by the following scenario: tRNAPhe(CUA)retains suffi-
ON
TABLE IV EFFECTOF THE AMBER ANTICODON CUA THE MISCHARGING OF E . coli tRNAs in Vioo" Partially mischarged
Mischargedb AspMe Ile, (748)f (16%)r Ile,. Metme Val,e
(a).
Arg (55%)p G h A (17%)f,g Gly, (37%)J Met,$ Thr, (86%). su+7 Trpd
Not mischargedd A h CYS Gln, (su+2) GlY, HisA Leu, (su+6) LYs Phe ProH Ser (su+l) Tyr (su+3)
OBased on the insertion of amino acids into position 10 of DHFR-amber unless otherwise indicated. All of the tRNAs conU,,, tain a CUA anticodon. In addition, AspM contains A, A,, . U,, and A,; Ala,, GluA, and HisA contain A,; and ProH contains residues 1-26 and 44-76 from tRNAproand residues 27-43 from tRNAPhe(CUA).The suppressor tRNAs are derived from the following wild-type tRNAs: Ile,, tRNA:"(GAU); Ile,, tRNAp(C,AU); Val, tRNA?'(U*AC); Arg, tRNAtrp(ICG); Gly,, tRNA?''(CCC); Gly,, tRNAglY(U*CC); Thr,, tRNAThr(UCU), Ala,, tRNA;'"(GGC); Gln,, tRNAg'"(CUG); Leu, tRNAp(U*AA); ProH, tRNAPro(CGG);Ser, tRNA,s"(CCA). The effect of changes in base modifications, if any, have not been assessed. All tRNAs were overproduced except Al%, Gly,, HisA, and Trp. Data for AI%, AspM, GluA, Gly,, Gly,, HisA, Ile,, Ilez, Lys, Met,,,, ProH, Thr,, and Val are from 107 and 108. Data for Arg is from 55; for Cys and Phe, from 52; for Gln,, Leu,, and Ser, from 26; for Tyr, from 59; and for Trp, from 79-81. Mischarging of Metf with Gln is based on in oitro (97, 69) and in oioo (113) data. No data are presented for Asn, which is inactive as an amber suppressor tRNA. U* in the anticodon of tRNAy" is uridine-5-oxyacetic acid, and in the anticodon of tRNA:IY and t R N A p is an unknown modified U. bMischarging is at least 95% based on DHFR-amber sequence analysis. "Partially mischarged tRNAs insert a mixture of cognate and noncognate amino acids into DHFR-amber. The percentage of noncognate amino acid inserted is indicated; however, it should be noted that this value does not necessarily correspond to the percentage of in oiuo mischarging. For example, tRNATrP(CUA)inserts 90% Gln, 10%Trp, but is charged equally with Gln and Trp in oioo (81). dLess than 5% of any other amino acid inserted into DHFR-amber. eMischarged with Lys. fMischarged with Gln. EAlso 6% Tyr and 6% Arg.
38
LADONNE A 76 C C
A I
3
.-. .-.
Acceptor stem D loop .''A
G
G
.-.
0
72
"Discriminotor"
70
.-.-. . . . . cT loop. 6.0
. D stem .-. .-.
T S .*45
.-.
*
.-.
30--*40
U
!b
I '
I?.
25'
0'2
n. SCIIULMAN
. . 35
Variable loop
A
3' end
1
Acceptor stem
Anticodon stem
w
Anticodon
FIG. 2. (A) Cloverleaf structure of a typical class-I tRNA, numbered according to 112. Bases conserved in all E . coli tRNAs are indicated. (B) Three-dimensional structure of yeast tRNAPhe (1, 2).
cient recognition elements to be aminoacylated by PheRS in uiuo (undoubtedly with significantly reduced efficiency). The amber suppressor tRNA is overproduced several hundred fold (52, 53), partially compensating for its lower affinity for PheRS; the level of charged tRNAPhe(CUA)is sufficient for translation of the relatively low concentration of UAG codons in the in uiuo suppression assay; and tRNAPhe(CUA)is a poor substrate for GlnRS and LysRS due to the presence of negative elements outside of the anticodon which prevent mischarging by these synthetases. Isoacceptor Val tRNAs contain either U or G at position 34 of the anticodon. The remaining two anticodon bases, A, and c36, are critical for in uiuo recognition of tRNAs by ValRS, since tRNAfMefcontaining the anticodon GAC,, inserts only Val, while tRNAfMet(GAU3&and tRNAfMCt (GC,,C) insert no detectable Val (Table V; 67a). A summary of key anticodon bases for in uiuo recognition of tRNAfMetand nonsense suppressor tRNAs by different synthetases derived by analyses of this kind is included in Table VI. It should be noted that the in uiuo data obtained by both the nonsense suppression and initiation assays are in excellent agreement with in uitro data, where available.
RECOGNITION OF
tHNAs
39
TABLE V ANTICODON-DEPENDENT MISCHARCINC OF E. coh tRNAfMetin Viuoa tRNAfMet anticodonb
Cognate amino acid.
GAU GAA GAC CUA
Ile Phe Val
-
Amino acid inserted Ile (>90%) Phe (>90%) Val (>90%) Gln (ND)
aBased on the insertion of amino acids into position 1 of pseudo-lacZ (Phe and Val; 67) or position 1 of DHFR-start (Ile; L. Pallanck and L. H. Schulman, 67a). tRNAfMetGAU, GAA, and GAC anticodon derivatives were expressed in oioo at a level comparable to that of endogenous tRNAs. tRNAfMet(CUA)was overproduced in oioo and was shown to initiate protein synthesis from a UAG codon at the start site of the chloramphenicul-acetyltransferasegene. The protein was not sequenced; however, complementary in oitro experiments showed that Gln was inserted by the tRNA (113). ND, Not determined. hChanges in base modifications have not been assessed. CAmino acid corresponding to the anticodon in the mutant tRNAfMet.
As illustrated by the example of Phe, it is not safe to assume that anticodon recognition is unimportant for the other amber suppressor tRNAs that retain their identity in oioo. Several such tRNAs, in addition to Phe, retain one or more bases present in the wild-type anticodon: Cys, As6; His, U3,+ and Tyr, U3,A3,. In uitro studies show that U,, is a recognition element for TyrRS (101~). However, it is likely that amber suppressor tRNAs that retain their identity have important recognition elements outside of the anticodon, and they may also contain negative elements for GlnRS and LysRS. Direct investigation of the effects of base changes at each site of the anticodon on the efficiency of aminoacylation by cognate synthetases will be required to determine the role of the anticodon in recognition of these tRNAs. Such experiments have been carried out only on tRNAA1"(36).This tRNA requires no specific anticodon bases for recognition by AlaRS (Table 11). The recognition of five Ser tRNAs containing different anticodon sequences by a single E. coli SerRS also suggests that the anticodon plays no role in the recognition of tRNAs by this enzyme. Table VI summarizes current knowledge on the role of the anticodon in recognition of specific E. coli tRNAs.
40
LADONNE H. SCHULMAN
ROLE OF
TABLE VI ANTICODON IN THE RECOGNITIONOF E. coli tRNAs BY E . coli AMINOACYL-tRNA SYNTHETASES~
THE
~
Anticodon recognized ‘4% Gln GlY Ile LYs Met Phe Thr Trp TYr Val
~~~~~~~
An ticodon recognition elements
,Y
c,
’
u,
’
G,
G5 c36 ’
b
usc C, A,. G , . A,.
U, A,
Unknown Asn Aspd CYS Glud His Leu Pro
Anticodon not recognized Ala Sere
c3-5 u, ’
Cmc urnc ‘43-5
’
c,
‘See Tales II-V, XIV, and XV for references. Anticodon-dependent insertion of an amino acid in t h o and/or in oitro aminoacylation studies have been used to assign the E. coli tRNAs that contain recognition eleY in Gln is assigned on the basis of the X-ray ments in the anticodon. , crystal structure of the tRNAC’” GlnRS complex and unpublished data of M. Jahn and D. SOIL b Anticodon recognition sites are unknown. CAdditional anticodon recognition sites may exist. dThe anticodon is required for in oioo identity (107, 108). Data on recognition are unclear. eSerine isoacceptor tRNAs contain base changes at all three positions of the anticodon; therefore, the anticodon probably does not contain recognition elements for SerRS, but this has not been directly determined.
3. E. coli METHIONINESYNTHETASE
The strongest evidence that the anticodon contains the major determinants for recognition of tRNAs by a synthetase comes from the case of E. coli MetRS (43, 82, 96-100). An extensive set of mutants of both tRNAfMetand tRNAMet shows that all three anticodon bases are required for efficient aminoacylation by the cognate synthetase, with the largest effects seen at C, in the “wobble” position (Table 11). In addition, transfer of the Met anticodon to E. coli tRNAVa’, tRNAPhe, or tRNA&Ieleads to efficient mischarging of these tRNAs by MetRS (Table 111). The importance of C, for in oioo recognition of Met tRNAs is illustrated by the loss of Met insertion by tRNAfMefon substitution of G,AU for the normal C,AU anticodon (Table V) and partial retention of Met identity by tRNAfMethaving the anticodon C,,CA (67a).
41
tRNAs
RECOGNITION OF
Comparison of the primary sequences of tRNAs efficiently aminoacylated by MetRS shows that, aside from the conserved bases in all E. coli tRNAs, only the anticodon bases are common (Fig. 3). However, examples of small effects of sequence changes at other sites have been observed. For example, transfer of the Met anticodon to E. coli tRNATv increases the specificity for aminoacylation (V/K,,,)of this tRNA by MetRS 15,00-fold, but is still l/50th of that of wild-type Met tRNAs (Table VII). A conversion of G,, to A,, in tRNATv(CAU) increases V / Y , 10-fold, and an additional change from G,-C,, to C3eG70 raises the activity of the tRNA to that of cognate Met tRNAs. Independent studies of the role of base 73 in aminoacylation of tRNAfMet have shown that A,, is not a recognition element for MetRS (Table VII; 30). Substitutions at this site lead to only small (two- to three-fold) changes in Vma, in the order A,, > U,, > C,,, C,,. Since A and U share no functional groups, direct positive contacts between MetRS and base 73 are unlikely. U,, is also found in bacteriophage T5 tRNAfMet, which is expected to be aminoacylated by MetRS in oioo. We conclude that G,, is a negative ele-
TABLE VII AMINOACYLATION OF tRNAs WITH E . coli MetRS ~~
~~~
tRNA Transcripts"
V (pnol /min/mg)
VlY,
1.1 1.2 1.2
1.9 1.5 1.5
1.7 1.3 1.3
1.4 2.9 >lo0 >loo
0.7 0.08 -
0.5 0.03 2 x 10-6 2 x 10-6
Apparent K , (pM)
tRNA,Met(CAU) tRNAval(CAU) tRNATrP(CAU)G,,+A,, + G, ' C7n+C3 G7n tRNATrP(CAU)G7,+A7, tRNATrP(CAU) tRNATrP(CCA) t RNAVal(UAC)
Relative VIK,
9 x 105 7 x 105 7 x 105
'
Apparent
K, ( W M )
Native tRNAs6 tRNAf'Met(CAU)A7, tRNAfMPt(CAU)A7,+ U, c'73 c73
1.1 1.1 1.1 1.1
-
2 x 105 0.15 X 105 1 1
Relative Vmax
Extent of aminoacylation (96)
1.0
100 99 57 48
0.64
0.36 0.34
OtRNAs were prepared by in oitro transcription. Data are from 43 and from L. H . Schulman and H. Pelka, unpublished. btRNAs were prepared by the addition of N7,CCA-OH to tRNAfMPtmissing the four 3'-terminal nucleotides using T4 RNA ligase (30).
42
n. SCHULMAN
LADONNE
76
0
0 0
0
10-0 0-0 0 - 0 ' 0
0-0 0 - 0 0-0
60
0-0 o
m
0
0
0
O
0 0
0
50
e e . 0 O
0
00.00
0 .
I I I I
0
.
I I I I I
10 0
0
0.0.0
0
0
0
0
20
0 - 0 0 - 0 0-•
30
-
40
0-0 0
0
35
FIG. 3. Composite structure of tRNAs aminoacylated by E. coli MetRS with kinetics similar (within a factor of 2 or 3) to cognate E. coli Met tRNAs (24, 114-117 and B. L. Seong, C. P. Lee and U.L. RajBhandary, unpublished). Open circles indicate the sites of bases conserved in most or all class-I E. coli tRNAs (see Fig. 2). A21 is also conserved in all class-I tRNAs except tRNAcYs. Letters indicate the positions of other conserved bases. Arrowheads indicate the positions of known major recognition elements. Dots indicate the positions of sequence variation. Small dots indicate sites where two different bases have been found; medium dots, where two unbonded bases that share no functional groups or three different bases have been found; large dots, where all four bases have been found. In addition, the size of the D-loop can vary from seven to nine nucleotides, the variable loop can contain four or five nucleotides, and a base-pair is not required at position 1.72 and several other internal sites. Base modifications have been ignored in compiling the composite.
RECOGNITION OF
tHNAs
43
ment for MetRS, which somewhat weakens interaction with noncognate tRNAs having this base. This could be particularly important to maintain fidelity in cases like that of wild-type tRNATrp, which has C , in the anticodon. The magnitude of the negative effect on MetRS produced by G,, is seen to vary with the tRNA context, being greater in tRNATq than in tRNAfMct(Table VII). The small effect (three- to four-fold) of the base-pair change at position 3.70 is also a context effect. C,*G,, is found in E. coli tRNAVa', which is efficiently charged by MetRS (Table VII) and A,.U,, is also an acceptable sequence at this site in tRNAfMet(B. L. Seong, C. P. Lee and U. L. RajBhandary, unpublished). As different nucleotides are functional at all sites outside of the anticodon (Fig. 3), the anticodon bases contain all of the base-specific recognition elements for E. coli MetRS. Functional groups shared by two different nucleotide bases could emerge as additional recognition elements at other sites.
B. Anticodon Recognition in Yeast tRNAs Much less information is available on the role of the anticodon in the recognition of yeast tRNAs. Tables I1 and I11 summarize the effect of anticodon base substitutions on the recognition of cognate and noncognate tRNAs by yeast Ala, Asp, Met, Phe, Tyr, and Val synthetases. In considering these data, it should be realized that, in general, yeast synthetases discriminate less well than E. coli synthetases between cognate and noncognate tRNAs. E. coli synthetases commonly show a specificity for aminoacylation of cognate tRNAs of 105 to 108, while yeast synthetases select cognate tRNAs with a specificity closer to 1W to lo6. The contribution of individual recognition elements, including those in the anticodon, to overall specificity is thus expected to be significantly lower for the yeast enzymes. Strong effects (>1O2) of single anticodon base changes on the recognition of cognate yeast tRNAs have been observed for yeast Asp, Met, and Val synthetases. Genetic studies have also implicated the anticodon as a recognition element for yeast MetRS (119). Single-base changes in the anticodons of yeast tRNAPhe and tRNATyr decrease the efficiency of aminoacylation by the cognate synthetase in uitro; however, the magnitude of the effect of such changes on recognition by these enzymes is much smaller, in the range of 3- to 14-fold (Table 11). Nevertheless, the effects of individual base substitutions are roughly additive, creating large effects on activity in tRNAs containing multiple mutations. In addition, the anticodon bases compose a significant part of the overall recognition set, at least in the case of tRNAPhc(see Section V, B), and switching the anticodons of tRNAPhe and tRNATyr leads to increased mischarging by the corresponding noncognate synthetase (Table 111).
44
LADONNE H. SCHULMAN
Base changes in the anticodon of yeast tRNAAla have little or no effect on the recognition by yeast AlaRS, as was observed for the E. coli Ala synthetase.
C . Summary The anticodons of 11E . coli tRNAs clearly contain one or more important recognition elements for cognate synthetases, and it is likely that this number will increase. In addition, two other E. coli tRNAs have been shown to have identity elements in the anticodon. Although the anticodon is not required for the recognition of tRNAAIa,and possibly tRNASer,these and all other E. coli tRNAs probably contain identity elements in the anticodon that are crucial for the discrimination of cognate and noncognate tRNAs by synthetases in uiuo. Where information is available, yeast tRNAs follow a similar pattern to that observed in E. coli. Thus, it is expected that many eukaryotic tRNAs have retained essential recognition elements in the anticodon as well, as directly demonstrated for bovine tRNATm (103).
IV. Role of the Acceptor Stem and the ”Discriminator” Base at Position 73 Aside from the anticodon, the region of tRNA structure most frequently implicated in synthetase recognition is the domain adjacent to the 3’-terminal CCA sequence, containing the first 3 bp of the acceptor stem (positions 1.72, 2.71, and 3.70) and the fourth base from the 3’ end (position 73) (Fig. 2). The latter base has been suggested to be a universal “discriminator” site that assists synthetases in sorting tRNA substrates (120);the acceptor stem has been postulated to be the site of the earliest recognition elements in the evolution of tRNAs (121).
A. Alanine Synthetases Among E. coli tRNAs, the acceptor stem contains recognition elements for Ala, Gln, His, and Ser, and this region has been implicated in recognition by several other synthetases. The most dramatic results have been obtained with Ala tRNAs, in which a single G,*U, base-pair is a major recognition element for AlaRS both in uiuo (35, 54) and in uitro (35, 36, 59). Amber suppressor tRNA derivatives of Ala tRNAs undergo a large loss of activity on conversion of G,-U,, to a standard Watson-Crick base-pair or on substitu-
RECOGNITION OF
tRNAs
45
tion of a U,*G,, sequence (Table VIII). In addition, transfer of the G,.U,, base-pair to amber suppressor derivatives of tRNAPhe, tRNAcys, and tRNALys converts each of these tRNAs into efficient Ala-inserting tRNAs. The mutant Cys and Lys tRNAs insert only Ala; however, tRNAPhe (CUA)G,-U,, inserts both Ala and Phe, indicating that PheRS can still recognize the mutant tRNAPhe. Mutations at several additional sites (Table VIII) lead to almost complete conversion of the identity of tRNAPheto that of Ala. This could result from a more favorable interaction of the altered tRNA with AlaRS and/or a less favorable interaction with PheRS. McClain et al. (56) have shown that sequences other than G,*U,O allow the insertion of Ala into protein by tRNAAIa(CUA)with low efficiency. Some of these sequences contain neither G, nor UT0. These workers have therefore suggested that a "helix irregularity," rather than a specific sequence at position 3.70, is recognized by AlaRS. However, in uitro data argue that some feature of the G,.U,, basepair is specifically recognized, as no activity is observed with tRNAs containing G,*C,; A,*U70, or U,'G70 using high concentrations of purified enzyme (Table IX). A minihelix consisting of the acceptor and T-stems of tRNAAla plus the unmodified T-loop (Fig. 4) is aminoacylated with a specificity only a fifth of that of the native tRNA, indicating that this truncated RNA contains the major determinants for recognition by AlaRS (122).A microhelix containing only the acceptor stem and a seven-membered loop is aminoacylated with a fiftieth of the specificity of the intact tRNA, indicating loss of contacts that improve both binding and the efficiency of aminoacylation. In uitro footprinting of the tRNAAla.AlaRScomplex show that the enzyme protects phosphates in the acceptor stem on the 3' side of residues 64-70 from nuclease attack (123).Base changes at positions 1.72, 2.71, 5.68, 6.67, and 7.66 in the acceptor stem, and 49.65, 50.64, and 51-63 in the T$C-stem allowed insertion of Ala by tRNA$'"(CUA) in uiuo (35),indicating that none of these sites is essential for recognition by AlaRS. In addition, base-pairs 5-68, 6-67, 7.66, 49.65, 50.64, and 51-63 are not conserved in amber suppressor derivatives of B. mori and human tRNAAla,which are efficiently aminoacylated by E . coli AlaRS in uitro and insert only Ala into DHFR-amber in E. coli (60).It has been suggested that bases 16, 17, 20, and 60 play a role in Ala identity (54); however, these bases are not conserved in the B. mori and human Ala tRNAs. In addition, the low levels (4-6%) of insertion of Lys brought about by mutations at these sites in E. coli tRNAAla(CUA)would very likely be blocked by the presence of a wild-type Ala anticodon containing G,,, making the significance of the Lys mischarging unclear. Sites outside of the acceptor and T-stems are likely to be involved in Ala identity by making negative contacts with noncognate synthetases.
TABLE VIII
EFFECTOF MUTATIONSON THE RECOGNITIONOF tRNAs in Vioo BY E . coh AlaRs tRNA ( a n t i d o n change)
tRNAtL"(GGC)+(CUA)
tRNAPhe(GAA+(CUA)
Additional mutations
Amino acid inserted
(%)a
Ala, 96 Ala, 18; Lys, 29; Gln, 44 Ala, 89 Ala, 55; Lys, 29; Gln, 6 Ala, 83;Gln, 12 Ala, 90 Ala, 75; Lys, 12 Ala, 97
Phe, 100 Ala. 24; Phe, 76 Ala, 63; Phe, 37. Ala, 96; Lys, 4
Suppression efficiency ( % ) b . c 4.126 0.076 0.636 0.3Qb 0.556 0.36h
0.22" 21c Inactive' Inactivec Very weakly activec 12= 786d 106
ND 146
tRNACys(GCA+(CUA)
None c3
tRNAL~5(U,,UU+(CUA)
'
G70*G3
'
u70
None G3
. C70+G3
.
G3 . AiO A3 c i o '
tRNAz'Y(U*CC+(CUA)
None G , C,O+G, None None '
tRNATYr(QUA+(CUA)
u3
3
'
U7"
.
'
7 '0
u3 .
'
7 '0
(1 X (17 x (1 X (17 X
AlaRS)
AlaRS) AlaRS) AlaRS)
CYS Ala, > 9 Y
Xbd
LYS, 94 Ala, 94 Ala, 39; Lys, 49 Ala, 22; Lys, 69 Gly, 16; Gln, 84
31" 34" 1.66
Gly, 5; Gln, 95 Tyr onlyf Tyr onlyf Tyr, 95; Gln, 5.f Ala, 95; Gln, Y
ND
3.6" 24
3" ND ND ND ND
"Insertion into DHFR-amber. The percentage of each amino acid at position 10 is given. Note that this may not correspond to the percentage of aminoacylation of the tRNA in oioo. All tRNAs were overproduced. See Table 11, footnote d, for the definition of anticodon minor bases. bSuppression of the amber allele A,, in the hcZ-Z fusion gene (52). Data are from 56 unless otherwise noted. See this reference for additional mutants. (125). Data are from 35. cSuppression of TrpA(UAG,) dData are from 52. eData are from 35. /Data are from 59.
48
LADONNE
n. SCHULMAN
FIG.4. (A) Structures of E . coli tRNAf", minihelix*la, microhelixAla, and minihelixTYr. Base changes from the wild-type sequence are indicated by arrows. (From 8 with permission.) (B) Sites of known major recognition elements in E. cob Ala tRNAs are indicated by arrows.
RECOGNITION OF
49
tRNAs
Retention of very weak Ala-inserting activity by tRNAA1"(CUA)mutants containing non-G,*U7, sequences may indicate the presence of additional weak recognition elements at other sites. Sequestering of low levels of aminoacylated tRNA by EFTu-GTP may also contribute to the in uiuo activity of these mutants. However, it is likely that these weak suppressor tRNAs would show no measurable in uiuo activity if they were not significantly overproduced. Two nonstandard base-pairs, G3eA70 and A3C70, also lead to the insertion of low levels of Ala by tRNALYs(CUA)(56), suggesting that mismatches at position 3.70 may assist in adapting the structure of a tRNA to the surface of AlaRS in a manner leading to inefficient aminoacylation in the absence of G,*U,,. These results are somewhat reminiscent of those seen in the mischarging of tRNATyr(CUA)acceptor-stem mutants with Gln, where introduction of sequences different from those present in tRNAGln leads to mischarging by GlnRS (see Section IV,C). Several suppressor tRNAs to which the G3.U7, sequence was transferred failed to insert Ala in uiuo, including tRNA,G'y(CUA) and tRNATYr(CUA) (Table VIII). The activity of tRNATyr(CUA)G3-U7,was examined in uitro and found to be a tenth of that of tRNAAIa(Table IX). Comparison of the kinetic
B
I
FIG.4. (cont.)
50
LADONNE
H.
SCHULMAN
TABLE IX AMINOACYLATION OF RNAs WITH E . coli AlaRSO Apparent K, (pM)
RNA
k,,, (SKI)
k , t K
( M - 1 s - 1 x 10-5)
Relative
k,,,lK,,
~~
tRNA:'"(UGC) tRNAf"(CUA) + U3,4+A, tRNATYr(CUA)+ C3G,o-*G,. U7, MinihelixA'a MinihelixTyrC, G7,+G3 . U7, Minihelixc~'C3. G7O+G3 . u70 + U,,+A7, MicrohelixAla tRNA;'"(CUA)G, U,,+G, C, '4, ' G,o '
MinihelixcW, . G7O+G3 MinihelixAlaA7,+ N7,
c70
u70
2.2 2.9 14.0 9.1 8.8 8.8
1.0 1.8 0.6 0.9 0.5 0.3
35.9
0.3 0.078 0.02 No activity at 4-pM tRNA, 20-pM AlaRS No activity at 4-pM tRNA, 20-pM AlaRS No activity at 4-pLM tRNA, 20-pM AlaRS No activity at 2-pM RNA, 0.75-pM AlaRS Rate A,, S- C7, > U,, > G7,
>90
4.5 6.2 0.43 1.0 0.53 0.32
1.0 1.38 0.10 0.22 0.12 0.07
a Data are from 36.59, 122, and 126. The concentration of Ala in the assays is suhsaturating; however, this does not greatly affect the kinetics of aminoacylation by AlaRS (127).
parameters for aminoacylation of the tRNA by TyrRS and AlaRS in uitro and estimates of the endogenous levels of the two synthetases suggested that the intracellular concentration of AlaRS was too low to compete effectively with TyrRS for tRNATYr(CUA)G3.U7,. Elevation of the AlaRS concentration by introducing a plasmid carrying the alas gene resulted in insertion of Ala by the tRNA in uiuo (Table VIII). The failure of tRNA,G'Y(CUA)G,-U,, to insert Ala in uiuo could be due to more favorable interaction of this tRNA with GlnRS (Table VIII) and/or to the presence of negative elements for AlaRS. A missense suppressor derived from wild-type tRNALYs(U*UU)containing a G , ~ C 7 0 ~ G , * U 7mutation 0 was isolated earlier in genetic studies and shown to insert either Gly or Ala in uiuo (124).Suppressor activity is lost when cells containing the mutant tRNA and a temperature-sensitive AlaRS are grown at an intermediate temperature, indicating that Ala is inserted by this tRNALys derivative (F. T. Page1 and E. J. Murgola, unpublished). The mutant Lys tRNA has also been known to accept Ala in uitro. The G3eU70 base-pair was predicted by sequence analysis to be a recognition element for E. coli AlaRS (128,129),as it is uniquely present in Ala tRNAs in E. coli. This structural feature has also been preserved in higher organisms (112).Early studies using reannealed acceptor-stem fragments derived from yeast tRNAAla showed that the acceptor stem contains sufficient information for in uitro aminoacylation by yeast AlaRS (130). The G,.U7, base-pair has recently been shown to be required for in uitro ami-
RECOGNITION OF
tRNAs
51
noacylation of human and B. mori Ala tRNAs by homologous and heterologous Ala synthetases (60), suggesting that this sequence is an important recognition element for all of the Ala enzymes. Although tRNACys(CUA)G,*U7,inserts only Ala in uiuo, this tRNA was inefficiently aminoacylated by AlaRS in uitro (35).Recent studies (126)indicate that this may be due largely to the presence of U,, in tRNACys. A minihelix containing the acceptor and T-arms of the Cys tRNA plus a change of U,, to A,, was aminoacylated in uitro by AlaRS with a specificity only a third of that of the Ala minihelix, while the U,,-containing minihelix was inactive (Table IX). Substitutions of any other base in place of the wild-type A,, sequence in the Ala minihelix also resulted in a significant reduction in both the rate and extent of aminoacylation, indicating that A,, is also a recognition element for AlaRS (Fig. 4). The effect of changes at A,, appear to be mainly on kcat, while changes at G3.U70 strongly affect both kcat and K,,, (36, 126). A change of A,, to U,, in the amber suppressor derivative of tRNA$Ia has no detectable effect on the identity of the tRNA in uiuo, indicating that G,.U,, is a dominant recognition element for this tRNA (Table VIII).
B. E. coli Serine Synthetase The in uiuo amber suppression assay has been very effectively used to study the structural requirements for recognition of tRNAs by E. coli SerRS. The original identity swap type of experiment was carried out by Normanly et al. (19), inserting 12 base changes into the structure of tRNA,L""(CUA)to convert it into a Ser amber suppressor tRNA (19).Subsequent studies show that only eight of these changes (in addition to the anticodon changes) are required for the Leu-Ser conversion (Fig. 5; 7). Six of the important sites are located near the acceptor end of the tRNA. Four generate sequences conserved in all E. coli Ser tRNAs and bacteriophage T, tRNASer: G,.C,,, G,C,,, and G73. Sequences found at position 3.70 in wild-type Ser tRNAs are either A,.U,, or U,*A,,; however, only A,*U,O brought about the desired conversion to Ser identity, possibly by blocking interaction of the tRNA with LeuRS (7). Thus, position 3.70 contains an identity element, but not necessarily a recognition element for SerRS. Substitution of 2 bp at positions 1-72and 3-70 in tRNASer(CUA)leads to a large loss of Ser suppressor activity and a gain of Gln-inserting activity (61) (Table X). The changes are to sequences important for the recognition of tRNAs by GlnRS (see Section IV,C); however, it is not clear that GlnRS would recognize native tRNAser(U*GA) containing the anticodon base G,, and having the same acceptor-stem mutations. Such a tRNA might retain Ser identity. In addition to the mutations in the acceptor-stem region, the complete conversion of tRNAp(CUA) to a Ser-inserting tRNA required an additional change at position 11.24 in the D-stem (Fig. 5). A C,,*G,4 sequence is found
52
LADONNE
N. SCHULMAN
16
0
0 I
G-C G -C
G
.-. .-.
0 - 0 7 0
0-0 0-0
G 0
O 0 * .
20..
.
p,
@$* ..GO
21
b* ttii;
Yo..
C-G 0 - 0 .-• 30 0 60
-
0-0
\
A
C
A A
e
* 35 U
O
0
35
FIG. 5. (A) Base changes involved in the in oiuo conversion of E. coli tRNAk' identity from Leu to Ser (7, 19). (B) Composite structure of E. coli and bacteriophage T, Ser tRNAs (112). Due to uncertainty in the alignment of the D-stem, this region of the selenocysteineinserting tRNASer has been omitted from the composite (see text). The large variable loop is not conserved in size or sequence. See the legend to Fig. 3 for definition of the symbols.
in T4 tRNASer and all four E. coli Ser tRNAs; however, the Ser tRNA that normally inserts selenocysteine at the site of UGA codons in specific E . coli proteins (131)has unusual D-stem and acceptor-stem structures (132).There are 8 bp in the acceptor stem, followed by two unpaired bases (9 and lo), and a 4-bp D-stem. By the conventional cloverleaf arrangement, the base-pair in the position equivalent to 11.24 in the other Ser tRNAs is a G C sequence, raising questions about the exact role of the 11-24 base-pair in the recognition of tRNAs by SerRS. Three of the five Leu tRNAs contain Cll.G24, suggesting that C - G does not inhibit LeuRS. Thus, structural features other than primary sequence may play a role in the interaction of SerRS with this region of its tRNA substrates. The long variable arm of Ser tRNAs also plays a role in discrimination between cognate and noncognate tRNAs by SerRS (101~). In uitro identity swap experiments designed to convert tRNATyr into a Ser-accepting tRNA suggest that the orientation of the variable arm, rather than its primary sequence, influences the interaction of tRNAs with SerRS. Comparison of the conserved sequences in Ser tRNAs (Fig. 5 ) suggests
RECOGNITION OF
53
tRNAs
TABLE X MUTATIONSAFFECTING in Vivo AMINOACYLATIONOF tRNAs
tRNA tRNA;*''
tRNAp
Amino acid inserted ( % ) c
Mutations" U*AA+CUA All (see Fig. 5) Omit G I . U,,+G, Omit C, G7,+GP Omit G , . C,,+A, Omit A,,+G,, Omit U,, Az4+Cl, VIGA-CUA VIGA+CUA + GI VIGA+CUA + A,
Leu, 99 Ser, 92 Leu, 15; Gln, Leu, 91; Gln, Leu, 72; Gln, Leu, 99 Leu, 38; Gln, Ser only
C,, C,,
, U . G,, '
'
C7z+U, U,O+G,
BY
'
A72
'
C70
78; Ser, < I 9 6; Ser, 20
39; Ser, 16
Gln, >90; Ser, 5-6
SerRSa Suppression efficiency (%)d.e 52-5gd 33-49d 12d 5-9d ll-12d 20-35d 35-48d 47e 47p
UData from t R N A p are from 7 and 19 and from Normanly and Abelson, unpublished. Data for tRNA? are from 61. bunnumbered sequences are anticodon sequences. c h e r t i o n into DHFR-amber at position 10. "Efficiency of suppression of derivatives of locl-Z containing amber mutations at different sites in the locl portion of the fusion gene. tRNAs were overproduced. "Etficiency of suppression at the A,, amber allele of lad-Z. tRNAs were not overproduced.
that there are few other sites outside of the acceptor stem region that could contribute to base-specific recognition by SerRS.
C. E. coli Glutamine Synthetase In addition to important sites in the anticodon, E. coli GlnRS also recognizes key structural features in the acceptor-stem region of tRNA substrates. Early evidence for this came from genetic studies, in which mutants of an amber suppressor Tyr tRNA were isolated that insert Gln at the site of UAG codons in uiuo and accept Gln in uitro (Table XI; 46-52). The first mutation obtained converted A,, to the Gln sequence G,, and led to insertion of Gln, but not Tyr, in uiuo. This mutation has the dual effect of increasing activity with GlnRS and reducing activity with TyrRS (49). Mutations at position 1.72 were subsequently isolated that converted the wild-type Tyr G,.C,, sequence to weak or mismatched base-pairs and led to the insertion of both Tyr and Gln in uiuo. These sequences did not correspond to the Gln sequence U,.A,,, suggesting that an easily disrupted base-pair, rather than a specific primary sequence, favors interaction with GlnRS. This was further suggested by later experiments with an amber suppressor derivative of E. coli tRNAfMet,which contains a C,.A,, mismatch at the 5' terminus and is also a substrate for GlnRS in uitro (97). An A*C mismatch at position 2.71 in
AMINOACYLATION
tRNA tRNA:'"(CUG) tRNAfMet(CAU-&UA)
Additional mutations None None 1'
'
A72+U1 1'
cl
tRNATYr(QUA+CUA)
. . G7?. . G72 +
A73jG73 GI . C 7 p A I . C7, GI - u,, '1
G2
'
'71jAP
'
. 7' 2 . 7' 1 '
tRNATyr(QU A)
OF
'71
G* . u,, Wild-type tRNA
tRNAs
TABLE XI BY E. coli GlnRS in Vioo AND in Vitro" Relative V,,,.J&b
6325 29 9 1 5
In oitro activity Incomplete charging at high [GlnRS] Complete charging at high [GlnRS] Complete charging at high [GlnRS] Complete charging at high [GlnRS] ND Active at high [GlnRS] Inactive at high [GlnRS] Inactive at high [GlnRS] Rate relative to tRNA2'" at 1 0 - ~ MtRNA'
aData on tRNAfMctare from 69 and data on tRNATyr are from 46-51. ND, Not determined. bApparent K,,,at subsaturating amino acid concentration. =Amino acids are inserted by tRNATyr derivatives into T4 am H36 head protein. dNo Tyr, according to 48; some Tyr, 46. eData are from 133.
Amino acid inserted in oiooc Gln ND ND ND ND Gln > Tyrd Gln Gln, 20; Tyr, 80 Neutral amino acid Gln, 30;Tyr, 70 Gln and Tyr TYr TYr TYr
+ Tyr
RECOGNITION OF
tRNAs
55
tRNATYr(CUA)also allowed in uiuo mischarging by GlnRS, although this sequence change is actually away from the wild-type G,*C,, sequence of tRNA”’I1. Again, the data suggest that unpairing of the acceptor stem facilitates interaction with GlnRS (49). tRNAfMef(CUA) and the position 1.72 mutants of tRNATYr(CUA)contain A,,, indicating that G,, is not essential for GlnRS recognition. This conclusion is also consistent with the results on the Gln-inserting amber suppressor tRNAs (Table IV), where only three of the five tRNAs mischarged by GlnRS have G,, (two have A,,). Conversion of the C,*A,, sequence in tRNAfMet(CUA)to a “glutamine” U,.A,, base-pair actually reduces the specificity for aminoacylation by GlnRS (Table XI; 69), suggesting that G,, plays a more important role when no mismatch is present at 1-72. The stronger C,*G7, base-pair further reduces the activity of tRNAmet(CUA), and in this structural context, G, is seen to enhance interaction with GlnRS fivefold. The X-ray structure of the tRNAG’”.GlnRS complex (12)reveals that the base-pair at position 1-72 is broken, and base-specific contacts are made at both positions 2.71 and 3.70 by GlnRS (see Section VII). G,, is involved in an RNA.RNA contact that facilitates the conformational change at the 3’ end of the tRNA. Each of the recognition elements in the acceptor stem contributes to the overall interaction between GlnRS and its tRNA substrates, but none is essential. Of the suppressor tRNAs mischarged by GlnRS, only tRNATrl’ (CUA) contains all of these elements. In addition, individual changes at each site do not eliminate the Gln acceptor activity of tRNAG1I1(CUA)in uiuo (M. J. Rogers and D. Soll, unpublished). U,, in the anticodon makes a much larger contribution quantitatively to recognition by GlnRS, increasing the specificity of the enzyme for tRNATq (C,,--*U,,) by 105 and for tRNAfMet(A,,.U,,+U35.A36) by 103 (Table 111). Nevertheless, the sum of the recognition elements in the acceptor stem makes a significant contribution to the recognition of tRNAs by GlnRS.
D. Other E. coli Synthetases tRNA1Iis is unique among E . co2i tRNAs in having only three unpaired bases at the 3’ terminus, plus an acceptor stem containing 8 bp (134)(Fig. 6). The role of this unusual structure has been investigated by examination of a series of tRNAHisderivatives prepared by in uitro transcription (Table XII; 42). In one set of experiments, the extra base at the 5‘ end (designated G- ,) which is paired with C,, has been removed to generate a “standard” tRNA 3’ terminus. This change causes a large decrease in the specificity for aminoacylation of the tRNA by HisRS, indicating the importance of the structure for recognition by the enzyme. The primary sequence at the -1.73 position is also important for efficient aminoacylation by HisRS. C, is
56
LADONNE ? I
H.
SCHULMAN
76
FC
F, - ;73 4 I
w
-I
IG-CC72
-
-
-
-
-
FIG. 6. The unusual structure at the acceptor end of E . coli tRNAHiS(134). Known major recognition elements (42) are indicated by arrows.
unique to His tRNA in E. coli (112),and conversion to any other nucleotide causes significant loss of activity, whether or not G - is present. Substitution of G - 1.C7-3 by an A- 1-U73base-pair also reduces activity to below 0.1%. Most of the observed effect is on the maximal velocity of the reaction. These data indicate that the G - ,*C, base-pair is an important recognition element for E. coli HisRS, affecting the positioning of the 3' end in the catalytic step of the aminoacylation reaction. The extra 5' G but not the base pair has been preserved in the His tRNAs of yeast and higher eukaryotes (112).The 5'-terminal G - is encoded in E. coZi, but is added post-transcriptionally to the cytoplasmic tRNAHisof higher organisms (135, 136). The nature of the base at position 73 plays an important role in the recognition of E. coli tRNAASpby AspRS (Table XIII; 40). Alterations of G,, reduce activity to 1/200 or less. In this case, significant changes in both K , and V,, are observed. The nucleotides that substitute best for G,, (U > A) share some functional groups with G , suggesting that direct contacts may be made by the enzyme at this site. The discriminator base also plays a role in the recognition of tRNATyr by E. co2i TyrRS, since conversion of A,, to G,, greatly reduces the Tyr-insert-
RECOGNITION OF
ROLE OF
57
tRNAs
THE
TABLE XI1 EIGHT-MEMBERED ACCEPTOR STEM IN THE AMINOACYLATION OF E. coli tRNAHisTRANSCRIPTS"
Sequence change
Apparent K , (PM)
Vmax (pmol/minlmg x 10-2)
4.0 3.7 4.8
100 7.8 1.5
None G-I C 7 p C 1 A,, G-I u73 G-I ' CiR Delete G - , Delete G - , + C,,+A,, '
10
6.1
10
4.1
Relative VIK, 1.0 0.084 0.013
u73
G7,
G-lC73+A-l . C, A-I A73 A-, u73 A-I ' G73 '
'
" D a t a a r e from 42
+,
ing activity of su tRNATyr(CUA)in oioo and the rate of aminoacylation by TyrRS in oitro (49, 101a). Modeling of the interaction between Bacillus stearothermophilus TyrRS and the acceptor stem of tRNA substrates has suggested that recognition of A,, may play a critical role in positioning the 3' terminus of tRNATyr at the active site (137; see Section VIII).
E. Summary A number of E. co2i tRNAs contain important recognition elements for their cognate synthetases in the acceptor stem and/or at the discriminator site (position 73). Neither AlaRS nor SerRS appears to recognize the anticodon of cognate tRNAs, and for these synthetases, critical recognition ele-
ON
TABLE XI11 EFFECT OF CHANGES IN THE "DISCRIMINATOR" BASE THE AMINOACYLATION OF tRNA TRANSCRIPTS BY E . coli AsuRS' tRNA
tRNAASP(GUC)G7, tRNAATP(GUC)G73-+A7, u73 c73 a
Data a r e from 40.
Apparent K", (PM)
Relative
0.32 1.4 5.0
1.0 0.008 0.08
a,x'
Relative VIK, 1.0 0.0018 0.0051 <0.0015
58
LADONNE H. SCHULMAN
ments are found in the acceptor-stem region. GlnRS binds to sites in the anticodon as well as the acceptor stem of tRNAGII1(see Section VII). The unusual acceptor stem of tRNAHisserves as a recognition element for HisRS, and the discriminator base is important for the recognition of tRNAAla, tRNAAsp, tRNAGln, tRNAHiS,tRNASer, and tRNATyr. Other E. coli synthetases, such as MetRS (Table VII) and PheRS (Table XVII), do not strongly discriminate one base from another at position 73. However, many E. coli tRNAs may contain identity elements at this site, for example, sequences protecting against mischarging by those synthetases that strongly interact with base 73 in their cognate tRNAs. Similarly, tRNAs recognized primarily through contacts at sites outside of the acceptor stem may contain important negative identity elements in this helical region near the amino-acid attachment site, which is likely to approach closely the surface of a synthetase as it discriminates between cognate and noncognate tRNAs.
V. Other Recognition Profiles A. E. coli Arginine Synthetase Comparison of tRNA sequences by computer analysis (128) led to the prediction that nucleotides 20 and 35 in E. coli Arg tRNAs might be recognition elements for ArgRS. The role of A,, in the D-loop of tRNAArghas been investigated, using an amber suppressor tRNA derivative (55,108).Deletion of A,, or conversion to U,, resulted in almost complete loss of Arg-inserting activity (Table XIV). Introduction of A,, into the D-loop of tRNAPhe(CUA) resulted in little production of mature tRNA from the plasmid-encoded gene. A second mutation at position 59 restored synthesis and resulted in the insertion of mainly Arg into H, folate reductase-amber. Positions 16, 17, 20, 59, and 60 contain some single-stranded bases that are brought into close proximity by tertiary structure interactions between the D- and T-loops (see Fig. 2). This has been referred to as a “variable pocket,” since this cluster contains different numbers and types of bases in different tRNAs. Early in the analysis of tRNA structure, it was suggested that this cluster, located in an accessible patch between sets of highly conserved residues, could serve as a recognition system for the discrimination of tRNAs by synthetases (138). A,, could be a recognition element which directly interacts with ArgRS, since it is unique to Arg tRNAs in E. coli. The exact position of this residue in the three-dimensional structure of the tRNA is dependent on the structure of the variable pocket. In the case of tRNAArg,residues in the T-loop do not appear to contribute directly to recognition by ArgRS, since none of these bases is conserved in Arg tRNAs (Fig. 7).
RECOGNITION OF
59
tRNAs TABLE XIV
EFFECTOF MUTATIONSON
THE RECOGNITION OF
tRNAs in Vivo BY E . coli ArgRSa
Amino acid inserted tRNA tRNAfrp(ICG)
CUA CUA CUA CUA UCA tRNAPhe(GAA) CUA CUA CUA CUA
Mutationsb
+ A,,+U,
+ AsS+Us,
+ A, + A,
+ +
deletion
insertion A, + Us9+A, Us9+A,
Efficiency (%)d Arg, 37; Lys, 55 Lys, 91 Arg, 38; Lys, 50 Arg, 5; Lys, 91e Arg only f Phe, 86 Arg, 72; Lys, 6; Thr, 16 Phe, 91; Leu, 7
30-62 12-28 29-59 43-55' 11-22 Poor tRNA synthesis 3-11 4-13
Data are from 55 unless otherwise noted. bunnumbered sequences are anticodon bases 34, 35, and 36. c h e r t i o n into DHFR-amber at position 10. dEficiency of suppression at the A,, and A, amber alleles of lacl-Z. eData are from 107 and 108. fData are from 1380. (1
The amber suppressor derivative of tRNAArgcontains a base change at C,,, a residue implicated in ArgRS recognition by earlier biochemical studies (83).Consistent with an important role for C, tRNAArg(CU,A) inserts mainly Lys in oioo (55), while the corresponding opal suppressor tRNA having a UC,,A anticodon inserts only Arg (138~). In oitro experiments using tRNA transcripts of tRNAArgwere carried out to evaluate the relative contributions of A,, and C, to recognition of tRNAs by ArgRS (Table XV; 100). The primary sequence of E. coli tRNAMetdiffers from the consensus sequence of conserved sites in Arg tRNAs by only these two nucleotides (Fig. 7). Conversion of the Met anticodon to an Arg anticodon resulted in a 40,OOO-fold increase in V,,/K, for aminoacylation by ArgRS, while substitution of A,, increased the activity 1000-fold. Introduction of both changes yielded a tRNAMefderivative that had nearly normal Arg acceptor activity (Table XV). Thus, A,, and C,, are both important recognition elements for ArgRS, and the bases at these sites make a large contribution to both the K , and V,, for aminoacylation. Few other conserved sites are found in the consensus structure of Arg tRNAs (Fig. 7). Nevertheless, tRNAArg(CUA)having a deletion of A,, and a base change at C,, retains the ability to insert a low level of Arg in uiuo (Table XIV). This raises the possibility of additional recognition elements, or of a weak compensating interaction with C, in the absence of C, as has been suggested for tRNAArg(CUA)having a deletion of base 26 (55).
60
LADONNE H . SCHULMAN 76
0
A
0
B
.
0
I
.-. .-. .-.
G--.
.-a70
-a
0-0
-
c
I I I I I
n
1 1 1 1 I
'
- 0
..... ....
U,D 20-1
G
0
.%
I l l 1
20A
OG
10.
0 - * G
0
4
: a e
C.
0 . .
G
e
.
..-. .-. -0
0-0
30.-040
C
.
A
a
c
C I,
.
35
35
FIG. 7. (A) Base changes involved in the in uitro conversion of E . coli tRNAMet into an efficient arginine acceptor tRNA (100)are indicated by arrowheads. Other bases shared by E. coli tRNAMet and E . coli and bacteriophage T4 Arg tRNAs are also indicated on the cloverleaf structure. (B) Composite structure of E. coli and bacteriophage T4 Arg tRNAs (112). The sequence of tRNAfB(ACG) is in question (55) and has been excluded from the composite. Arrowheads indicate major known recognition elements. See the legend to Fig. 3 for definition of the symbols.
B. Yeast Phenylalanine Synthetase Earlier in uitro studies revealed the importance of the anticodon nucleotides to the recognition of tRNAs by yeast PheRS (Table 11; 101).Subsequent experiments show that bases at positions 20 and 73 also play an important role in the aminoacylation of tRNAPhe (Table XVI; 37, 139-141). TABLE XV AMINOACYLATIONOF tRNA TRANSCRIPTS WITH E. coli ArgRSa Apparent
K,,, (+M)
tRNA ~~~~
tRNA*=(CCG) tRNA,Met(CCG)Uzo+Azo tRNA,Met(CCG) tRNA,Mct(CAU)Uzo+Az, t RN A,Met(CA U) Data are from 100.
~
1.1 1.2 5.2 4.4
>loo
V (+mol/min/mg)
Relative
VIK,
~
2.0 0.9 0.03 0.0007 -
10 x 1oR 5 x 106 40 X I@ 1 x 18 1
61
tRNAs
RECOGNITION OF
TABLE XVI AMINOACYLATION OF tRNA TRANSCRIPTS WITH YEAST PheRSa tRNA Yeast tRNAPhe(CAA) Yeast tRNAPhe(GAA)Gzo+U,, A7dJ7, E . coli tRNAPhe(GAA)U,, + c, G7n+G, c70 E . coli tRNAPhe(CAA)Uz,+G,, + c, G7,-rC3 c7, Yeast tRNAMet(GAA)A,,+G, + G,, . C,+C,, C , + A,g+U5g Yeast tRNAAr~(GAA)Cz~+G,o+ U,, + c59+u59 + C73+A7, Yeast tRNAArg(GAA)Cm+Czo + U,, + c59+us9 Yeast tRNATyr(GAA) U,u~o_,U,-2+~,, + other changes6
Apparent K , (PW
k,,,
Relative
(min-1)
kcatlKm
0.35
160
2.10
80
1.0 0.083 0.083
'
'
1.80
35
0.042
'
'
0.42
100
0.52
0.41
130
0.68
0.38
110
0.64
1.00
60
0.13
0.36
250
1.5
Data are from 37 and 139. b o t h e r changes: C , . G72+G, . c72, U S A7,+C2 U,, A,, A,, A,,-C,, . G,, and A4,pG&. 0
G,,,
c, . G7o+G3.
c70, c12. G,+
Conversion of G,, to U,, or of A?, to G,,, reduces k,,,lK, for Phe acceptor activity to 1112th. G,, is unique to tRNAPhe in yeast and is one of the variable pocket nucleotides. High-resolution NMR studies of tRNAPhetranscripts containing G or U at position 20 indicate that the structures of the two tRNAs are nearly identical (142), suggesting that the change in activity on mutation of this site is due to the loss of specific contacts with PheRS. Footprinting studies of the yeast tRNAPhe.PheRS complex show that the protein contacts the entire surface of the tRNA (143),consistent with the location of widely separated recognition elements. Extensive studies of the interactions involved in maintaining the threedimensional structure of tRNAPhe reveal that none of the specific bases involved is required for PheRS recognition; however, the proper tertiary structure must be maintained (141).In addition, changes in unbonded bases at positions 16, 17, 59, and 60 have less than a two-fold effect on activity, indicating that G,, is the only required base in the variable pocket. Transfers of the GAA anticodon, G,,, and A,, to other yeast tRNAs yield mutants with nearly wild-type Phe acceptor activity (Table XVI). In addition, conversion of U,, in E. coli tRNAPheto G,, makes the E. coli tRNA a good substrate for the enzyme. Comparison of the sequences of all of the tRNAs that are efficient substrates for PheRS (Fig. 8) indicates that there are few additional conserved sites.
62
LADONNE €1. SCHULMAN 0
76
0 0
.-. .-.
1G 0
A
-
-
4
c
.
0 - a 7 0 - 0
0
.-a
60 m
0 - 0
0
0 0 0 O
.
0
50
0
0
O
0
.
U
I I I I *.*.
0
0
G
20
A
G
I I I I I
0e.e
lo.
.
0
..*.o
0 0
.
0 .
0 - 0 0 - 0 30 G CtO
-
- u
A
0
s
0 A
G
35 FIG. 8. Composite structure of tRNAs aminoacylated by yeast PheRS with kinetics similar (within a factor of 2 or 3) to cognate yeast tRNAPhe(139-141). Arrowheads indicate major known recognition elements. See the legend to Fig. 3 for definition of the symbols. (Adapted from 139 with permission.)
C. E. coli Phenylalanine Synthetase Both in uiuo and in uitro studies indicate that the anticodon contains major recognition elements for E. coli PheRS (Tables V and XVII; 67, and E. F. Tinkle and O.C. Uhlenbeck, unpublished). In uiuo experiments using the amber suppressor derivative of tRNAPhehave suggested that additional sites, including U,,, G27.C43, G,,*C,,, G,,, U,,, U,,, ,U and A,, contribute to Phe identity based on mischarging of tRNAs containing mutations at these sites (54,57). Since tRNAPhe(CUA)retains its identity in uiuo with only one
RECOGNITION OF
63
tRNAs
TABLE XVII AMINOACYLATION OF E . coli tRNAPheTRANSCRIPTS WITH E . coli PheRSa Apparent
K , (PM)
Mutation None C3 ' G7n-tC3 G o G3 C, + GAA-tAAA CUA '
+
ul6-tcl6
+ Cl7-tUl7
+ U2n-tGzo +
'27
'
c43+A27
+ U45+G, + u.5Ll-tc.59
+ u,+c, +
A73-tG73 c73
u73
'
'43
Relative
k,
0.20 0.11
100 70
0.22 0.19 1.10 0.30 0.11 0.95 0.19 0.23 0.35 0.35
80 80 110 100 110 70 70 80 80
70
Relative
k,llK, 1.0 1.2 <10-2 Greatly reduced 0.7 0.8 0.2 0.7 0.12 0.15 0.7 0.7 0.5 0.4
aE. F. Tinkle and 0. C. Uhlenbeck, unpublished.
wild-type anticodon base (A3&,it is likely that additional recognition elements exist outside of the anticodon. However, the interpretation of results obtained in the absence of G , and A,, is unclear, since these bases contain strong recognition elements that would enhance interaction with PheRS and inhibit mischarging by noncognate enzymes. Examination of the effect of mutations on in uitro aminoacylation of E . coli tRNAPheby E . coli PheRS (Table XVII) shows that the largest effects outside ofthe anticodon occur at positions 20,45, and 59 (five- to eight-fold reductions in kcat/&), suggesting that these sites play some role in tRNAPherecognition. It remains to be determined whether other positive or negative identity elements are present in E. coli tRNAPhe. The exact role of nucleotides in the variable pocket is also unclear. Native tRNAPhecontains a modified base, dihydrouridine, at position 20. This base occurs commonly at position 20 in E . coli tRNAs. In addition, it is structurally quite different from U, which also functions well at position 20.
D. Summary Both the anticodon and the variable pocket have been implicated in the recognition of E. coli Arg tRNAs and yeast and E. coli Phe tRNAs. While specific contacts may be made with cognate synthetases in the variable pocket domain, particularly at position 20 in the D-loop, the structural complexity of this region of tRNA structure leaves some doubt as to the nature of the interaction. The variable pocket also contains a metal-ion binding site
64
LADONNE €1. SCHULMAN
(144),which could play a role in tRNA-synthetase recognition. In addition, changes in the anticodon loop affect the structure at the junction of the D- and T-loops (145,146), suggesting that interaction of synthetases with bases in the anticodon could affect recognition sites in the variable pocket domain in a complex manner. The distribution of recognition elements over a larger number of widely separated sites also places more stringent constraints on the overall structure of the tRNAs recognized by the enzymes in this group.
VI. Role of Modified Bases A. E. coli lsoleucine Synthetase A minor species of E. coli Ile tRNA that reads the codon AUA (147) contains a modified base at the wobble position of the anticodon (148).This base, called lysidine, is derived from cytidine by attachment of a Lys residue to the 2 position of the pyrimidine ring (Fig. 9). Prior to modification, the tRNA contains a CAU Met anticodon and is efficiently aminoacylated in uitro by E. coli MetRS, but not by IleRS (149).Conversely, the modified tRNA1Ie is a poor substrate for MetRS, but a good substrate for the cognate synthetase. Thus, the lysidine base plays a dual role in the identity of the tRNA, blocking mischarging by the noncognate enzyme and enhancing interaction with IleRS. A post-transcriptional modification also occurs in the AUA-reading Ile tRNAs of bacteriophage T4and spinach chloroplasts, which similarly encode tRNA"" genes having a CAU anticodon (112). The major species of E. coli tRNA"" has the anticodon GAU. If the base at the wobble position is directly recognized by IleRS, either two different interactions occur with G,, and lysidine 34, or an equivalent functional group is contacted (Fig. 9). C, may also be a negative element for IleRS, while any base other than C,, strongly inhibits the recognition of tRNAs by
a
b
C
FIG. 9. Structures of nucleotides present at position 34 of the anticodons of E . coli Ile tRNAs before and aRer post-transcriptional modification (148).(a) Guanosine, (b) lysidine, and (c) cytidine.
RECOGNITION OF
65
tRNAs
E. coli MetRS, as noted earlier. Substitution of the Ile anticodon GAU for the Met anticodon CAU in E. coli tRNAfMetconverts this tRNA into an Ileinserting species (Table V; 67a). This suggests direct recognition of one or more anticodon bases by IleRS; however, post-transcriptional modifications resulting from the anticodon substitution have not yet been determined.
6. Yeast Arginine Synthetase I n oitro studies indicate that base modifications play an important role in the discrimination of yeast ArgRS against yeast tRNAAsp (150).Transcripts of wild-type tRNAAsP containing no modified bases are aminoacylated by ArgRS with a specificity 500-fold that of fully modified native tRNAAsPp, reducing the discrimination to only 20-fold (Table XVIII). Mischarging of unmodified tRNAAsPwas not observed with yeast HisRS, PheRS, or ValRS (150). tRNAAspcontains unique modified bases at only three sites (IJI13, ,IJ and mlG,,). Native tRNAAsPhas a K, for aminoacylation by ArgRS only 12fold higher than that of tRNAArg,indicating significant &nity of the native noncognate tRNA for the synthetase. Mischarging of native tRNAAsp is mainly avoided by a reduced kcat for aminoacylation (Table XVIII), as observed for a number of other noncognate interactions (151). The unmodified tRNA has an altered conformation, which may allow it to be more readily accommodated to the tRNA binding site of ArgRS, and/or one or more of the modified bases in native tRNAAspmay interfere directly with aminoacylation by the noncognate enzyme (150).
C. Summary Modified bases could contribute to tRNA identity by serving as positive recognition elements for synthetases or as negative elements blocking mischarging reactions. E. coli IleRS and yeast ArgRS are examples of synthetases for which modified bases clearly assist in the discrimination of TABLE XVIII
MISCHARCINCOF YEAST tRNAAsP TRANSCRIPT BY YEAST ArgRSa tRNA
Yeast synthetase
Native tRNAAsP(GUC) tRNAAsP(GUC) transcript Native tRNAArqUCU) Native tRNAA\p(GUC) tRNAAsP(GUC) transcript
Asp Asp Arg Arg Arg
K, (pM)
0.044 0.028 0.073 0.86 0.11
k,,, (s-l)
Relative k,,J~,”
0.66 0.38 0.70
1.0 0.9 1.0
O.ooo65
O.ooOo79
0.045
0.043
“Data are from 150. ‘Jk,,,/K,,, are relative to the native tRNA for each synthetase.
66
LADONNE H . SCHULMAN
tRNAs. Enhanced activity resulting from a base modification was reported earlier, when it was shown that methylation of G,, in E. coli tRNAPhe increases its rate of aminoacylation by yeast PheRS 10-fold (152). The interpretation of this result is unclear, however, since Schizosaccharomyces pombe tRNAPhe lacks this modification and is aminoacylated with the same kinetics as yeast tRNAPhecontaining the modification (153).A modified base in the middle position of the anticodon of yeast tRNATyr ($35) also has a small effect on the aminoacylation of this tRNA by yeast TyrRS (Table 11). The efficient aminoacylation of plant viral RNAs by yeast and plant synthetases (154) and of tRNA transcripts by cognate enzymes (Table I) suggests that modified bases have no direct positive role in the recognition of most tRNAs. Native tRNAs have a more rigid ordered structure, however, which can be mimicked in tRNA transcripts by elevating the divalent cation concentration (37). Thus, modifications enhance aminoacylation activity by “fine-tuning” the structure of tRNAs. At present, there is little direct evidence for a general role for modified bases as negative elements for tRNA identity, although modified bases in or near the anticodon are likely candidates. In uitro transcripts of yeast tRNAPhe are discriminated against by yeast TyrRS to the same extent as native tRNAPhe (37). Similarly, transcripts of E. coli tRNAMetand tRNAVa’ are not mischarged by E. coli GlnRS, GluRS, IleRS, LysRS, or PheRS (43), and transcripts of E . coli tRNAVa’, tRNAThr, and tRNAArg are not mischarged by E. coli MetRS (43, 44, 100). The results with E. coli IleRS and yeast ArgRS suggest, however, that other specific examples of negative regulation of aminoacylation by post-transcriptional tRNA modifications will come to light as more extensive studies are carried out.
E. coli Glutamine tRNA and Glutamine Synthetase
VII. The Complex of
The most exciting event in recent studies of tRNA-synthetase interactions has been solution of the crystal structure of a complex of E. coli tRNAGIn, GlnRS, and ATP at 2.8A resolution (12), allowing details of the molecular basis for the recognition of a tRNA by a synthetase to be revealed for the first time. This achievement was made possible by the earlier cloning and sequencing of the gene for GlnRS and overproduction of the protein and the isoacceptor tRNAF’”(CUG) (156-158). GlnRS is a 63.4-kDa protein containing 553 amino acids arranged in an elongated structure made up of four domains (12).The surface of the protein contacts regions of the tRNA extending from the anticodon to the 3’terminus, along the inside of the L-shaped tRNA structure (Fig. lo), in a manner similar to that originally proposed by Rich and Schimmel (159) as a general binding mode for tRNA-synthetase
FIG. 10. E. coli GlnRS complexed with E. coli tRNA;ln(CUG) and ATP. Protein a-helices are represented as tubes sequentially lettered and p-strands are shown as arrows sequentially numbered, both from the amino terminus. The dinucleotide fold domain includes residues from P-strands 1-3 plus a-helix G and P-strand 10. The acceptor-end binding domain includes the chain between the amino end of a-helix D to the carboxyl end of P-strand 8. The two P-barrel anticodon binding domains consist of P-strands 13-19 and P-strand 20 to the carboxy terminus plus p-strand 12. (From 12 with permission.)
68
LADONNE H. SCHULMAN
complexes. The tRNA adopts an unusual conformation at both ends of the molecule. Bases C,, and G,, in the anticodon are unstacked, and the central anticodon base (U35) is stacked under A,, and buried in a tightly fitting protein pocket. The base-pair at the end of the acceptor stem (1.72) is broken, and the 3' terminus forms a hairpin structure in which the unbonded bases loop back toward the anticodon, rather than extending away from the body of the tRNA (Fig. 10). Base-specific contacts are made in both of these widely separated regions of the tRNA. Refinement of the crystal structure in the anticodon binding domain reveals a set of amino-acid side-chains that interact with a known major recognition element, U,, (99). These strong interactions, involving several charged amino-acid residues, explain the requirement for U at the middle position of the anticodon of GlnRS substrates, since no other base could make the appropriate hydrogen bonds with the protein (Fig. 11). Contacts are also made between the protein and each of the other anticodon bases. The protein pocket containing C,, could also accommodate a U residue, the base present in tRNA7'" (U*UG), but not a purine. Most of the contacts to G,, could not be made with the A residue found at the corresponding position of the amber anticodon CUA,,, and in uitro studies show that tRNA,G'"(CUA) is less efficiently aminoacylated by GlnRS than wild-type tRNA,Gln(CUG)(M. Jahn and D. Sol], unpublished). Thus, all three anticodon bases appear to contribute to the recognition of Gln tRNAs, with U,, having the dominant role. In addition, residues 37 and 38 on the 3' side of the anticodon interact with the protein, although it is not yet clear whether these are base-specific contacts (99). The hairpin structure at the 3' end of tRNAGlnis stabilized by extensive interactions with GlnRS and by a sequence-specific RNA-RNA interaction between the 2-amino group of G,, and a phosphate oxygen of A,, (Fig. 12). The bases of residues A,, C,,, and G,, are stacked on each other, while C,, is looped out to contact side-chains of the protein. The side-chain of an aliphatic amino acid (Leu,,,) is wedged between base A,, of the disrupted U,.A72 base-pair and base-pair G2.C7, (Fig. 12). No sequence-specific contacts are made with base 1 or 72, in keeping with the data described earlier showing that a variety of weak or mismatched base-pairs can function at this position. However, base-specific contacts are made with the adjacent basepairs G,.C7, and G3*C70, implicating these sites as recognition elements for GlnRS (12). Consistent with this, in uitro studies show that a G,*C,,+A,.U7, mutation in tRNAg'"(CUA) greatly reduces the rate of aminoacylation of the tRNA by GlnRS (M. Jahn and D. Sol], unpublished). The side-chain of Asp,,, contacts the 2-amino group of base G, in the minor groove of the acceptor stem, and the main-chain carbonyl of Pro181is hydrogen-bonded to the 2-amino group of G2. These amino-acid residues plus
RECOGNITION OF
tRNAs
69
Cytosine
H\N/H
I
I Adenine
Guanine
FIG.11. Schematic drawing of hydrogen-bonding interactions between the anticodon base Us in tRNACln and GlnRS (99). The protein binding pocket excludes cytidine due to ionic hydrogen bonds from an Arg residue to the pyrimidine 0 - 4 and from a Glu residue to the ring N-3. Adenine and guanine are excluded by size from the binding site. (Courtesy of T. Steitz.)
70
LADONNE
n.
SCHULMAN
FIG. 12. The acceptor end of tRNAClnin the complex with E . coli GlnRS. The side-chain of L e ~ extends ~ 3 ~from a p-turn and wedges between the bases of G2 and A72, disrupting the last base-pair of the acceptor stem, UI.A72. The enzyme stabilizes the hairpin conformation via the interaction of several basic side-chains with the sugar-phosphate backbone. An intramolecular hydrogen bond between the 2-amino group of G73 and the phosphate of A71 further stabilizes this conformation. (From 12 with permission.)
IleIs3 and a buried water molecule which contacts G,C,, form a hydrogenbonding surface which is complementary to that of the two G.C base-pairs at positions 2.71 and 3-70. Interestingly, mutation of Asp,, to Asn,,, leads to a partial relaxation of specificity of GlnRS, allowing in vivo and in uitro mischarging of the amber suppressor derivative of tRNATyrand in uitro mischarging of a specific subset of wild-type E. coli tRNAs (13, 133, 160), further establishing a role for this
RECOGNITION OF
71
tRNAs
region of the protein in tRNA recognition. The mutant enzyme aminoacylates tRNAF'"(CUG) with one-tenth the K,,,of wild-type GlnRS, and much more efficiently aminoacylates the A,.U,, derivative of tRNA2'" (CUA) than the wild-type enzyme (S. Englisch, P. Hoben and D. Soll, unpublished). A mutation from Ile~,gto ThrlZ9 in GlnRS allows weaker mischarging of su 3 tRNATYr(CUA)than observed with the Asn,,, mutant (13).I1elzglies close to the phosphate of C74, and the mutation may result in the formation of a stabilizing contact not made by wild-type GlnRS (13). The known recognition elements in tRNAz'"(CUG) are summarized in Fig. 13. Other bases that contact the protein and that may provide additional discrimination are also indicated. Recognition elements include bases that make sequence-discriminating interactions with GlnRS, and two structural features that facilitate the essential conformational change at the 3' terminus of tRNAFln(CUG), the RNA-RNA interaction involving G,, and the weak base-pair at position 1.72. +
35
FIG.13. Major known recognition elements in E . coli Cln tRNAs are indicated by arrowheads. Additional bases that contact GlnRS in the complex are also indicated. See Sections 1v.C and V11 for references and discussion.
72
LADONNE I f . SCHULMAN
VIII. tRNA Binding Domains of Other Synthetases E. coli AlaRS is the largest of the E. coli synthetases, having four identical subunits, each containing 875 amino acids (161).Deletion analysis has revealed that the functional domains of each subunit are arranged in an approximately linear fashion, with the amino-acid activation domain nearest the amino terminus of the polypeptide, followed by sequences required for the aminoacylation of tRNAAIa, and then by an oligomerization domain near the carboxy terminus (162).Several other synthetases have an arrangement of functional domains similar to that seen in AlaRS (4).The smallest fragment of AlaRS able to complement an alaS null mutant strain is a monomeric enzyme containing amino acids 1 to 461. Further deletions show that sequences that contribute most to tRNA binding are located between residues 368 and 461 (Table XIX). In addition to interactions in this domain, the 3' end of the tRNA must also bind to amino-acid residues near the active site during the transfer step of the aminoacylation reaction. An amino-acid residue (Lys?,), which lies close to the acceptor end of tRNAAla in the AlaRS*tRNAA'"complex, has been identified by crosslinking and shown by site-directed mutagenesis to affect tRNA binding (163;Table XIX). Mutations in the protein that allow aminoacylation of an amber suppressor derivative of tRNAA1"containing a G,.U70+G,C70 base change have also recently been obtained (P. Schimmel, personal communication). Characterization of these mutants should lead to the identification of amino-acid residues important for recognition of the key structural feature required for tRNAAIaidentity. High-resolution X-ray crystal structures are available for E. coli MetRS and B. stear. TyrRS (16,167-172);However, cocrystals of complexes containing the cognate tRNAs have not yet been obtained. Native E. coli MetRS is a dimeric protein of identical subunits, each containing 676 amino acids (173,174). Limited trypsin digestion releases peptides from the carboxy terminus of the protein to produce a biologically active monomeric enzyme containing amino acids 1 to 547 (MetRS,,) (175,176). This form of the synthetase has been crystallized in both the presence and absence of ATP (16).Crosslinking experiments show that the tRNA binding site is located largely in the carboxy-terminal half of MetRS (177,178),with residues close to the 3' end of the tRNA located in the amino-terminal domain near the active site (179). Coupling of a crosslinker between anticodon base C,, and Lys,= in MetRS identified a region of the protein near the anticodon binding domain (178).This domain is located at the extreme periphery of the MetRS molecule at a maximal distance from the active site (16,167).Site-directed mutagenesis of nine amino acids in this region having side-chains potentially
SYNTHETASE MUTATIONS THATAFFECT
Synthetaseb (subunit structure)
E . coli AlaRS,,
(wt)
tRNA binding sites
4
Mutation None
TABLE XIX THE BINDINGAND/OR AMINOACYLATION OF tRNAs"
KmCor relative binding d
Relative
k.f
klK,,,
Location of amino acid in synthetase-tRNA complex
Comments
l.Od.9
1.0f
1.0
12.19
0.w
0.02
Near active site
Crosslinks to oxidized A76
0.29 2.19
1.0f 0.05.f
5.0 0.02
Dispensible domain
2.89
0.121
0.04
Dispensible domain
Coupling between dispensible and indispensible domains Coupling between dispensible and indispensible domains Complements ahS null strain Complements alas null strain Does not complement alas null strain Does not complement alas null strain
Reference
(a,)
4
Delete 809-875
1
Delete 462-875
1
Delete 386-875
1
Delete 369-875
2
None
0.8 at pH 5.0d 5 x lo-* at pH 5.0d 5 x lo-, at pH 5.0d < 5 x 10-5 at pH5.0d 1.0e
Delete 553-557 and 1.og add four unrelated AAs (RQRD)
-0.001f -0.001f
1.W
1.0
0.W
0.2
163 164
165
165
162, 166 162, 166 162, 166 162. 166
182
(continued)
TABLE XIX (Continued)
Synthetaseb (subunit structure)
E . coli GlnRS,
(wt)
kcor
tRNA binding sites
1
Mutation
relative bindingd
kf
Relative klK,
Location of amino acid in synthetase-tRNA complex
Comments
Reference
None
(a)
E . coli GlyRS a303 (wt) (a282)
2
Aspm+Asn
Contacts NH, of G ,
Mischarging mutant
GlY Ile129+Thr None
Near phosphate 74
Mischarging mutant Mischarging mutant
1.0
Cys,+Gln
0.08
13, 133, 160 13 13
8689
%A 4
Ala
Steric or conformational effect
191
0.80
191
0.01
192
Inactive Inactive
192 189, 192
Inactive
189, 192 197
a303 p575
Delete 8576-689
a303 P383 a303
Delete 0384-689 No p subunit
PM9
No a subunit
E . coli MetRS,,,
(wt)
1
None
Does not bind tRNAGly Binds tRNAGlY 1.09
1
Delete 548-676
1.09
1.0
1.0
Prow+Leu
6.0c
1.0
0.16
2.9f
2.9
(a2)
MetRS,,
Complements metG mutant strain
(a)
Near anticodon
176
18
Yeast MetRS,,
(wt)
1
Tyr,,+Ala In 531J None
62.59
1.3
0.02
2.99 8005300K
0.6 1.5 1.0
0.2 0.002
1.0a
Near anticodon base C, Near active site Near active stie
18 176 176
1.0
(4 Asp,,+Tyr
Acquires ability to acy- 119 late tRNA?, (CAUt.(CCU)
Lysffi,+Ala
0.5 0.5
Asn
0.1 0.1 u1 4
Yeast PheRS a595 (wt) (azP2) P503 a595 Pa1 E. coli ThrRS,, (wt) ( 4
(wt)
m
h
m
h
m
1960
m
196a
1.0
0
2&
Delete Pl-172 None
1
+
No binding
Inactive
0.115=
1.Of
1.0
0.025c
0.W
1.7
Glu,,+ Lys Arh-His
1.66C
1.W
0.07
None
1.4~
0.45e
1.0
Gln,,+Ala
2.7~
0.4SC
0.52
Glu,+Lys
B. stear TyrRS,,,
Presumably near anticodon Presumably near anticodon Presumably near anticodon Presumably near anticodon
196 202 Super-repressor of thrS translation Defective in repression of thrS translation
202 202
187
(a21 ~~
Near G ;
188
(continued)
TABLE XIX (Continued)
Synthetaseb (subunit structure)
tRNA binding sites
0
Mutation
K,,,c or relative bindingd
Thr,,+Ala Lys,,+Asn
0.6~ Footnote 1
Ar&+Gln Asn,,,+Ala Lys,,,+Asn
Footnote 1 >looc 1.2c
Gln Glu,,,+Asp Gln Ala Trp,,+Ala Phe Gln Arg,,-Gln Lys,+Asn Lys, and Lysm Ar&+Gln Ar&,,+Gln Arh,+Gln Arb+Gln Lys,,,-,+Asn Lys,,,+Asn Delete 320-419
kf 0.14e
Relative klK,,,
0.73
Location of amino acid in synthetase-tRNA complex
Comments
Ribose 1" Greatly reduced rate of transfer from preformed Tyr-AMP
ND 0.003e
0.52 0.007
Phosphates 69, 70n Near A,,"
0.6~ 1.4~ 0.3=
O.6ge 0.99' 0.38e
3.65 2.24 4.25
Phosphates 73, 74"
8. 3c 1.7~ 11.4~
0.10e 0.87~ 0.84e ND ND
0.04 1.62 0.23 0.062 0.036
ND ND ND ND ND ND
0.008
Additional tRNA contact in transtition state
Toxic mutation
>l o o C >28=
>looc >loo=
>l o o C >l o o C >loo=
>l o o C No binding
van der Walls contacts to GI and
0.054
0.038 0.052
0.030 0.041 Inactive
188 188 188 188 187 188 188 188 1 1
1 1
'473"
Phosphate 67" Phosphate 6 8 n Near ribose 76"
Reference
0
187 187 188 187 187 187 187 187 187 184
TvrRS,,,
1
Phe,,+Asp
tRNA binds
(a)
Inactive
Mutation at subunit interface
186
aData are for the aminoacylation of cognate tRNAs. Mutations listed have little or no effect on the kinetic parameters for amino-acid activation unless otherwise noted. wt, Wild-type. ND, not determined. bSubscript indicates the number of amino acids in each subunit. c& in pM. dBinding relative to the corresponding wild-type synthetase.
ekc,t (s-l).
fRelative Vma. gRelative K,,,. h F. Fasiolo, personal communication. i H. Bedouelle, personal communication. iThe in531 mutant contains Lys,=+Met Tyr,,+Ala + an insertion of Glu-Leu-Ala between amino acids 531 and 532. kFrom 203. T h e s e mutations also affect the activation of Tyr. mResidues 657-659 in yeast MetRS correspond to residues 459-461 in the anticodon binding domain of E. coli MetRS. “Based on the model of the B. steor. TyrRS tRNAphecomplex (188). OEquivalent to Lysm and Lys,, in E. coli TyrRS. These residues are crosslinked to the 3’-oxidized terminus of tRNATyr (180).
+
4
78
LADONNE
n. SCHULMAN
capable of forming hydrogen bonds to anticodon bases showed that only one mutation, Trp,,,+Phe, had a significant effect on the recognition of tRNAMet (18). The effect of the mutation is only on the initial complex formation, with the rate of aminoacylation remaining unchanged (Table XIX). Examination of the interaction of the Phe,,l mutant enzyme with a series of anticodon derivatives of tRNAMet and several noncognate tRNAs (Table XX) suggests that Trp461stabilizes the interaction with the Met anticodon, interacts with the 5' while blocking binding to non-Met anticodons. Trp461 end of the anticodon, possibly directly with the key anticodon base for the recognition of tRNAMet, C,, and strongly excludes anticodons containing U, G, or A at this position (18).Mutation of the adjacent Pro,, residue to Leu increases the K,,,somewhat, but does not alter the anticodon preference of the wild-type enzyme, suggesting that this mutation only introduces a structural alteration of the a-helix containing TT~,,~. The crystal structure of MetRS,,, reveals that the extreme carboxy terminus of the truncated protein is connected to the amino-terminal domain and forms part of the active site of the enzyme (16, 176).The shortest protein to complement an E . coli strain having a defective chromosomal metG (MetRS) gene contains amino acids 1 to 537 (176). Site-specific changes at amino acids 528 and 531 plus a three-amino-acid insertion between residues 531 and 532 lead to a drastic increase in K, for the aminoacylation of tRNAMet (176; Table XIX), implicating the 528-531 region in interaction with the 3' end of the tRNA. Periodate-oxidized tRNAMet crosslinks through the 3'-terminal A?, to several Lys residues near the active site, including Lys,, and Lys,,,. Sequences similar to that surrounding Lys,,, in MetRS (Lys-Met-Ser-LysSer) occur in several other synthetases, including a site in E . coli TyrRS TABLE M AMINOACYLATION OF tRNAs BY WILD-TYPEAND MUTANTE . coli MetRS,," ~~
~
~~
Wild-type MetRS,, Km
tRNA
Anticodon
(PM)
tRNA,Mel
CAU (wt) CAG UAU GAU
1.2f 0.2 63 f 16 >100 >loo
GGU tRNAnr tRNAVd
GGU UAC
>100 >100 >100
Trp,,pPhe
Relative
1.0 1.8 x 10-3
0.8 x 1.2 x 1.5 x 2.6 X 1.7 x
Km
(PM)
k,llK,
>100 >100
10-4
134 2 56
10-5
27 2 4 17 2 1 10 2 4 71 2 34
10-5 10-5 10-6
Relative k,,llK, 0.7 X 10-2 1.4 x 10-5 0.6 x 10-5 0.6 x 10-5
2.8 X 10-6 1.3 x 10-6 2.9 X 10-7
OData are from 18. All tRNAs were prepared by in oitro transcription. MetRS,, monomeric, truncated derivative of native MetRS (see Table XIX). wt, Wild-type.
is a
RECOGNITION OF
tHNAs
79
crosslinked to the oxidized 3' terminus of tRNATyr(180).This has led to the suggestion that sequences related to Lys-Met-Ser-Lys are important for binding the 3' end of tRNAs during aminoacylation (181).A Lys,,,+Glu mutation in E. coli MetRS leads to inactivation of the ATP-PP, exchange activity of the protein (198),however, and the corresponding Met-Ser-Lys sequence in E . coli GlnRS contacts ATP, not tRNAG'", in the crystal structure of the complex (12),suggesting that the conserved sequence is important for the catalytic site of synthetases rather than for tRNA binding. Site-directed mutagenesis of amino-acid residues in yeast MetRS corresponding to the anticodon binding domain of E. coli MetRS reduce the aminoacylation activity of the yeast enzyme as well (F. Fasiolo, personal communication; Table XIX). Genetic experiments also reveal a mutation in yeast MetRS that compensates for an anticodon base change from CAU to CCU in the yeast initiator tRNA (119).This mutation (Asp,,,pTyr) is located some distance from the presumed anticodon binding domain, based on a model of the enzyme made by sequence comparison with E. coli MetRS, and has not yet been characterized biochemically. B. stearothermophilus TyrRS utilizes a different mode of tRNA binding from those discussed above. The enzyme is a small dimer of identical subunits, each containing 419 amino acids (183).Residues in the amino-terminal domain (1 to 319) make up the active site and the dimerization interface, while residues in the carboxy-terminal domain (320 to 419) are required for tRNA binding (184). A single tRNA binds to both subunits of the enzyme, with protein contacts between the amino-terminal domain of one subunit and the acceptor stem of tRNATyr, and additional strong contacts between the carboxy-terminal domain of the second subunit and other regions of the tRNA (185). A truncated dimer containing only amino acids 1 to 319 does not bind tRNATyr;however, dissociation of the subunits by introducing a mutation at the subunit interface yields monomers capable of binding, but not aminoacylating, the tRNA (186). An extensive set of site-directed mutants of B . stearothermophilus TyrRS has been generated to define the amino-acid residues critical for tRNA binding (187, 188;Table XIX). This analysis has revealed a set of eight positively charged amino acids that make strong contacts to the tRNA, in a manner analogous to the backbone interactions seen in the GlnRS*tRNAG'l) complex. Many of these residues are located in the disordered carboxyterminal domain of the crystal structure of B. stearothermophilus TyrRS (170).However, high-resolution structures of amino acids 1 to 319 complexed with tyrosyl-adenylate and with tyrosine are available (170, 172). These structures, along with the crystal structure of yeast tRNAPhe, and the TyrRS mutational analysis, allow detailed modeling of the interaction between the amino-terminal domain of the protein and the tRNA acceptor stem (187,188).
80
LADONNE
n. SCHULMAN
In the model, contacts are made between GIU,,~, Arg,,,, and Lys,, and phosphate groups 67-70, 73, and 74 (Table XIX). In contrast to the GlnRS complex, the TyrRS model also postulates direct protein contacts to the discriminator base, A,,, a known recognition element of tRNATyr. It is suggested that this base plays a key role in orientation of the 3' end of the tRNA at the active site through interaction with Lys,,,, Glu152, and the main-chain carbonyl of Ala,,, and van der Waals contacts with Trp1=. Study of a mutant of Lys,,, reveals that this amino acid makes an additional contact with tRNATyr in the transition state. Location of Lys,,, near A,, in the model has led to the suggestion that recognition of A,, in the transition state may govern the rate of aminoacylation of tRNAs by TyrRS (188).A,, is positioned close to Lys,, and ArG, at the active site, and the side-chains of Lys,, and Lys,, are near the 2' and 3' OH groups of the terminal ribose in the model. As was observed in the GlnRS*tRNAG'" complex, the TyrRS model reveals a tight complementarity in shape between the structure of the tRNA and the synthetase (188). Overproduction of either E. coli or B . stearothermophilus TyrRS is toxic to E. coli cells (H. Bedouelle, personal communication), suggesting that the Tyr synthetases weakly interact with other tRNAs and mischarge one or more noncognate species when present at elevated concentrations. E. coli GlyRS, yeast PheRS and E. coli PheRS have the subunit structure O L ~ Pbind ~ , two molecules of tRNA per molecule of enzyme, and require both subunits for activity (189-196). Construction of deletion mutants of E. coli GlyRS has shown that the carboxy-terminal half of the @subunit is required for tRNA aminoacylation, but not for ATP-PP, exchange (192).In contrast, the amino-terminal portion (1 to 172) of the P-subunit of yeast PheRS contains the main tRNA binding sites (196). E. cob ThrRS regulates its own expression at the translational level by interacting with a site in the 5' leader region of its mRNA that resembles the anticodon stem and loop of Thr tRNAs (199,200).ThrRS mutants defective in translational repression have been isolated and shown to have increased &'s for the aminoacylation of tRNAThr (201, 202). Point mutations in the mRNA stem-loop structure lead to constitutive synthesis of ThrRS. Mutants of the enzyme (super-repressors) capable of compensating for mutations in the stem structure have been isolated; they aminoacylate tRNAThr with a decreased K , (201,201;Table XIX). In addition, these mutants increase the suppressor activity of an amber suppressor derivative of tRNAzhr which is poorly aminoacylated by wild-type ThrRS (202). Attempts to isolate ThrRS mutants that compensate for mutations in the anticodon-like G.U sequence in the loop of the mRNA structure were unsuccessful, suggesting that such mutants may be toxic to cells as a result of altered specificity in the recognition of tRNA anticodons and the mischarging of noncognate tRNAs.
RECOGNITION OF
tRNAs
81
As can be seen from the above discussion, there is considerable diversity in the way that tRNAs interact with their cognate synthetases, and no obvious correlation exists between the mode of tRNA binding and the pattern of recognition elements present in the tRNA. Knowledge of the detailed interactions that occur in additional tRNA-synthetase complexes will be required before any common features are revealed, if they exist. Cocrystals of a complex of yeast AspRS(a,), and two molecules of tRNAASpsuitable for high-resolution X-ray analysis have recently been obtained (204). Solution of the structure of this complex is eagerly awaited.
IX. Concluding Remarks The next few years promise exciting new developments in our understanding of tRNA-synthetase recognition. Mutational analysis of tRNAs is proceeding at a rapid pace, and should lead to the definition of major recognition sites in many tRNAs in the near future. Solution of new crystal structures and accompanying mutational studies will soon provide new insights into the tRNA binding sites of additional proteins. The wealth of information obtained from the cocrystal structure of E. coli GlnRS and tRNAGln has inspired renewed efforts in many laboratories to obtain crystals of additional tRNA-synthetase complexes. Recognition of tRNAs by GlnRS involves base-specific protein-RNA contacts, a base-specific RNA-RNA contact, and dramatic local conformational changes in the tRNA. It remains to be determined whether all or only some of these features are conserved in other tRNA-synthetase interactions, and to what extent recognition involves conformational changes in the proteins as well. The requirement for cognate tRNA in the activation of amino acids by ArgRS, GlnRS, and GluRS implies the induction of structural changes at the active sites of these enzymes on tRNA binding. The structure of the GlnRS.tRNAG’”complex suggests that there may be structural connectivity between the anticodon binding domain and the active site domain. Changes in key recognition elements are often seen to d e c t both K , and kcat for aminoacylation, suggesting that initial binding may be followed by a reorientation of the 3’ terminus of the tRNA at the active site and/or by induced changes in the enzyme structure. Early experiments suggested that synthetases may undergo conformational transitions dependent on the binding of cognate tRNAs (205). Additional solution studies directed at resolving discrete steps in tRNA recognition and catalysis during aminoacylation and their dependence on specific sequences in the tRNA and protein would be useful in clarifying the dynamic aspects of the recognition process. Additional studies of the deacylation activity of synthetases toward mischarged tRNAs would also be useful to determine whether identical struc-
82
LADONNE
n. SCHULMAN
tural features in tRNAs govern the aminoacylation reaction and the aminoacyl-tRNA hydrolysis reaction catalyzed by these enzymes. In vioo approaches to the study of tRNA identity would benefit from greater flexibility in the types of test tRNAs that can be assayed, and from greater attention to the balance of tRNA and synthetase levels in the cell. The design of suitable in uiuo assays remains a formidable challenge, which will occupy some of us for years to come.
ACKNOWLEDGMENTS I would like to thank all my colleagues who provided preprints and results of unpublished studies for use in this review. I am also grateful to Gourisankar Ghosh and Leo Pallanck for a critical reading of the manuscript, and to Rita Romita for expert typing. Studies carried out in my laboratory were supported by research grants GM16995 from the National Institutes of Health and NP-19 from the American Cancer Society.
REFERENCES 1. S.-H. Kim, F. L. Suddath, G. J. Quigley, A. McPherson, J. L. Sussman, A. H. J. Wang, N. C. Seeman and A. Rich, Science 185,435 (1974). 2. J. D. Robertus, J. E. Ladner, J. T. Finch, D. Rhodes, R. S. Brown, B. F. C. Clark and A. Klug, Nature 250, 546 (1974). 3. E. Westhof, P. Dumas and D. Moras, ] M B 184, 119 (1985). 4. P. Schimmel, ARB 56, 125 (1987). 5. L. L. Kisselev, This Series 32, 237 (1985). 6. P. R. Schimmel and D. So11, ARB 48, 601 (1979). 7. J. Normanly and J. Abelson, ARB 58, 1029 (1989). 8. P. Schimmel, Bchem 28, 2747 (1989). 9. L. H. Schulman and J. Abelson, Science 240, 1591 (1988). 10. M . Yarus, Cell 55, 739 (1988). 11. U. L. RajBhandary, Nature 336, 112 (1988). 12. M . A. Rould, J. J. Perona, D. So11 and T. A. Steitz, Science 246, 1135 (1989). 13. J. J. Perona, R. N. Swanson, M. A. Rould, T. A. Steitz and D. Soll, Science 246, 1152 (1989). 14. H. Bedouelle and G. Winter, Nature 320, 371 (1986). 15. E. Labouze and H. Bedouelle, ] M B 205, 729 (1989). 16. S. Brunie, C. Zelwer and J.-L. Rider, ]MB 216, 411 (1990). 17. P. Mellot, Y. Mechulam, D. LeCorre, S. Blanquet and G . Fayat, J M B 208, 429 (1989). 18. G. Ghosh, H. Pelka and L. H. Schulman, Bchem 29, 2220 (1990). 19. J. Normanly, R. C. Ogden, S. J. Horvath and J. Abelson, Nature 321, 213 (1986). 20. R. Cieg6, D. Kern and J.-P. Ebel, Biochimie 54, 1245 (1972). 21. D. Kern, R. Gieg6 and J.-P. Ebel, EJB 31, 148 (1972). 22. M. Yarus, Bchem 11, 2352 (1972). 23. M. Mertes, M. A. Peters, W. Mahoney and M. Yam, ] M B 71, 671 (1972). 24. L. H. Schulman, in “Transfer RNA: Structure, Properties and Recognition” (P. Schimmel, D. Sol1 and J. Abelson, eds.), p. 311. CSHLab, Cold Spring Harbor, New York, 1979. 25. J. D. Smith, in “Nonsense Mutations and tRNA Suppressors” (J. E. Celis and J. D. Smith, eds.), p. 109. Academic Press, New York, 1979. 26. H. Ozeki, H. Inokuchi, F. Yamao, M. Kodaira, H. Sakano, T. Ikemura and Y. Shimura, in
RECOGNITION OF
27. 28. 29. 30. 31.
32. 33. 34.
35. 36. 37. 38. 39. 40. 41.
tRNAs
83
“Transfer RNA: Biological Aspects” (D. So11, J. Ahelson and P. R. Schimmel, eds.), p. 341. CSHLab, Cold Spring Harbor, New York, 1980. C. Squires and J. Carbon, Nature N B 233, 274 (1971). J. W. Roberts and J. Carbon, Nature 250, 412 (1974). A. G. Bruce and 0. C. Uhlenheck, Bchem 21, 855 (1982). H. Uemura, M. Imai, E. Ohtsuka, M. Ikehara and D. SOH, NARes 10, 6531 (1982). E. Ohtsuka, S. Tanaka, T. Tanaka, T. Miyake, A. F. Markham, E. Nakagawa, T. Wakahayashi, Y. Taniyama, S. Nishikawa, R. Fukumoto, H. Uemura, T. Doi, T. Tokunaga and M. Ikehara, PNAS 78, 5493 (1981). B. L. Seong and U. L. RajBhandary, PNAS 84, 334 and 8859 (1987). J. J. Perona, R . Swanson, T. A. Steitz and D. Soll, J M B 202, 121 (1988). T. Meinnel, Y. Mechulam and G . Fayat, NARes 16, 8095 (1988). Y.-M. Hou and P. Schimmel, Nature 333, 140 (1988). S. J. Park, Y.-M. Hou and P. Schimmel, Bchem 28, 2740 (1989). J. R. Sampson and 0. C. Uhlenheck, PNAS 85, 1033 (1988). T. Samuelsson, T. Boren, T.-I. Johansen and F. Lustig, JBC 263, 13692 (1988). K. B. Hall, J. R. Sampson, 0. C. Uhlenheck and A. G. Redfield, Bchem 28,5794 (1989). T. Hasegawa, H. Himeno, H. Ishikura and M. Shimizu, BBRC 163, 1534 (1989). V. Perret, A. Garcia, H. Grosjean, J.-P. Ehel, C. Florentz and R. Gieg6, Nature 344, 787 (1990).
42. H. Himeno, T. Hasegawa, T. Ueda, K. Watanahe, K. Miura and M. Shimuzu, NARes 17, 7855 (1989).
43. 44. 45. 46.
L. H. Schulman and H. Pelka, Science 242, 765 (1988). L. H. Schulman and H. Pelka, NARes 18, 285 (1990). W.-C. Chu and J. Horowitz, NARes 17, 7241 (1989). Y. Shimura, A. Aono, H. Ozeki, A. Sarahhai, H. Lamfrom and J. Ahelson, FEBS Lett. 22, 144 (1972).
47. M. L. Hooper, R. Russell and J. D. Smith, FEBS Lett. 22, 149 (1972). 48. J. D. Smith and J. E. Celis, Nature N B 243, 66 (1973). 49. J. E. Celis, M. L. Hooper and J. D. Smith, Nature N B 244, 261 (1973). 50. A. Ghysen and J. E. Celis, J M B 83, 333 (1974). 51. H. Inokuchi, J. E. Celis and J. D. Smith, J M B 85, 187 (1974). 52. J. Normanly, J.-M. Masson, L. G. Kleina, J. Ahelson and J. H. Miller, PNAS 83, 6548 (1986).
53. J.-M. Masson and J. H. Miller, Gene 47, 179 (1986). 54. W. H. McClain and K. Foss, Science 240, 793 (1988). 55. W. H. McClain and K. Foss, Science 241, 1804 (1988). 56. W. H. McClain, Y.-M. Chen, K. Foss and J. Schneider, Science 242, 1681 (1988). 57. W. H. McClain and K. Foss, J M B 202, 697 (1988). 58. Y.-M. Hou and P. Schimmel, Nature 333, 140 (1988). 59. Y.-M. Hou and P. Schimmel. Bchem 28, 4942 (1989). 60. Y.-M. Hou and P. Schimmel, Bchem 28, 6800 (1989). 61. M. J. Rogers and D. Soll, PNAS 85, 6627 (1988). 62. M .Yarus, S. W. Cline, P. Wier, L. Breeden and R. C. Thompson,JMB 192, 235 (1986). 63. M. Yarus, Nature N B 239, 106 (1972). 64. R. Swanson, P. Hoben, M. Sumner-Smith, H. Uemura, L. Watson and D. SOH, Science 242, 1548 (1988). 65. E. J. Murgola, ARGen 19, 57 (1985).
66. N. E. Prather, E. J. Murgola and B. H. Mims,JMB 172, 177 (1984). 67. R. Chattapadhyay, H. Pelka and L. H. Schulman, Bchem 29, 4263 (1990).
a4
LADONNE H. SCHULMAN
670. L. Pallanck and L. H. Schulman, PNAS 88, in press (1991). 68. B. L. Seong and U. L. RajBhandary, PNAS 84, 8859 (1987). 69. B. L. Seong, C.-P. Lee and U. L. RajBhandary, JBC 246, 6504 (1989). 70. D. L. Riddle and J. Carbon, Nature N B 242, 230 (1973). 71. L. H. Schulman and H. Pelka, PNAS 80, 6755 (1983). 72. J. F. Curran and M. Yarus, Science 238, 1545 (1987). 73. C. M. Cummins, T. F. Donahue and M. R. Culbertson, PNAS 79, 3565 (1982). 74. R. F. Gaber and M. R. Culbertson, MCBiol4, 2052 (1984). 75. L. Bossi and D. M. Smith, PNAS 81, 6105 (1984). 76. J. R. Roth, Cell 24, 601 (1981). 77. L. Fralova and L. L. Kisselev, Biokhimiya (Moscow) 29, 1177 (1964). 78. C. Mathews and K. van Holde, “Biochemistry,” p. 962. Benjamin-Cummings, Redwood City, California, 1990. 79. M. Yaniv, W. R. Folk, P. Berg and L. Soll, J M B 86, 245 (1974). 80. M . Yarus, R. G . Knowlton and L. Soll, in “Nucleic Acid-Protein Recognition” (H. Vogel, ed.), p. 391. Academic Press, New York, 1977. 81. R. G. Knowlton, L. Sol1 and M. Yarus, ] M B 139, 705 (1980). 82. L. H. Schulman and J. P. Goddard, JBC 248, 1341 (1973). 83. K. Chakraburtty, NARes 2, 1793 (1975). 84. R . W. Chambers, S. Aoyasi, Y. Furukawa, H. Zawadzka and 0. Bhanot, JBC 248, 5549 (1973). 85. H. Pelka and L. H. Schulman, Bchem 25, 4450 (1986). 86. A. Theobald, M. Springer, M. Grunberg-Manago, J.-P. Ebel and R. GiegC, EJB 175,511 (1988). 87. R. W. Chambers, 0. S. Bhanot, S. Aoyagi, Y. Furukawa and H. Zawada, FP 33, 1422 (1974). 88. M. S. Qiu, Y. X. Jin, W. Q. Li, J. R. Bao and D. Wang, Sci. Sin. [ B ] 31, 695 (1988). 89. Y. X. Jin, M. S . Qiu, W. Q. Li, K. Q. Zeng, J. Bao, P. Gong, R. Wu and D. Wang, Anal. Biochem. 161, 453 (1987). 90. L. Raftery and M. Yarus, J M B 184, 343 (1985). 91. R. P. Singhal, Bchem 13, 2924 (1974). 92. C. W. Hill, G. Combriato and W. Dolph, J . Bact. 117, 351 (1974). 93. D. L. Riddle and J. Carbon, Nature N B 242, 230 (1973). 94. E. L. Sabban and 0. S. Bhanot, JBC 257, 4796 (1982). 95. T.Muramatsu, K. Nishikawa, F. Nemoto, Y. Kuchino, S. Nishimura, T.Miyazawa and S. Yokoyama, Nature 336, 179 (1988). 96. L. H. Schulman and H. Pelka, PNAS 80, 6755 (1983). 97. L. H. Schulman and H. Pelka, Bchem 24, 7309 (1985). 98. L. Stern and L. H. Schulman, JBC 252, 6403 (1977). 99. M. Rould, J. J. Perona and T. Steitz, personal communication. ZOO. L. H. Schulman and H. Pelka, Science 246, 1595 (1989). 101. A. G . Bruce and 0. C. Uhlenbeck, Bchern 21, 3921 (1982). 101a. H. Himeno, T. Hasegawa, T. Ueda, K. Watanabe and M. Shimizu, NARes. 18, 6815 (1990). 102. M. Springer, M. GraEe, J. Dondon and M. Grunberg-Manago, E M B O J . 8, 2417 (1989). 103. V. Scheinker, S. F. Beresten, T.D. Mashkova, A. M. Mazo and L. L. Kisselev, F E E S Lett. 132, 349 (1981). 104. L. A. Bare and 0. C. Uhlenbeck, Bchem 25, 5825 (1986). 105. L. A. Bare and 0. C. Uhlenbeck, Bchem 24, 2354 (1985). 106. 0. C. Uhlenbeck, Chem. Scr. 26B, 97 (1986).
RECOGNITION OF
tRNAs
85
107. L. G. Kleina, J.-M. Masson, J. Normanly, J. Abelson and J. H. Miller, J M B 213, 705 (1990). 108. J. Normanly, L. G. Kleina. J.-M. Masson, J. Abelson and J. H. Miller, J M B 213, 719 (1990). 109. M . Springer, M. GrafTe, J. S. Butler and M. Grunberg-Manago, PNAS 83, 4384 (1986). 110. H. Moine, P. Romby, M. Springer, M. Grunberg-Manago, J.-P. Ebel, C. Ehresmann and B. Ehresmann, PNAS 85, 7892 (1988). 111. M .Springer, M. Graffe, J. Dondon, M. Grunberg-Manago, P. Romby, B. Ehresmann, C. Ehresmann and J.-P. Ebel, Biosci. Rep. 8, 619 (1988). 112. M . Sprinzl, T. Hartmann, J. Weher, J. Blank and R. Zeidler, NARes 17, r l (1989). 113. U. Varshney and U. L. RajBhandary, PNAS 87, 1586 (1990). 114. U. L. RajBhandary and H. P. Ghosh, JBC 244, 1104 (1969). 115. K. Takeishi, T. Ukita and S. Nishirnura, JBC 243, 5761 (1968). 116. M. Simsek, U. L. RajBhandary, M. Boisnard and G. Petrissant, Nature 247, 518 (1974). 117. P. Guillemaut and J. H. Weil, BBA 407, 240 (1975). 118. D. R. Smith and J. M. Calvo, NARes 8, 2255 (1980). 119. A. M. Cigan, L. Feng and T. F. Donahue, Science 242, 93 (1988). 120. D. M. Crothers, T. Seno and D. G. Still, PNAS 69, 3063 (1972). 121. C. deDuve, Nature 333, 117 (1988). 122. C. Francklyn and P. Schimmel, Nature 337, 478 (1989). 123. S. J. Park and P. Schimmel, JBC 263, 16527 (1988). 124. N. E. Prather, E. J. Murgola and B. H. Mims, JMB 172, 177 (1984). 125. E. J. Murgola and K. A. Hijazi, MGG 191, 132 (1983). 126. J.-P. Shi, C. Francklyn, K. Hill and P. Schimmel, Bchem 29, 3621 (1990). 127. M. Jasin, L. Regan and P. Schimmel, JBC 260, 2226 (1985). 128. T. Atilgan, H. B. Nicholas, Jr., and W. H. McClain, NARes 14, 375 (1986). 129. W. H. McClain and H. B. Nicholas, Jr.. JMB 194, 635 (1987). 130. N. Imura, G. B. Weiss and R. W. Chambers, Nature 222, 1147 (1969). 131. F. Zinoni, A. Birkman, T. Stadtrnan and A. Bock, PNAS 83, 4650 (1986). 132. W. Leinfelder, E. Zehelein, M. Mandrand-Berthelot and A. Bock, Nature 331, 723 (1988). 133. P. Hoben, Ph.D. thesis, Yale University, New Haven, Connecticut, 1984. 134. C. E. Singer and G. R. Smith, JBC 247, 2989 (1972). 135. 0. Orellana, L. Cooley and D. Soll, MCBiol 6, 525 (1986). 136. L. Cooley, B. Appel and D. Soll, PNAS 79, 6475 (1982). 137. E. Labouze and H. Bedouelle, J M B 205, 729 (1989). 138. J. E. Ladner, A. Jack, J. D. Robertus, R. S. Brown, D. Rhodes, B. F. C. Clark and A. Klug, PNAS 72, 4414 (1975). 1380. W. H. McClain, K. Foss, R. A. Jenkins and J. Schneider, PNAS 87, 9260 (1990). 139, J. R. Sampson, A. B. DiRenzo, L. S. Behlen and 0. C. Uhlenbeck, Science 243, 1363 (1989). 140. J. R . Sampson, A. B. DiRenzo, L. S. Behlen and 0. C. Uhlenbeck, Bchem 29,2515 (1990). 141. L. S. Behlen, J. R . Sampson, A. B. DiRenzo and 0. C. Uhlenbeck, Bchem29,2523 (1990). 142. K. B. Hall, J. R . Sampson, 0. C. Uhlenbeck and A. 6. Redfield, Bchem 28,5794 (1989). 143. P. Romby, D. Moras, M. Bergdoll, P. Dumas, V. V. Vlassov, E. Westhof, J. P. EbelandR. Giegk, J M B 184, 455 (1985). 144. A. Jack, J. E. Ladner, D. Rhodes, R. S. Brown and A. Klug, JMB 111, 315 (1977). 145. W. J. Krzyzosiak, T. Marciniec, M. Wiewiorowski, P. Romby, J. P. Ebel and R. Gieg6, Bchein 27, 5771 (1988).
86
LADONNE 11. SCHULMAN
146. D. Moras, A. C. Dock, P. Dumas, E. Westhof, P. Romby, J. P. Ebel and R. GiegC, PNAS 83, 932 (1986). 147. F. Harada and S. Nishimura, Bchem 13, 300 (1974). 148. T.Muramatsu, S. Yokoyama, N. Horie, A. Matsuda, T.Ueda, Z. Yamaizumi, Y. Kuchino, S. Nishimura and T.Miyazawa, JBC 263, 9261 (1988). 149. T.Muramatsu, K. Nishikawa, F. Nemoto, Y. Kuchino, S. Nishimura, T.Miyazawa and S. Yokoyama, Nature 336, 179 (1988). 150. V. Perret, A. Garcia, H. Grosjean, J,-P, Ebel, C. Florentz and R . GiegC, Nature 344, 787
(1990). 151. J. P. Ebel, R. Gieg6, J. Bonnet, D. Kern, N . Befort, C. Bollack, F. Fasiolo, J. Gangloffand G . Dirheimer, Biochimie 55, 547 (1973). 152. B. Roe, M . Michael and B. Dudock, Nature 246, 135 (1973). 153. T.McCutchan, S. Silverman, J. Kohli and D. Soll, Bchem 17, 1622 (1978). 154. A. L. Haenni, S. Joshi and F. Chapeville, This Series 27, 85 (1982). 156. F. Yamao, H. Inokuchi, A. Cheung, H. Ozeki and D. Soll, JBC 257, 11639 (1982). 157. P. Hoben, N. Royal, A. Cheung, F. Yamao, K. Biemann and D. Soll, JBC 257, 11644 158. 159. 160. 161. 162. 163. 164. 165. 166. 167. 168. 169. 170. 171. 172. 173. 174. 175. 176. 177. 178. 179. 180. 181. 182. 183. 184. 185. 186. 187.
(1982). J. J. Perona, R. Swanson, T.A. Steitz and D. Soll,]MB 202, 121 (1988). A. Rich and P. R. Schimmel, NARes 4, 1649 (1977). H. Inokushi, P. Hoben, F. Yamao, H. Ozeki and D. Soll, PNAS 81, 5076 (1984). S. D. Putney, N. J. Royal, H. N. deVegvar, W. C. Herlihy, K. Biemann and P. Schimmel. Science 213, 1497 (1981). M. Jasin, L. Regan and P. Schimmel, Nature 306, 441 (1983). K. Hill and P. Schimmel, Bchem 28, 2577 (1989). L. Regan, L. Buxbaum, K. Hill and P. Schimmel, JBC 263, 18598 (1988). M. Jasin, L. Regan and P. Schimmel, JBC 260, 2226 (1985). L. Regan, J. Bowie and P. Schimmel, Science 235, 1651 (1987). S. Brunie, P. Mellot, C. Zelwer, J.-L. Risler, S. Blanquet and G . Fayat, J . Mol. Graphics 5, 18 (1987). C. Zelwer, J. L. Risler and S. Brunie, J M B 155, 63 (1982). T.N. Bhat, D. M. Blow, P. Brick and J. Nyberg, JMB 158, 699 (1982). D. M. Blow and P. Brick, in “Biological Macromolecules and Assemblies” ( J . A. Jurnak and A. McPherson, eds.), Vol. 2, p. 442. Wiley, New York, 1985. P. Brick, T. N. Bhat and D. M. Blow, J M B 208, 83 (1989). P. Brick and D. M. Blow, J M B 194, 287 (1987). D. G. Barker. J. P. Ebel, R. Jakes and C. J. Bruton, EJB 127, 449 (1982). F. Dardel, G. Fayat and S. Blanquet, J . Bact. 160, 1115 (1984). D. Cassio and J. P. Waller, EJB 20, 283 (1971). P. Mellot, Y. Mechulam, D. LeCorre, S. Blanquet and 6. Fayat, ] M E 208, 429 (1989). D. Valenzuela and L. H. Schulman, Bchem 25, 4555 (1986). 0. Leon and L. H. Schulman, Bchem 26, 5416 (1987). C. Hountondji, S . Blanquet and F. Lederer, Bchem 24, 1175 (1985). C. Hountondji, F. Lederer, P. Dessen and S. Blanquet, Bchem 25, 16 (1986). C. Hountondji, P. Dessen and S. Blanquet, Biochimie 68, 1071 (1986). G. Prevost, G. Eriani, D. Kern, G. Dirheimer and J. Gangloff, EJB 180, 351 (1989). G. Winter, G. L. E. Koch, B. S. Hartley and D. G. Barker, EJB 132, 383 (1983). M. Waye, G . Winter, A. J. Wilkinson and A. R. Fersht, EMBO J . 2, 1827 (1983). P. Carter, H. Bedouelle and G. Winter, PNAS 83, 1189 (1986). A. R. Fersht, Bchem 26, 8031 (1987). H. Bedouelle and G. Winter, Nature 320, 371 (1986).
RECOGNITION OF
tRNAs
87
188. E. Labouze and H. Bedouelle, J M B 205, 729 (1989). 189. G . M. Nagel, S. Cumberledge, M. S. Johnson, E. Petrella and B. Weber, NARes 12, 4377 (1984). 190. T. A. Wehster, B. W. Gibson, T. Keng, K. Biemann and P. Schimmel, JBC 258, 10637 (1983). 191. A. T. Profy and P. Schimmel, JBC 261, 15474 (1986). 192. M. J. Toth and P. Schimmel, JBC 265, loo0 (1990). 193. Y. Mechulam, G . Fayat and S. Blanquet, J. Bact. 163, 787 (1985). 194. A. Dueruix, N. Hounwanou, J. Reinbolt, Y. Boulanger and S. Blanquet, BBA 741, 244 (1983). 195. F. Fasiolo, N . Befort, Y. Boulanger and J:P. Ebel, BBA 217, 305 (1970). 196. F. Fasiolo, A. Sanni, S. Potier, J.-P. Ebel and Y. Boulanger, FEBS Lett. 242, 351 (1989). 196a. P. Walter, L. Despoils, M. Laforet, J.-P. Ebel and F. Fasiolo, Biochimie 72, 537 (1990). 197. F. Lawrence, S . Blanquet, M. Poiret, M. Robert-Gero and J. P. Waller, EJB 36, 234 (1973). 198. A. Brevet, J. Chen, F. Leveque, P. Plateau and S. Blanquet, PNAS 86, 8275 (1989). 199. H. Moine, P. Romby, M. Springer, M. Grunberg-Manago, J.-P. Ebel, C. Ehresmann and B. Ehresmann, PNAS 85, 7892 (1988). 200. M. Springer, M . Graffe, J.S. Butler and M. Grunberg-Manago, PNAS 83, 4384 (1986). 201. M. Springer, M. Graffe, J. Dondon, M. Grunberg-Manago, P. Romby, B. Ehresmann, C. Ehresmann and J.-P. Ebel, Biosci. Rep. 8, 619 (1988). 202. M. Springer, M. Graffe, J. Dondon and M. Grunherg-Manago, E M B O J . 8, 2417 (1989). 203. K. Muench, JBC 251, 5195 (1976). 204. M. Ruff, J. Caverelli, V. Mikol, B. h r b e r , A. Mitschler, R. Gieg6, J. C. Thierry and D. Moras, J M B 201, 235 (1988). 205. D. Riesner, A. Pingoud, D. Boehme, F. Peters and G . Maass, EJB 68, 71 (1976).
This Page Intentionally Left Blank
Ribosome Biogenesis in Yeast'
I
I
H. A. RAud
AND
R. J. PLANTA~
Biochemisch kboratorium Vrije Unioersiteit 1081 HV Amsterdom, The Netherlands
I. Transcription of Ribosomal-RNA Genes . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Genetic Organization and Structure of Yeast rRNA Genes . . . . . . . . . 8. Transcription Initiation by Yeast RNA Pol I ...................... C. Transcription Termination by Yeast RNA Pol D. Regulation of Yeast RNA-Pol-I Transcription .............. E. Transcription of 5-S rRNA by Yeast RNA Pol 11. Expression of Ribosomal-protein Genes . . . . . . . A. Genetic Organization and Structure of Yeast Ribosomal-protein Genes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Transcriptional Regulation of Ribosomal-protein Synthesis . . . . C. Post-transcriptional Regulation of Ribosomal-protein Synthesis . . . . . 111. Processing and Assembly of Ribosomal Constituents . . , , , , . , A. Processing of Pre-rRNA ................... B. Modification of Pre-rRNA . . . . . . . . . . . . . . . . . . . . . . . C. Modification of Ribosomal Proteins ........................ D. Nucletxytoplasmic Transport and Assembly ..................... References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
91 91 92 99 101 102 103 103 104 109 111 111 116 117 118 124
The formation of functional ribosomes is a highly complex phenomenon requiring the interplay of a large number of molecular processes. Ribosomes contain, depending on their origin, some 60-80 different components, proteins as well as RNA molecules, most in a single copy per ribosome. Since normally growing cells generally contain no free pools of these ribosomal components, the expression of the numerous ribosomal genes must be subject to tight coordinate control to ensure the production of equimolar amounts of the various rRNA and ribosomal-protein (r-protein) constituents.
1 Abbreviations and terminology: r-protein or rp-: ribosomal protein; rp-mRNA, rp-gene: mRNA, gene encoding r-protein; snRNA: small nuclear RNA; ITS: internal transcribed spacer; ETS: external transcribed spacer; NTS: non-transcribed spacer; YEp: yeast episomal plasmid; YCp: yeast centromeric plasmid; UAS: upstream activating sequence; NLS: nuclear localization signal; RAP: repressor-activator protein; ABF: ARS-binding factor (SUF); linker-scanning: mutational analysis in which consecutive regions of a DNA sequence are replaced one by one by a synthetic oligonucleotide; confocal laser scanning microscopy: microscope technique employing zero depth-of-field, which allows sequential focusing on different planes within a cell; RPG: ribosomal protein gene; TUF: transcription upstream factor. 2 To whom correspondence may be addressed.
89 Progress in Nucleic Acid Hesearch and Molrrular Liiol0gy. Nil, 41
Copyright 0 1991 by Academic Press, Inc. All rights nfreproduction in any form reserved.
90
n. A.
F L W ~ AND R. J. PLANTA
In addition, cells can increase or decrease the expression of all members of the set of ribosomal genes in a concerted fashion in response to variations in environmental conditions, such as amino-acid deprivation, and changes in carbon source or temperature, which alter the demand for protein biosynthetic capacity. As far as prokaryotic (i.e., Escherichia coli) ribosome biogenesis is concerned, the main features of this regulation have now been elucidated (1,2). Control of ribosome biogenesis in E. coli involves a number of linked feedback loops in which excess ribosomes, in some as yet not completely understood way that requires translational initiation, inhibit rRNA (and incidentally also tRNA) transcription. The balance between the synthesis of rRNA and r-protein is subsequently redressed mainly, although not exclusively, through the action at the translational level of a small number of r-proteins. These “repressor” r-proteins all bind individually to either 16-S or 23-S rRNA. However, upon failing to find an rRNA partner, they instead associate with their own mRNA and in this way prevent further translation. Since the polycistronic E. cob mRNAs encoding r-proteins (rp-mRNA) show a phenomenon called “translational coupling,” binding of a single specific repressor r-protein blocks expression of a complete translational unit and thus the production of all, or at least a large number, of the r-proteins encoded by the mRNA in question. In this way, r-protein translation is directly coupled to the assembly process. Ribosome assembly in prokaryotes has been studied mainly in in uitro assembly systems. These studies have led to the elucidation of the assembly pathways for both the small and large subunits (3, 4 ) and have recently resulted in the identification of the “initiator” r-proteins (5, 6), whose association with the rRNA forms the first step in the assembly process. While the end result of regulation of ribosome biogenesis in eukaryotes is the same as in prokaryotes-namely, equimolar production of all ribosomal constituents-it should be realized that different means must be used to achieve this goal, since ribosome formation in eukaryotic cells differs from that in prokaryotes in several hndamental aspects: (a) it involves the participation of three different RNA polymerases; (b) there are (often considerable) differences in gene dosage for the individual components, even those of the same type; (c) the genes encoding r-proteins (rp-genes) do not form operons; and (d) the various stages in the formation of ribosomal constituents, as well as their assembly into active ribosomes, occur in different cellular compartments. Because of its accessibility to genetic and physiological manipulation, the yeast Saccharomyces cereuisiae has become one of the most popular organisms for studying the questions raised by the coordinate control of ribosome biogenesis in eukaryotes. The genes for the various yeast rRNAs as well as
RIBOSOME BIOGENESIS IN YEAST
91
those for about 40 of the yeast r-proteins have been cloned and subjected to detailed studies. As a result, the amount of information collected on the structure and function of ribosomal genes in yeast surpasses that available for any other eukaryote. This information has given us important insights into the regulatory mechanisms controlling the expression of these genes. In addition, progress has been made in our laboratory in developing systems that provide access to the hitherto largely unexplored field of eukaryotic ribosome assembly, including the mechanism of rRNA processing. Although there is still a long way to go, these studies should eventually lead to a full description of the way in which ribosomes are formed in yeast cells, as well as the mechanisms by which the rate of ribosome formation is adjusted to the requirements of the cell at any given moment.
1. Transcription of Ribosomal-RNA Genes A. Genetic Organization and Structure of Yeast rRNA Genes The genetic organization of the rRNA genes in S. cerevisiae is basically similar to that found in other eukaryotes. The S. cerevisiae genome contains a cluster of approximately 140-200 repeats of a 9. l-kb rDNA unit arranged in tandem on the long arm of chromosome XI1 (7). In addition, R-loop analysis has revealed the presence in yeast cells of a small number of circular DNA molecules consisting of one or more of these rDNA units, whose function is still unclear (8).However, since replicative intermediates of these circular molecules have been observed occasionally, they may play a role in regulating rRNA gene dosage. The organization of the tandem repeats of S. cereoisiae rDNA, as well as the fine structure of one such repeat, is depicted in Fig. 1A. Each unit contains a single operon transcribed by RNA polymerase I (Pol I), which encompasses one gene each for 1 7 4 , 5 . 8 3 , and 2 6 3 rRNA3, in that order. The three genes are separated by two internal transcribed spacers (ITS1 and -9, while external transcribed spacers (ETSs) are present upstream from the 17-S gene and downstream from the 26-S gene. The latter ETS (3’ ETS) is considerably longer than originally supposed on the basis of structural analysis of the longest Pol-I precursor transcript (37-S pre-rRNA) detectable in yeast cells (see Section 1,C) (9). The ITS and ETS sequences are removed post-transcriptionally in an ordered series of steps (see Section 111,A). Pro-
3 The actual numbers by which the two high-molecular-weight rRNA species as well as the precursor transcripts derived from the rRNA operon are indicated vary slightly from one laboratory to another.
92
ti. A. R A UAND ~ R. J . PLANTA
FIG. 1. Fine structure of the rDNA repeat of the yeast S. cereoisioe. (A) Slightly more than one repeat is shown to clarify the tandem nature of the repeats in the rDNA locus. Regions encoding the mature rRNA sequences are indicated by black bars. Striped boxes represent regions involved in transcription initiation. Pol-I and Pol-111 transcription-initiation sites are indicated by bent arrows. Shaded bars correspond to transcribed, open bars to non-transcribed, spacer sequences. An exception has been made for the region between T2 and T3B, which appears to be transcribed by only a minor portion of the Pol-I molecules (see Section 1.C). TO through Tp indicate the positions of processing sites (0)and termination sites (0)for Pol I. (B) The general structure of an rRNA minigene is shown. The length of the initiating and 3'-endgenerating fragments varies, depending on the purpose of the experiment. The reporter fragment is a piece of DNA not normally present in yeast.
cessing of the 3' ETS must occur rapidly, since no precursor containing this complete ETS can be detected in uiuo. Each pair of rRNA operons in the rDNA cluster is separated by about 2 kb of non-transcribed spacer (NTS), divided into two parts (NTS1 and -2) by a single 5-S rRNA gene. Thus, in S. cereuisiae, in contrast to most other eukaryotes, the number of 5-S rRNA genes equals that of the genes for the other rRNA species. The 5-S gene is transcribed by RNA Pol I11 into a precursor having a short 3' extension (7-13 nucleotides) relative to the mature 5-S rRNA molecule (10). The direction of transcription of the 5-S gene is opposite that of the large rRNA operon. A number of additional 5-S rRNA genes differing from those in the 9.1-kb repeats are located at the telomere-proximal end of the array (11). However, it is not known whether these genes are transcriptionally active. No 5-S rRNA sequence heterogeneity within one specific S. cereuisiae strain has come to our attention.
B. Transcription Initiation by Yeast RNA Pol I The first indication concerning sequence elements important for transcription initiation by yeast Pol I came from a comparative analysis of the regions containing the initiation sites in five different, but evolutionarily relatively closely related, yeast strains (12).The Pol-I transcription-initiation
RIBOSOME BIOGENESIS IN YEAST
93
site in Saccharomyces arbb berg ens is,^ S. cerevisiae, Saccharomyces rosei, Klu yveromyces lactis, and Hansenula wingei, all members of the subfamily Saccharomycetoideae, has been mapped by SL nuclease, R-loop, and reverse transcription analyses, using the 3 7 4 precursor transcript of the large rRNA operon as a reference. This precursor carries a 5‘-triphosphate group, indicating that it has not been subjected to processing at its 5’ terminus (13,14). In each case, the 5’ end of the 37-S precursor mapped at a unique position located within a 23-bp sequence (positions -9 to $14 with respect to the start site) that, in contrast to the adjacent NTS and ETS sequences, is strongly conserved in all five strains. Therefore, this conservation was taken to indicate an important role for the sequence in Pol-I transcription. Functional analysis of the yeast Pol-I promoter has been limited almost exclusively to in uivo experiments, using cells transformed with mutant rRNA genes, although in vitro systems based on permeabilized cells (15), isolated nuclei (16), or crude cell extracts (17) have been described. However, these systems suffer from the drawback that they are too inflexible to allow detailed mutational analyses. Only recently has a yeast in vitro system been developed that exhibits faithful transcription by Pol I (18). Therefore, most of our present knowledge of the yeast Pol-I promoter is derived from in vivo experiments using cells transformed with genes carrying mutant Pol-I promoters. However, it was necessary to find a way to distinguish the transcripts of these mutant genes from those produced by the inevitable excess of wild-type chromosomal rDNA units. This problem was solved by using the “rRNA minigene assay system” (19-21). The basic minigene (Fig. 1B) consists of two rRNA regions, an “initiating fragment” and a “3’-end-generating fragment” separated by a “reporter” sequence of foreign origin that allows specific detection of the minigene transcript by Northern hybridization. The initiating and 3’-end-generating fragments consist of the 5’ and 3’ ends of the rRNA operon, respectively, each flanked by a length of spacer sequence sufficient to include the elements required for correct initiation on the one hand and formation of a discrete 3’ end on the other. The minigenes of rRNA can be introduced into yeast cells using either episomal (both YEpand YCp-type) or integrating vectors (20, 22, 23). In all cases, the minigenes are indeed transcribed by Pol I, as shown by the insensitivity of their transcription to high concentrations of a-amanitin (20, 22). Using the minigene system, the borders of the yeast Pol-I promoter were defined by deletion mapping (24). Starting with an initiating fragment encompassing the sequence between positions -207 and + 128 with respect to the transcription start site, we found that transcription remained unaffected 4 Recently, it has become clear that S. carlsbergensis is in fact not a separate species, but should also be classified as belonging to the species cerevisiae.
94
H. A. RAUt AND R. J . PLANTA
by 5’ deletions up to position -149. However, removal of an additional 16 bp reduced transcription by more than 80%, indicating that the sequence between positions - 149 and - 133 contains an important part of the yeast Pol-I promoter. Analysis of 3’-deletion mutants showed that no more than 15 bp downstream from the start site are required for accurate and efficient transcription. This downstream border of the Pol-I promoter coincides with the 3’ end of the conserved sequence identified in the comparative studies described above. To analyze the fine structure of the yeast Pol-I promoter, a series of linker-scanning mutants was constructed covering the region between - 146 and +8 (25). When the transcription of minigenes carrying these mutant promoters (in the context of an otherwise wild-type, full-length NTS), was quantified, we found that the yeast Pol-I promoter consists of three distinct domains (Fig. 2). Mutations in either domain I (-28 to +8)5 or domain I1 (-70 to -50) had a severe negative effect on the efficiency of transcription, reducing the amount of correctly initiated transcripts to 4-10% of the control. The sequence of the region separating domains I and I1 appeared not to be crucial for Pol-I transcription, although linker-scanning mutations in this region did reduce the amount of minigene transcripts by about 40%(Fig. 2). However, the length of this region is of vital importance. When the spacing of domains I and I1 was increased by 4 bp (i.e., almost one-half of a helix turn), transcription was reduced to less than 10% (25), suggesting that the formation of a stable transcription complex depends either on simultaneous binding of a single trans-acting factor to both domains, or on interaction between different trans-acting factors binding to these two domains at the same face of the DNA helix. Mutations in domain I11 (- 146 to -76) were considerably less debilitating than those in domains I and I1 (Fig. 2), with the strongest effect shown by mutations at the 5’ end of the domain (-146 to -134). This result is in agreement with the deletion mapping experiments discussed above. The relatively high activity displayed by mutant - 102 to -91 might indicate that the 3’ border of domain I11 is located somewhat farther upstream than position -76. So far, our results do not allow us to conclude whether the spacing between domains I11 and I1 is important. The structure of the yeast Pol-I promoter as revealed by these deletion mapping and linker-scanning experiments shows a considerable degree of similarity with the general model derived from in oitro studies of insect and vertebrate Pol-I promoters (reviewed in 26), which may extend to plants as well (27, 28). In this model, a core element (approximately -40 to - 10) acts as the binding site for a species-specific transcription factor (factor D as used 5
The indicated borders of the yeast Pol-I promoter domains are approximate.
RIBOSOME BIOGENESIS I N YEAST
95
FIG. 2. Linker-scanning analysis of the yeast Pol-I promoter. (A) Bars indicate the relative efficiencyof transcription of the various linker-scanning mutants analyzed. The controls, shown to the left, were arbitrarily set at 100%.SIRT is a minigene containing the full-length, wild-type NTS, while NIRT carries a linker in the S m d site located outside the promoter proper (position -208). The position of the linker in the various mutants is indicated by the rectangles. The solid rectangle indicates the - 102 to -91 mutant mentioned in the text. Numbers show the distance (in base-pairs) to the transcription-initiation site, which is indicated by the bent arrow. Asterisks show the limits of the promoter region as determined by deletion mapping. (B) Schematic representation of the domain structure of the yeast Pol-I promoter. (Adapted from 25.)
in 29), while an upstream element (approximately - 150 to - 110) increases the efficiency of transcription, when tested under stringent conditions, by binding of additional transcription factors. The yeast domains I and I1 together, although extending somewhat farther upstream, probably correspond to the core element. It should be noted that in Xenopus Zueuis, the core element may also consist of two, albeit more closely spaced, domains (30, 31).Yeast domain I11 appears to be analogous to the upstream element. So far, no proteins binding to any of these domains have been identified in yeast. Although the region between positions -149 and +15 is both necessary and sufficient for accurate initiation of transcription by yeast Pol I, initiation is stimulated about 10- to 20-fold by the presence of an 160- or 190-bp (depending on the type of transcription unit) EcoRI-Hind111 fragment located about 2 kb upstream from the start site (22, 23, 32; cf. Fig. 1).Again, minigene constructs showed that this element acts as a true enhancer, since its stimulating effect is independent of position or orientation, although the degree of stimulation is influenced to some extent by the nature of the sequence context (22,23). Moreover, a single enhancer stimulates transcrip-
96
H. A. RAW)? AND R. J. PLANTA
tion of both copies of a tandem repeat containing two minigenes, irrespective of its location upstream, downstream, or between the two genes (33). The enhancer segment contains binding sites for two different proteins (32,34)called REBl (or RBPl) and REB2, respectively, that can be detected in crude yeast extracts by gel-retardation analysis. DNase I and chemical footprinting showed the REBl (RBP1) site to encompass a 14- to 20-bp region starting 10 bp downstream from the EcoRI site marking the 5’ end of the enhancer fragment (32, 34). The REBB site (-20 bp) is located some 10 bp downstream from the REBl (RBP1) site (34). Interestingly, a second REBl (RBP1) binding site is centered on position -212 upstream from the transcription-initiation site (32, 34). The two sites display considerable sequence similarity, but have opposite orientations. In particular, an 8-bp sequence in the middle of the binding site is absolutely conserved. Gelretardation assays showed that the promoter-proximal site has a 4- to 5-fold higher affinity for REBl (RBP1) compared to the site within the enhancer fragment (32, 34). Although the promoter-proximal REBl (RBP1) binding site is located outside the actual promoter region, as defined by deletion mapping and linker scanning, its presence suggests a function for REBl (RBP1) in enhancement of rRNA transcription. This suggestion was reinforced by our observation that both REBl (RBP1) sites are actually occupied in uiuo (32). However, when we deleted either part or all of the enhancer site, or destroyed the promoter-proximal site by insertion of a linker into the SmaI site at position -208, there was no detectable effect on the efficiency of minigene transcription (32). A longer 5‘ deletion of the enhancer, which also encompasses about half of the REB2 binding site, reduces transcription by a factor of only about four, which makes it unlikely that REBB binding is essential for enhancer activity (23).Moreover, this reduction may well be an overestimate, since deletions extending to within the REBl (RBP1) binding site, which in our hands did not affect enhancer activity, have been reported (23)to reduce transcription to about a third. The most likely explanation for this discrepancy is that the authors did not correct for differences in copy number. We have found that copy numbers of rDNA-containing centromeric plasmids, as used in 23, can differ significantly from one transformant to another (35). In contrast to deletions at the 5’ end, even small deletions at the 3’ end of the enhancer segment cause a drastic reduction in its stimulator y activity (23).Therefore, the main element responsible for enhancer function appears to reside closely upstream from the HindIII site located about 300 bp downstream from the 3’ end of the 26-S gene. It is interesting to note that the yeast enhancer segment contains additional functional elements. First, the enhancer segment also is one of a pair of rDNA fragments (the other one being a fragment spanning the Pol-I
RIBOSOME BIOGENESIS IN YEAST
97
transcription-initiation site) that stimulate local mitotic recombination between homologous sequences when inserted together at different sites in the yeast genome (36).This HOTl activity appears to be due to Pol-I transcription of the region adjacent to the insert containing the two homologous regions. The authors suggested that HOTl activity might be responsible for maintaining sequence homogeneity within the rDNA cluster. On the other hand, mitotic recombination within the yeast rDNA cluster was strongly suppressed both by the combined action of DNA topoisomerases I and I1 (37) and by the product of the S I R 2 gene (38),which sheds some doubt on this proposed role of HOTl. Second, a replication-fork barrier lies about midway in the enhancer region (39). However, the most noteworthy additional functional element present in the enhancer region is the major terminator for Pol I, discussed in more detail in Section I,C, which is located about 100 bp downstream from the 5’ border of the enhancer. The close proximity of the Pol-I transcription terminator and enhancer has led us to propose a model for enhancer function that envisages a functional linkage between enhancer and promoter (40) (Fig. 3). In this model, each rDNA transcription unit is thought to form a loop that juxtaposes its enhancer/terminator and promoter elements. Pol-I molecules that have traversed the rDNA unit and have reached the terminator are supposed to be transferred back to the promoter. The enhancer might be actively involved
FIG.3. Model for stimulation of yeast Pol-I transcription by the enhancer located in NTSI. T-E, Terminatodenhancer element; P, promoter. (Adapted from 40.)
98
n. A. mud AND R. J.
PLANTA
in this transfer or, alternatively, might just serve to bring terminator and promoter together, thus generating a local high concentration of Pol-I molecules. This “loop-out” model is supported by the recent observation that both Pol-I and Pol-I1 enhancers can exert their stimulating effect in trans (41,42).The model also takes into account the presence of the independently transcribed 5-S rRNA gene, which forms part of a second loop (Fig. 3). As mentioned above, destruction of either one of the two REBl (RBP1) binding sites leaves enhancer function in minigenes unaffected (32). However, the minigene experiments cannot be taken as absolute proof for the absence of any involvement of REBl (RBP1) in enhancement of transcription of the genomic rRNA operons. It should be kept in mind that the minigenes used in these studies were carried on episomal plasmids, causing their topology and cellular location to differ substantially from that of the genomic rDNA units, which form an array of tandem repeats in the nucleolus. The loop-out model allows for a role of REBl (RBP1) in enhancer function, for example, by anchoring the enhancedterminator and promoter elements of the genomic rRNA operons to the nuclear matrix at closely neighboring sites. However, the fact that REBl (RBP1) is dispensable for transcription enhancement in minigene constructs implies that some sort of interaction between enhancedterminator and promoter occurs even when they are unable to bind this protein. Whatever the role of the REBl (RBP1) protein, its presence is crucial for cell survival, since the gene is essential (Q. Ju and J. R. Warner, personal communication). Recently, it was found that REBl (RBP1) is identical to the Y factor (43, 44),which creates a nucleosome-free region in the GAL1-10 upstream activating sequence (45).REBl (RBP1) binding sites are present in the UASs of many yeast protein genes as well as in centromeres and telomeres (43). Although the protein itself is only a weak activator of Pol-I1 transcription, it acts synergistically with other activators to give as much as 170-fold stimulation. The loop-out model has been extended (33) to account for the observation that the enhancer element also acts from a downstream position and can even stimulate transcription of two adjacent minigenes. In this model, several (or all) enhancer/terminator and promoter elements are juxtaposed, facilitating transfer of a terminating Pol-I molecule to any of a number of different promoters. Again, one should realize that these experiments used minigenes that, although integrated into the yeast genome, were still dislocated from the natural site of Pol-I transcription. Thus, while it is clear that a functional linkage can be established in these minigene constructs between any enhancer and any promoter, irrespective of their relative location, constraints in the chromosomal rDNA locus might be more severe. We are currently trying to resolve this question by using “tagged rDNA units integrated into
RIBOSOME BIOCENESIS IN YEAST
99
the rDNA locus (35;see also Section 111,A). Since the transcripts of these units can be clearly distinguished from those of the wild-type genes, we should be able to analyze the effect of enhancer mutations on the transcription of individual rRNA operons in their natural context.
C. Transcription Termination by Yeast RNA Pol I The longest precursor rRNA molecule detectable in yeast cells ( 3 7 3 prerRNA) has a 3’ end that maps only 7 bp downstream from the 3’ terminus of the mature 26-S rRNA sequence (46). This 3’ end, however, does not correspond to the actual Pol-I transcription-termination site, a conclusion initially drawn from the observation that, in yeast cells carrying the ma82.1 mutation, minigene transcripts extending beyond this point were detected (40). The ma82.1 mutation inactivates an endonuclease first shown to be involved in 3’-end maturation of yeast 5-S rRNA (10).Apparently, the same endonuclease is involved in (rapid) 3‘ processing of longer transcripts of the rRNA operon to 37-S pre-rRNA. Analysis of minigenes in which the processing sites had been deleted (40) showed that yeast Pol I most likely terminates at position +210 downstream from the 3’ end of the 2 6 4 gene. This site, designated T2, is located about 100 bp downstream from the 5’ border of the enhancer segment (cf. Fig. 1).Some transcription up to about position +700 (T3) was also observed when T2 was deleted as well. The conclusion that Pol-I transcription proceeds a considerable distance into the NTS was confirmed by in oitro run-on experiments using both permeabilized cells and isolated nuclei (9). In good agreement with the minigene data, these experiments showed transcription of the genomic NTS sequences up to about position +700, with attenuation occurring at two sites located in regions + 18 to +270 and +270 to +721, respectively. No transcription beyond T3, which is located upstream from the 3‘ end of the 5-S gene (Fig. l), could be detected. Since neither the minigene nor the run-on analyses allow a definitive distinction to be made between a processing site and a genuine temination site, spacer regions containing T2 or T3, as well as the region containing the processing sites TO and T1 (-70 to +100; cf. Fig. 1) were subjected to functional analysis (9). Each region was cloned in the middle of the reporter sequence of an rRNA minigene, and the products of transcription were analyzed for the presence of “upstream” (3’ end at the termination site), “downstream” (5’ end at the termination site), and “read-through” transcripts by Northern blotting, reverse transcription, and S 1 mapping. The results clearly demonstrated that Pol-I transcription does pass TO and T1, marking these sites as processing sites, since downstream transcripts having a 5’ end mapping at the appropriate location could be detected by both reverse transcription and S 1 nuclease analyses. Northern blotting did not
100
n. A. MUG
AND R. J. PLANTA
detect these downstream or read-through transcripts, demonstrating that processing at these sites is highly efficient and that the downstream part of the transcript is rapidly degraded. Identification of TO and T1 as processing sites is confirmed by the recently described in uitro processing of a synthetic rRNA transcript at these sites (47). Analysis of the transcription products of a minigene into which the T2 region had been inserted revealed no downstream transcripts, leading us to conclude that T2 is an actual termination site for yeast Pol I. By the same reasoning, two further termination sites, T3A at position +690 and T3B at position +950, were identified (Fig. 1). Since data from both the run-on and the minigene experiments indicate T2 to be a highly efficient terminator, we suspect that T3A and T3B act as failsafe terminators to prevent any Pol-I molecules that escape T2 from interfering with 5-S rRNA transcription. Our own deletion mapping data (9, 40), in combination with those of others (23),confine the sequences both required and sufficient for termination at T2 to the region between positions +120 and +211. The actual requirements may be even less, since a naturally occurring deletion of basepairs +181 to f197 did not affect the function of T2 (9). Short sequence elements (12-18 bp) direct termination of transcription by Pol I in mice, X. Zueuis, and humans by binding a truns-acting factor (48-50). Our results exclude a role for REBl (RBP1) in termination by yeast Pol I, since deletion of about half of the binding site for this protein, which abolishes its interaction with the DNA, leaves termination unaffected (40). A more extensive deletion reaching about halfway into the REB2 binding site, on the other hand, abolished termination at T2 (23), suggesting a role for the REB2 protein in this process. Comparison of the sequences surrounding T2, T3A, and T3B did not reveal any significant conservation that might mark a cisacting element(s) responsible for transcription termination. However, this does not rule out the involvement of a common truns-acting factor at these three sites, since several examples of proteins that interact with DNA at specific sites in an (apparently) sequence-independent manner are known
(51-53). Whereas none of our experiments revealed any Pol-I transcription beyond T3B (+950), functional analysis of further regions of the NTS nevertheless disclosed the presence of still another (albeit, in our minigene test system, inefficient) termination site at position -300 upstream from the Pol-I transcription-initiation site (Tp; cf. Fig. 1). This situation is similar to that reported for X. Zueuis, mice, and (probably) humans (54-56).However, inactivation of Tp reduces transcription initiation at the associated start site only slightly, even in a situation in which this inactivation leads to considerable read-through transcription by Pol-1 molecules that started at the pro-
RIBOSOME BIOCENESIS I N YEAST
101
moter of a preceding minigene (9). This result, as well as the absence of spacer promoters in yeast, makes it unlikely that Tp has a function similar to that of the promoter-associated terminators in vertebrates, which stimulate transcription initiation at the downstream promoter (54,56, 57) either by “hand-over” of Pol-I molecules transcribing the spacer or, more likely, by preventing disruption by these molecules of the stable pre-initiation complex formed at the promoter (58-60). Inactivation of Tp was achieved by inserting a linker into the SmaI site at position -208 almost 100 bp downstream (9). Thus, an element essential for termination at Tp is located a considerable distance from the actual termination site. Note that, as discussed above, the same linker insertion also destroys the promoter-proximal REBl (RBP1)binding site, which may indicate a role for this protein in termination at Tp.
D. Regulation of Yeast RNA-Pol4 Transcription Since ribosomes constitute a critical component of the protein synthetic machinery, the rate of ribosome production is tightly coupled to the cellular growth rate (61-63). In prokaryotes, there is considerable evidence that the rate at which ribosomes are formed is controlled primarily at the level of initiation of rRNA synthesis (see the introduction to this article and references therein). Although it is likely that in yeast cells, too, initiation of rRNA synthesis is a central point of control in ribosome biogenesis, little is known about the specific mechanisms. Moreover, it is clear that additional important general regulating mechanisms operate in yeast, such as those directly controlling the transcription of the r-protein genes (see Section II). Growth-rate control of ribosome production in yeast has been studied mainly by analyzing the effects of a carbon-source upshift. Changing the carbon source of the growth medium from ethanol to glucose results in a rapid 2.5 to 4-fold increase in the transcription of both r-protein and rRNA genes (64).While the outlines of the mechanism stimulating transcription of r-protein genes under these conditions are becoming visible (see Section II), that responsible for the increase in rRNA synthesis remains obscure, although the Pol-I enhancer may be involved (65).In this respect, it is noteworthy that the promoter of the gene encoding the transcriptional activator TUF of the majority of yeast r-protein genes (the RAP1 gene; see Section II,B) contains a REBl (RBP1) binding site (43) which establishes a possible link between rRNA and r-protein synthesis. An even more direct link is suggested by the Fact that yeast rDNA also contains a TUF binding site about 100 bp downstream from the start of the 2 6 4 rRNA gene (66). However, although this site has a high affinity for TUF in uitro, nothing is known about
102
H. A. RAUk AND R. J . PLANTA
in uiuo binding. Possibly, TUF, a nuclear scaffold protein (67),influences PolI transcription by affecting the topology of the rDNA. The finding that REB2 is probably identical to ABFI (43), a transcriptional activator of r-protein genes not controlled by TUF (see Section II,B), constitutes another possible example of such a direct linkage between rRNA and r-protein synthesis. Finally, an indirect link via TUF may also exist, since the gene for a common subunit of yeast Pol I and Pol I11 contains a TUF binding site in its upstream region (68).Thus, rRNA transcription might also be regulated via changes in the supply of active polymerase molecules. Saccharomyces cereuisiae, like E . coli, shows a stringent response in that amino-acid deprivation leads to a specific inhibition of rRNA transcription (66, 69, 70).The search for ppGpp (or a related compound), known to act as an inhibitor of rRNA transcription in amino-acid-starved E. coli cells, was unsuccessful, however. Also, the availability of a relaxed yeast mutant strain (71)has so far failed to throw more light on the mechanism of the stringent response in yeast. A mild heat-shock (23"C+36"C) transiently decreases transcription of rRNA genes in yeast (72).Again, the basis for this regulatory response in not known. A similar effect, however, is observed for r-protein genes as well as for several genes encoding non-ribosomal proteins (73).
E. Transcription of 5-S rRNA by Yeast RNA Pol Ill As in other eukaryotic cells, transcription of 5-S rRNA in yeast is carried out by RNA Pol 111. Transcription initiation depends on the transcription factors TFIIIA, TFIIIB, and TFIIIC that form a stable initiation complex with the promoter located in the coding region of the 5-S RNA gene (74). TFIIIB is the actual transcription activator protein, while TFIIIA and TFIIIC are required for assembly of TFIIIB into the transcription complex (75).Since yeast 5-S rRNA inhibits its own synthesis in uitro (76),it is likely that production of 5-S rRNA in oiuo is tuned to that of the other rRNA species by the same feedback system operating in vertebrate cells, in which excess 5-S rRNA sequesters TFIIIA (77). It is unclear how Pol-I and Pol-111 transcription remain balanced in a change in physiological conditions that either increases or decreases the cellular demand for ribosomes, although the TUF-controlled production of their common subunit (see Section I, D) may be involved. However, there is no obligatory coupling between Pol-I and Pol-I11 transcription. A yeast strain carrying a temperature-sensitive PolI11 mutation continues to produce 37-S rRNA for a considerable time when placed at the restrictive temperature (78). Although each yeast 5-S rRNA gene is part of an rDNA repeat, transcription of these genes does not respond to the Pol-I enhancer (65).
RIBOSOME BIOGENESIS I N YEAST
103
11. Expression of Ribosomal-protein Genes A. Genetic Organization and Structure of Yeast Ribosomal-protein Genes Whereas the equimolar production of the 17-S, 5.8-S, and 26-S rRNA species is ensured by the organization of these genes into multiple tandem copies of a contiguous transcription unit, no such linkage exists for the genes encoding the r-proteins (rp-genes). Even in the few cases in which two rpgenes are located in each other’s immediate neighborhood, they are independently transcribed. Such an arrangement has been reported for the genes encoding r-proteins L46 and S24, which are only 640 bp apart and arranged in a head-to-head fashion (79). A similar situation holds for the genes encoding rp29 and L32, separated by a 600-bp intergenic region (80). Finally, there are two pairs of RP28-S166 genes linked in a head-to-tail fashion, again by about 600 bp of DNA (81,82).A recent remarkable finding is that two yeast r-proteins, S37 from the small and an as-yet-unidentified species from the large subunit, are encoded as the carboxy-terminal part of fusion proteins with ubiquitin (83, 84), a situation also encountered in mammals and plants (83, 85). About three-quarters of the r-proteins in S. cerevisiae that have been analyzed genetically are derived from duplicate genes. In all cases, both gene copies are functional, although their expression levels often differ considerably (86-90). The duplicate copies encode identical, or virtually identical, proteins that are functionally indistinguishable (89, 91). However, their intron, leader, and trailer sequences display substantial differences. The group of r-proteins encoded by single-copy genes so far consists of L3,L29, L25 (92), L32 (go), the ubiquitin-fused S37 (84), and the phosphoproteins L44, L44’, and L45 (93),as well as the related acidic proteins A0 and A 1 (94). Only a few yeast rp-genes have as yet been mapped to specific chromosomes. The first of these were the ones conferring resistance against the antibiotics trichodermin (U), cycloheximide (L29),and cryptopleurin (RP59). The former two-single-copy ones-are located on chromosomes XV and VII, respectively (95, 96). One of the duplicate copies of the RP59 gene has been mapped to chromosome I11 (97). One of the two RP28-Sl6 gene pairs resides on chromosome XIV, the other on chromosome XV (82).The genes for the acidic proteins L44’ and L45 were both traced to chromosome IV, while that for L44 is located on either chromosome VII or XV (98). The general structure of yeast rp-genes is depicted in Fig. 4. The most striking feature of this structure is the presence of an intron close to the 5’ fi
S16 was formerly called rp55.
104
H . A. RAUg AND R. J. PLANTA
I ,
UAS
FIG. 4. Generalized structure of a yeast rp-gene. Coding sequences, the intron, and the leader region are indicated by the vertically striped bars, solid bars, and an open bar, respectively. Highly conserved nucleotides in the intron are shown. Boldface nucleotides are universally conserved. The diagonally striped boxes represent UAS elements; the dotted box, the Trich region. Average distances are indicated in base-pairs. Py, Pyrimidine.
end of the gene, since introns are rare in yeast non-ribosomal genes (reviewed in 99). Of 39 rp-genes analyzed so far, 28 contain an intron, usually within 10-20 codons downstream from the translation start. In two instances (ZIP29 and S31), the intron is located in the 5’-untranslated leader sequence of the gene. In the case of two of the ubiquitinlr-protein fusions, the intron is present in the ubiquitin-encoding part of the gene. The UB13 gene encoding S37 does not contain an intron (82). The common occurrence of an intron in rp-genes has led to speculation about a regulatory role for splicing in rprotein synthesis. So far, however, only one instance of regulation at this level has been uncovered (100; see Section 11,C).
B. Transcriptional Regulation of Ribosomal-protein Synthesis Despite the difference in gene copy number, the cellular levels of the mRNAs for several different yeast r-proteins (rp-mRNA) are approximately equal (101).Since the various rp-mRNAs have about the same stability ( l o ] ) , this suggests that the rate at which r-proteins are produced is controlled primarily at the level of transcription. Over the past few years, ample evidence supporting this suggestion has been accumulated, although additional regulation at the post-transcriptional level has also been detected (see Section 11,C). The first intimation of possible cis-acting elements involved in transcriptional control of r-protein synthesis came from a comparison of the 5’-flanking sequences of 21 different yeast rp-genes (102, 103). This comparison revealed two conserved elements, at that time designated HOMOLl and RPG boxes, located 250-450 bp upstream from the ATG start codon (cf. Fig. 5). Deletion mapping and linker-scanning experiments, carried out on several different rp-genes (104-108), demonstrated that these elements indeed play a central role in controlling rp-gene expression and, therefore, should be considered upstream activating sequences (UASs). These experiments also revealed a third element in the form of a T-rich region located closely downstream from the UAS elements (104; cf. Fig. 4). Similar regions act as promoter elements in other, non-ribosomal, yeast genes (109). Although virtually all yeast rp-genes possess a T-rich region (104-109),the
RIBOSOME BIOCENESIS I N YEAST
105
relative importance of this element seems to vary from one gene to another. Deletion mapping of the RP59 promoter showed 40% residual transcription when only the T-stretch was still present (106). Similar experiments on the L25 promoter, however, demonstrated that the T-stretch by itself does not support significant transcription of this gene (105).Nevertheless, in this case, as well as that of the L16’ (104)and L29 (107) genes, the T-stretch appears to act in conjunction with the UAS elements to promote transcription. On the other hand, the intergenic region separating the S24 and LA6 genes contains only a single T-stretch, located between the (duplicate) UAS elements and the transcription start of the LA6 gene. Since the same UAS elements are essential for expression of the S24 gene (108), either S24 gene transcription does not require a T-stretch, or the T-stretch can also function from a position upstream from the UAS elements. The latter possibility seems less likely in view of the highly conserved 5’+3’ order of UAS elements and T-stretch in rp-genes. The HOMOLl and RPG boxes, although originally considered distinct elements, in fact are different representatives of the same functional UAS (now called the RPG box) that acts as a binding site for an abundant transcription factor variously known as TUF, SBF-E, M P 1 , GRFI, and TBA (this plethora of aliases is due to the multihnctionality of this factor, discussed further on in this section). The first indication for the existence of this transcription factor came from the analysis of protein-DNA interactions in the 5’-flanking sequence of the TEFl and TEF2 genes encoding yeast elongation factor E F - l a (121,112).Using footprint and gel-retardation analyses, a protein, called TUF, was identified that bound to both the HOMOLl and RPG boxes present in the TEFl and TEF2 genes, as well as the RP5lA rp-gene. Subsequently, the same protein was shown to bind to the RPG boxes of various other yeast rp-genes (113).Sequence comparison, as well as determination of the relative affinity of various different RPG boxes for the protein (108),led to the following consensus binding sequence: 5’-ACACCCATACATTT-3’. (The most strongly conserved nucleotides are shown in boldface type. ) With only a few exceptions, yeast rp-genes carry two copies of the RPG box (110) in either orientation. Although there is no evidence for a cooperative effect between the two copies in binding of the TUF factor (113),both contribute synergistically to the final level of transcription, albeit often to a different degree. Removal of the upstream copy from the L16 gene, for example, reduced transcription by more than 90%, while deletion of the downstream copy led to a reduction of only about 30% (104). Similar results were obtained for the L25 gene, although in this case the downstream copy is 7
L16
was formerly
called rp39.
106
H . A. RAUt AND R. J. PLANTA
the stronger (114).The differences in activity are probably due to differences in nucleotide sequence of the RPG boxes, which affect the affinity for the TUF factor (113) and possibly the orientation of a particular RPG box. Replacement of the two naturally occurring copies of this element in an L25galK fusion gene by a single synthetic copy in either orientation revealed a clear orientation-dependent difference in activity (114). Also, a certain distance-dependent variation in activity cannot be excluded, since the stimulatory effect of the synthetic RPG box on transcription of the L25-gaZK fusion gene was found to diminish when its distance from the ATG start codon was reduced to about 100 bp (114). Apparently, the various factors contributing to promoter strength have been carefully balanced in the various yeast rp-genes to ensure the production of (approximately) equimolar amounts of all rp-mRNAs. In cases in which the r-protein is encoded by duplicate genes, the contribution of the individual gene copies to the final amount of mRNA is not necessarily equal. The two RP51 gene copies produce 40% and 60% of the rpdl-mRNA, respectively (86),while for L16 and RP28 genes, this ratio is about 30:70 and 15:85, respectively (89, 115). Again, the same factors mentioned above are probably responsible for these differences. The structures of the two RP28 promoters are particularly suggestive of this idea, since the most highly expressed copy contains two RPG boxes with high affinity for the TUF factor, whereas the other carries only a single low-affinity site (113). However, no comparison of promoter strength between promoters that differ only in their RPG box(es) has so far been described. TUF binding regions are not only able to combine with themselves in a synergistic manner to create stronger activation sites, but also with other sites, notably a T-rich sequence. The basis for this effect is not yet clear, but it may well involve binding of additional protein factors, albeit not in a cooperative manner (116). There is evidence that the rapid increase in transcription of rp-genes observed after a nutritional upshift is mediated through the RPG boxes. Removal of the two RPG boxes of the L25 gene abolished the typical response of this gene to a carbon-source upshift. The response could be restored by insertion of a synthetic RPG box, even in the absence of the T-stretch, demonstrating that a single element is sufficient (115). Similar results were obtained for one of the S16 genes ( I 1 7). However, the transient reduction in rprotein synthesis caused by a heat-shock, although in part due to a lowering of the transcription rate, is not mediated by the RPG boxes (73;see also Section 11,C). Although the rate of rp-gene transcription can be adapted to changes in the physiological conditions via the RPG boxes, it cannot be adjusted further once these conditions are stable. This was demonstrated by inactivating one
RIBOSOME BIOGENESIS IN YEAST
107
of the two gene copies encoding rp51 (86),L16, or rp59 (89).Such inactivation caused a reduction in the steady-state level of the pertinent rp-mRNA, demonstrating that there is no increase in transcription of the single surviving gene copy to compensate for the deletion (see also Section II,C). So far, four yeast rp-genes have been found that do not carry any RPG box in their 5'-flanking sequence. The first of these were the genes encoding S33 and L3 (113,218).In both cases, again an abundant protein factor, called S U F or TAF, respectively, that binds to a specific sequence in the upstream region of the gene was identified. We have recently demonstrated, by competition-binding experiments, that, in fact, SUF and TAF are the same protein ( 119). Footprinting and methylation interference analyses ( 119) identified the binding site as RTCRYN,ACG (R = purine; Y = pyrimidine; N = nucleotide). The rp-genes for L2 [two copies (120)]and L45 contain this same protein binding site (121,122;our own unpublished results). However, analysis of the role of the UAS (UAS,) for this set of r-proteins has not progressed to the level reached in the studies of the RPG box. As far as S33 is concerned, removal of the UAS, lowers transcription by as much as 80% when cells are grown in 0.04% glucose/2% ethanol. Upon growth in 2% glucose, however, deletion of the UAS, results in only a slight reduction in transcription. Under these conditions, transcription appears to depend on a cis-acting element located downstream from the UAS, , that binds another protein factor (123).Nevertheless, the carbon-source upshift effect, which is normal for S33, depends on the presence of the intact UAS, (123).In contrast to our observations on S33, deletion of the UAS, from the L.3 gene causes a drastic reduction in transcription even in cells grown on 2% glucose
(118). Similar to TUF, S U F binding sites can combine synergistically with themselves and other activator sites to form elements that promote transcription more strongly (116). A solitary S U F site constitutes a relatively weak activator site (5- to 30-fold weaker than a high-afEnity TUF site), but the synergism (e.g., with a T-rich sequence) can cause transcription to rise to a level 4-10 times the sum of the levels obtained with each of the elements separately. As already demonstrated by the occurrence of RPG boxes in the 5'flanking sequences of the TEFl and TEF2 genes, the role of TUF is not limited to transcription activation of yeast rp-genes. The same holds true for SUF/TAF. In fact, both proteins are involved in either positive or negative regulation of quite a number of other, non-ribosomal, genes, and are implicated in the control of several more. Furthermore, both TUF and SUF/TAF play additional important roles in the cell. TUF acts as a nuclear scaffold protein (67) and binds to yeast telomeres (124, 125), whereas SUF/TAF is implicated in DNA replication because it interacts with the conserved B
108
H . A. R A U t AND R. J. PLANTA
domain of a number of ARS elements (125-128). This multifunctional character of the two proteins has caused them to be known by a variety of aliases (Table I). Two proteins (called SBF-E and SBF-B or GRFI and ABFI, respectively) that recognize the same binding sites as TUF and SUF/TAF, play an important role in the functioning of the silencer that suppresses the H M k and HMRa mating-type loci (66, 125, 129, 137). This function of TUF is correlated with its ability to act as a nuclear scaffold protein (67). Since the sequence to which SBF-E binds acts as a transcription activator site when taken out of its context in the silencer, the protein binding to this site was also designated RAPl [for repressor activator protein (129)].This name now appears to be generally accepted. The SUF factor now is generally designated ABFI (for ARS binding factor). RAPl binding (=RPG box) as well as ABFI binding (=UAS,) sites have been found in the 5'-flanking sequences of a large number of yeast genes by sequence comparison (see 121,133 and 138 for recent compilations). Among these are genes encoding components of the transcriptional and translational (including the rp-genes) machinery, as well as genes involved in cellular differentiation, the cell division cycle, nutrient transport, and glycolysis. A TABLE I NOMENCLATUREAND MOLECULAR WEIGHTS OF TUF AND SUF FACTORS" Nameb TU F SBF-E RAPl
MW (kDa)c 150 92.5
120 GRFI TBA
Reference
Nameb
1 1 1 , 112 129 130, 131 131 125 124
SUF TAF SBF-B ABFld
MW (kDa)c
147
135 81.6
GFI BAFl TyBF OBFl
120 123
Reference 113 118 129 125, 126 127 132 133 134 135
"Abbreviations are defined in footnote 1 on p. 89. bIt should he noted that definitive experimental proof for the fact that the proteins listed in this column are indeed identical has not been provided in all cases. GMolecular-weight values were generally derived from electrophoretic analysis on SDSlpolyacrylamide gels. Boldface numbers indicated values calcualted from the nucleotide sequence of the gene. dThere are indications that ABFI may he present in two different forms in the cell, both of which are functional (116, 136).
RIBOSOME BIOGENESIS IN YEAST
109
number of nuclear genes encoding mitochondria1 components also contain ABFI binding sites (132). The common feature linking these genes is their involvement in cell growth. Although there is experimental proof for only some of the non-ribosomal genes carrying this site that the RAPl and ABFI binding sites are actually involved in transcriptional activation (see 66, 1 2 5 , 133, 138 and 139 and references therein), there is little doubt that both proteins act as global regulators of gene activity. It is therefore not surprising that both RAPl and ABFI are essential for cell survival (127, 131). The nature and efficiency of their regulatory function must be determined by interaction with additional, more specific, factors, that, for the most part, have yet to be characterized. The SIR gene products required for silencer function are likely to be such factors (66). Furthermore, an 82-kDa protein that is crosslinked to both RAPl and ABFI when bound at their respective sites has been identified (118). Finally, the GCRl gene product has been implicated in RAP1-, but not ABFI-, mediated regulation, particularly of the A D H l , T E F l , T E F 2 , and RP59 genes (140). As discussed above, the rapid elevation of rp-gene transcription in response to a nutritional upshift is mediated through the RPG box or UAS, However, the precise role of the RAPl and ABFI factors in this response is not yet clear. The amount of (active) RAPl varies with growth rate (139,141). However, the kinetics of this variation and those of the increase in rp-gene transcription are considerably out of step, the latter being much more rapid than the former (141). Tseng et al. (139) suggested that post-translational modification (phosphorylation) of RAPl might be involved in regulating its activity. On the other hand, an increase in growth rate does cause the level of ABFI to rise rapidly. The question, therefore, remains as to how expression of the two classes of rp-genes, one carrying the RPG box, the other, UAS, elements, is coordinated.
C. Post-transcriptional Regulation of Ribosomal-protein Synthesis As discussed above, transcriptional regulation occupies the foremost position among the processes controlling r-protein synthesis in yeast. However, additional regulation does occur at several post-transcriptional levels, to wit splicing, rp-mRNA stability, and stability of the r-protein. The mechanism of nuclear mRNA splicing in S . cereoisiae, which is almost exclusively limited to rp-gene transcripts, has recently been reviewed (99).There are no fundamental differences between this process in yeast and that in other eukaryotic cells, except that, unlike the situation in metazoan cells, the 3’ portion of the intron (downstream from the branch point) appears not to be involved in the initial phases of yeast spliceosome assembly. Furthermore, the yeast splicing machinery appears to be more fastidious in its sequence requirements. Sequence conservation at the 5’ end and particu-
110
H. A. RAUd AND R. J . PLANTA
lady around the branch point is much stronger in S. cereuisiae than in metazoan pre-mRNA introns (cf. Fig. 4). Despite the fact that introns in yeast occur almost exclusively in rp-gene transcripts, splicing plays only a minor role in the control of yeast r-protein synthesis. In general, splicing is not the rate-limiting step in the production of mature mRNA (142),although splicing of L29 pre-mRNA seems to be an exception (143).However, there is one well-documented example of splicing regulating the production of an r-protein. Introduction of extra copies of a cDNA encoding r-protein L32 into yeast cells did not elevate the level of the protein, but did cause an increase in the level of L32 pre-mRNA (100). Since this effect was not observed when a cDNA clone lacking the ATG translation start codon was used, it was concluded that the L32 protein regulates its own synthesis via feedback inhibition of its pre-mRNA splicing. This regulatory mechanism resembles the translational feedback that plays a central role in controlling r-protein production in E. coZi. It is reasonable to assume that the feedback regulation of L32 pre-mRNA splicing is based on competition between a pre-ribosomal particle and the precursor mRNA transcript for binding of L32. Evidence in support of this mechanism was recently supplied by the observation that blocking rRNA synthesis in a yeast mutant containing a conditionally expressed Pol-I subunit gene also leads to accumulation of L32 pre-mRNA (144). Regions of L32 pre-mRNA important for regulation of its splicing are located close to its 5' end, as well as near the 5' splice site (F. Eng and J. €3. Warner, personal communication). It is not yet clear whether L32 can bind directly to (pre-) rRNA. Of course, such direct L32/rRNA interaction is not essential for competition-based feedback regulation. Binding of L32 to the pre-ribosomal particle via proteidprotein interaction would serve just as well. Feedback regulation of splicing has also been observed for r-protein L1 from X. Zaeuis (145),and a structural similarity between the two introns in question and X . laeuis 2 8 4 rRNA has been noted (146). So far, however, there is no experimental evidence that L1 pre-mRNA and 2 8 4 rRNA directly compete for binding of L1. Subjecting yeast cells to a mild heat-shock (23"+36"C) leads to a severe, though transient, decline in r-protein synthesis, in part due to a temporary, non-rp-gene-specific, transcriptional arrest (73). In addition, however, rpmRNAs are specifically destabilized. The half-lives of S10 and L25 mRNA decrease by a factor of about three. When transcription is blocked prior to, or concomitant with, the heat-shock, either by addition of 1,lO-phenanthroline (73) or by using a temperature-sensitive Pol-11 mutant (147, 148), the stability of rp-mRNA does not change. Thus, de nouo synthesis of a protein factor seems to be required to effect the (temporary) destabilization of rp-mRNA by heat-shock. Both the nature of this factor and its target on the rp-mRNA remain to be identified.
RIBOSOME BIOGENESIS IN YEAST
111
When yeast cells are supplied with supernumerary copies of an rp-gene, the level of the corresponding rp-mRNA increases proportionally, but the amount of r-protein does not (143, 149-153). Initially, translational control was thought to be responsible, at least in some cases, notably that of L3 (143). Later experiments, however, refuted this notion and, using pulsechase techniques, demonstrated that r-protein levels are kept constant by the rapid turnover of excess protein (149-153). As discussed above, L32 is the only known exception to this rule. Yeast r-proteins, except for the acidic species (see below), appear to be inherently unstable when not immediately assembled into ribosomal precursor particles, a feature also apparent when synthesis or processing of rRNA is blocked (144, 154). The molecular cause of this extreme instability [t,,, = 12 minutes (143, 150, 151)] is unknown. The amino-terminal amino acids of the large majority of yeast r-proteins do not belong to the set conferring instability on a test protein in yeast (91, 155). Possibly, r-proteins contain a destabilizing element within their amino-acid sequences (P. J. Schaap, J. van’t Riet and H. A. RauC, unpublished). Anyway, the data discussed above clearly show that yeast cells fine-tune the supply of most r-proteins by an assembly-mediated rapid degradation of any excess produced. The exception is the set of acidic r-proteins, the only species for which a significant pool of free protein is present in the cytoplasm (156-158). The reason for this excess has yet to be elucidated. Transcriptional regulation of the genes encoding the acidic rp-genes appears to conform to the normal pattern using either RAP1 or ABFI as activators (122;our own unpublished results). Differences in post-transcriptional regulation are probably thus responsible for the “abnormal” amounts of these proteins. Experiments in which the minor (in terms of mRNA production) duplicate copy of an rp-gene was inactivated without a significant effect on growth rate (86, 89, 90) suggest that, even in wild-type cells, r-protein production is (slightly) in excess of actual need. On the other hand, no dosage compensation occurred at the level of translation when the supply of r-protein was curtailed either by knocking out the major copy (86, 89, 90) or by lowering the transcription of a conditionally expressed copy (159).Thus, the rate of translation of an rp-mRNA, like the rate of transcription of the rp-gene, is set at a fixed value by the physiological conditions.
111. Processing and Assembly of Ribosomal Constituents A. Processing of Pre-rRNA As discussed above, the Pol-I transcript of the yeast rRNA operon extends to position +210 downstream from the 3’ end of the mature 2 6 3 rRNA sequence. However, this transcript is cleaved very rapidly to generate
H. A. RAUd AND R. J. PLANTA
112
the 37-S precursor rRNA having seven extra nucleotides at its 3’ end. This cleavage appears to be carried out by the product of the RNA82 gene (40) also involved in 3’ processing of yeast 5-S rRNA (10).The same endonuclease carries out 3’ processing of the upstream member of a pair of dimeric yeast tRNA genes as well (160).Whereas minigene transcription in wild-type cells produces transcripts having 3’ ends at positions -1 (TO, corresponding to the 3’ end of the mature 26-S sequence) and +7, in rna82.1 mutant cells transcripts ending at positions +15 to +50 (site T1; cf. Fig. 1) abound. However, 3’-end formation at - 1 and + 7 is not completely abolished by the mutation, indicating that yeast cells have the means to circumvent the rna82.1 defect. Normal 3‘ processing of the Pol-I transcript thus appears to entail endonucleolytic cleavage at positions + 15 to +50 by a so-far-unidentified nuclease, followed by further endonucleolytic cleavages at positions + 7 and -1 carried out by the RNA82 gene product. Alternatively, the mature 26-S rRNA terminus might be produced by exonucleolytic removal of the final seven extra nucleotides. Yip and Holland ‘(47) recently reproduced these processing events in uitro, using a partially purified yeast extract. Upon incubation of a synthetic minigene transcript extending to position +210, they observed 3’-end formation at positions -1, +7, and +12. In contrast to the results obtained in uiuo, processing products -70 and 10 nucleotides in length, respectively, did accumulate in uitro. The former should be due to endonucleolytic cleavage in the +15 to +50 region. The identity of the latter was not established, but it could be the product of endonucleolytic cleavage of the 37-S pre-rRNA that generates the mature 3’ end. Formation of 3’-ends at -1 and + 7 requires the presence of an element(s) located between positions -36 and +74 (40)that acts in an orientation-dependent manner (9,47). An imperfect helix extending from positions +9 to +55, conserved in even distantly related Saccharomycetoidae, might constitute such a cis-acting recognition signal (40).Furthermore, this processing depends on the presence of Mg2+ ions. No evidence for the involvement of an RNA-containing component has been obtained so far (47). Figure 5 shows the sequence of processing events leading to the formation of mature 17-S, 26-S, and 5.8-S rRNAs from yeast 37-S pre-rRNA (161, 162). First, virtual simultaneous cleavages at sites A1 and A2 remove the complete 5’ ETS and separate the 17-S and covalently linked 5.8-S and 26-S rRNA sequences. A second pair of (almost) simultaneous cuts at positions B1 and B2 produces the mature 5’ end of 5.8-S rRNA and the mature 3’ end of 26-S rRNA, respectively. A third pair (C1 and C2) then results in the removal of most of ITS2, uncovering the mature 5’ end of 26-S rRNA and producing the 7-S precursor of 5.8-S rRNA. Subsequent cleavage at C 3 leads to the formation of mature 5.8-S rRNA. All cleavage events mentioned so far
-
113
RIBOSOME BIOGENESIS IN YEAST
M 500 bp
5.5 s a
32 S
-I
A
18s
A
A
A1
A2
A
Bi
' A 82
37 s 29 SA 29 SB
M
c1 c 2 7s
26 S
m-
A
c3
nucleus cytoplasm
18s
A _.
A3
I
5 s
- I
17 S
5.8 S
26 S
FIG.5. Processing of the primary Pol-I transcript in yeast to the mature rRNA species. The top line shows a single rDNA repeat acmrding to the conventions used in Fig. 1. The Pol-I transcription-initiation (bent arrow) and termination (T2) sites are indicated. Below are shown the various processing intermediates identified in yeast cells. The hypothetical primary transcript is shown shaded. Thick bars correspond to the mature sequences; thin bars to the spacer sequences. Processing sites are indicated by arrowheads. The names of the various intermediates are shown to the left and right. The structure of the unusual 3 2 4 precursor produced when site A2 has been deleted (see Section III,A) is outlined above the 3 7 4 precursor.
occur in the nucle(o1)us. The final processing of the 18-S precursor to 17-S rRNA by cleavage at A3, however, is a cytoplasmic event (163). The yeast rRNA processing scheme differs in several respects from that worked out for mammals. In this case, the primary processing event appears to be removal of the 5' ETS by means of two or three consecutive endonucleolytic cleavages (164-166),followed by removal of the 3' ETS, again in two steps (167). Further processing occurs at, or very close to, the ends of the various mature rRNA sequences (168). Processing of Tetrahymena thermophila rRNA appears to follow a similar course of events, except that, as in yeast, the 5' ETS is removed by a single cleavage (169). The lack of an in uitro system for yeast that supports processing at sites Al-C3 has severely hampered identification of the cis-acting elements required for these cleavages. We have now developed a system allowing mutational analysis of yeast rDNA in uiuo that should enable us to delineate these
114
H. A. RAUd AND R. J. PLANTA
elements (35, 170, 171). The system consists of a complete rDNA unit in which both the 17-S and 26-S rRNA genes have been “tagged” by insertion of an oligonucleotide having a unique sequence. The rDNA unit is transformed into yeast cells on a centromeric plasmid to preclude recombination with the chromosomal rDNA repeats. The plasmid-derived transcripts can easily be detected by Northern hybridization using probes complementary to the tags. The presence of the tags, inserted into one of the variable segments of each of the genes (172), in itself does not affect ribosome biogenesis or function. In a first series of experiments, we studied the effect of deletions in the 5’ ETS as well as both ITS regions on the biogenesis of 1 7 4 and 2 6 4 rRNAs. As far as the 5’ ETS is concerned, we found that deletion of XlO-4OO bp from the 5’ end, the 3’ end, or the middle of this region completely abolished formation of mature (tagged) 1 7 4 rRNA. However, accumulation of tagged 26-S rRNA, assembled into functional 604 subunits, remained unaffected even when all but 75 of the 699 bp of the 5’ ETS were deleted (171).This result clearly demonstrates that the presence of the 5’ ETS in cis is essential for the formation of the 40-S ribosomal subunit, whereas it appears to be dispensable for 6 0 3 subunit formation. Deletion of about two-thirds of the 17-S gene also did not affect 6 0 4 subunit formation (35),a surprising result in view of the fact that the first steps in yeast rRNA processing occur at the level of a 90-S ribonucleoprotein particle containing the complete Pol-I transcript (173; see Section 111,D). Deletion of a 160-bp region from ITS1 centered on processing site A2 again abolished accumulation of mature (tagged) 1 7 4 rRNA, while leaving the formation of 60-S subunits from tagged 26-S rRNA unaffected (171). This indicates that cleavage at site A2 is a crucial step in the formation of 40-S subunits. Cells containing the mutant rDNA unit accumulated an unusual 3 2 4 precursor that must have arisen from the processing of 37-S pre-rRNA at site A l . In an snR10.3 yeast mutant, in which the gene encoding snRlO RNA (sn = small nuclear) has been destroyed, processing at A2 is blocked (174).Instead, cleavage at site B1 is used to separate the 1 7 4 rRNA and 5.8Sl26-S rRNA sequences. We assume that in our case also the unusual 3 2 4 precursor is cleaved at B2, resulting in the formation of a normal processing intermediate (29-SB; cf. Fig. 5) en route to mature 26-5 rRNA and 504 subunits. We could not detect the 21-S precursor of 17-S rRNA that should be the other product of this cleavage. Therefore, we infer that this precursor is not an effective substrate for 4 0 4 subunit formation and is rapidly degraded. ITS2 has been called a pseudointron because it separates the 5.8-S RNA, which is homologous to the 5’ terminal 150 nucleotides of prokaryotic 23-S rRNA, from the 26-S rRNA sequence, equivalent to the rest of the 23-S
RIBOSOME BIOGENESIS IN YEAST
115
molecule (172).However, ITS2 must play a role at some stage of 60-S subunit formation since its complete deletion blocked rRNA processing at the stage of the 29-SB precursor equivalent, which is then degraded (171).The same result was obtained when ITS2 was only partially deleted, which shows that correct removal of ITS2 is crucial for 6 0 4 subunit formation. Since these experiments were carried out using an rDNA unit in which only the 2 6 4 rRNA gene contained a tag, we do not know the effect of the ITS2 deletions on 4 0 4 subunit biogenesis. Apart from the involvement, demonstrated by genetic analysis, of snRlO RNA and the RNA82 gene product, evidence has recently become available for involvement of three further trans-acting factors in yeast rRNA processing. Two of these factors also are snRNAs. The snR128 (U14) species appears to be required for 3 7 3 pre-rRNA processing, because its depletion causes severe underaccumulation of mature 1 7 4 rRNA and its 18-S precursor (175). Most likely, snR128 plays a role in processing at A1 or A2, although an indirect effect of this factor on rRNA maturation cannot be excluded. In contrast to the snR1O gene, the gene encoding snR128 is essential for cell viability ( 1 76). Yeast snR17 RNA is homologous to metazoan U3 snRNA and is associated in uiuo with 37-S pre-rRNA (174).Again, its gene is essential (177).While at present there is no direct evidence for a role of snR17 RNA in yeast rRNA processing, recent in uitro experiments strongly support the notion that its mammalian counterpart is involved in the first processing step that removes the 5'-terminal portion of the 5' ETS from the primary rRNA transcript (178). The in uiuo crosslinking of U 3 snRNA to the 5' ETS of both human (179) and rat (180) pre-rRNA constitutes further support for this role. It is unclear whether the yeast U 3 homolog fulfills the same function, because no equivalent cleavage within the 5' ETS of yeast 374 pre-rRNA has as yet been detected. Nine additional yeast snRNAs have been implicated in rRNA processing by virtue of their probable nucleolar localization and association with one or more precursor rRNA species (174, 176). A further trans-acting factor important for yeast pre-rRNA processing is the product of the RRPl gene, essential for cell viability (181, 182). In cells carrying the rrpl-1 temperature-sensitive mutation, processing of the 29-SB precursor appears to be blocked at 37"C, indicating the protein to be involved, directly or indirectly, in the cleavage at site C1. The precursor is subsequently degraded, in agreement with our studies of the rDNA units containing a partial deletion of ITS2. Remarkably, the same mutation also slows down the conversion of the 18-S precursor to 17-S rRNA (181). Since this conversion occurs in the cytoplasm, whereas processing of 29-SB prerRNA is a nucle(o1)arevent, it seems most likely that the RRP1 gene product affects processing indirectly, possibly because it is responsible for modifica-
116
H. A. RAU6 AND R . J . PLANTA
tion(s) in the rRNAs that play a role in this process. The fact that the rrpl-1 mutation also causes hypersensitivity to aminoglycoside antibiotics, while the gene does not seem to encode a ribosomal protein (181),supports this hypothesis. Many mutations affecting the sensitivity of ribosomes toward aminoglycosides have been mapped to 163 rRNA of E . coli and chloroplasts (183).The rrpl-1 mutation, but not a disruption of the RRPl gene, is (partially) suppressed by a second-site mutation in a locus on chromosome 111 designated SRD1 (182). Thus, either the SRDl protein interacts directly with the RRPl gene product or regulates the expression of this gene (182). The RRPl gene has been sequenced, but the deduced amino-acid sequence of the protein gives no clue to its function (182). Although it is likely that several r-proteins play a role in rRNA processing, only in the case of S37 has any evidence for such a role been reported. Lack of this r-protein retards the conversion of 20-S pre-rRNA to mature 17S rRNA (84; see also Section 111,D).
B. Modification of Pre-rRNA A second type of structural alteration introduced during maturation of pre-rRNA consists of the modification of nucleotides located at specific sites in the chain (172, 184). Most of these modifications concern 2‘-O-methylation of the ribose moiety. At a few positions, methyl groups are linked to the base. As a consequence of this modification, mature yeast 17-S and 2 6 4 rRNAs contain 22 and 43 methylated nucleotides, respectively. In addition, one hypermodified nucleotide, identified as l-methyl-2-(a-amino-a-carboxypropy1)pseudouridine (mx), is present in 17-S rRNA. Furthermore, both 1 7 4 and 2 6 4 rRNAs carry a large number of pseudouridine residues (184, 185), most of which, however, have yet to be assigned a location.N As discussed in more detail elsewhere (173), methylation starts at the level of 37-S pre-rRNA. However, most of the methyl groups are introduced at the level of the individual 18-S and 294 rRNA precursors. Modification takes place in the nucle(o)lus, except for the formation of the two 6-dimethyladenine residues near the 3’ end of the 17-S rRNA and the completion of mX, both of which occur in the cytoplasm shortly before conversion of the 18-S rRNA precursor into mature 1 7 4 rRNA. Virtually nothing is known as yet about the enzymes involved in yeast pre-rRNA modification or the way in which the specific residues to be modified are selected. The same holds true where the role of modification in the biogenesis of ribosomes is concerned. A more detailed discussion of possible roles of individual modified nucleotides in ribosome formation and function can be found in 172. 8 See “The Numerous Modified Nucleotides in Eukaryotic Ribosomal RNA,” by 9. E. H. Maden, in Vol. 39 of this series. [Eds.]
RIBOSOME BIOGENESIS IN YEAST
117
C. Modification of Ribosomal Proteins Several yeast ribosomal proteins are modified post-translationally, either by methylation (186)or by phosphorylation (187,188). Four methylated r-proteins (S31, S32, L15, and L41) have been detected. The biological relevance of this methylation is not known. Interestingly, however, we have shown L15 to be the yeast equivalent of EL11 (189),one of the most strongly methylated E. cold ribosomal proteins (190).The two proteins are part of the ribosomal GTPase center and appear to play a role in numerous ribosomal function